date generated: 2022-03-15
Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch
Here is the first few lines of the input profile.
## x
## 0610009B22Rik 0.2684894
## 0610009E02Rik -0.7521235
## 0610009L18Rik -1.1838923
## 0610010K14Rik -0.0433030
## 0610012G03Rik -0.1930476
## 0610030E20Rik 1.0496464
Here are some metrics about the input data profile:
Profile metrics | |
---|---|
num_genesets | 1604 |
num_genes_in_profile | 16805 |
duplicated_genes_present | 0 |
num_profile_genes_in_sets | 8283 |
num_profile_genes_not_in_sets | 8522 |
Here is a plot of the input profiles. Note the dynamic ranges.
Here is the contour plot of the profile including all detected genes.
Gene sets metrics | |
---|---|
num_genesets | 1604 |
num_genesets_excluded | 437 |
num_genesets_included | 1167 |
Significance is calculated by -log10(p-value). All points shown are FDR<0.05.
Significance is calculated by -log10(p-value). Top N sets shown irrespective of FDR.
set | setSize | pANOVA | s.dist | p.adjustANOVA |
---|---|---|---|---|
MET ACTIVATES RAP1 AND RAC1 | 11 | 1.04e-03 | -0.571 | 2.96e-02 |
SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | 11 | 2.15e-03 | -0.534 | 5.11e-02 |
ACTIVATION OF RAC1 | 13 | 1.76e-03 | -0.501 | 4.48e-02 |
INITIAL TRIGGERING OF COMPLEMENT | 10 | 1.00e-02 | 0.470 | 1.54e-01 |
CYTOSOLIC IRON SULFUR CLUSTER ASSEMBLY | 13 | 6.33e-03 | 0.437 | 1.15e-01 |
EUKARYOTIC TRANSLATION ELONGATION | 87 | 1.86e-12 | 0.437 | 2.18e-09 |
CREB1 PHOSPHORYLATION THROUGH THE ACTIVATION OF ADENYLATE CYCLASE | 11 | 1.22e-02 | -0.437 | 1.71e-01 |
NF KB IS ACTIVATED AND SIGNALS SURVIVAL | 13 | 6.81e-03 | 0.433 | 1.22e-01 |
ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | 16 | 2.78e-03 | 0.432 | 6.36e-02 |
SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | 20 | 9.09e-04 | 0.428 | 2.65e-02 |
SCAVENGING BY CLASS A RECEPTORS | 14 | 7.55e-03 | 0.412 | 1.31e-01 |
SEROTONIN RECEPTORS | 10 | 2.92e-02 | -0.398 | 2.96e-01 |
COLLAGEN CHAIN TRIMERIZATION | 40 | 1.46e-05 | 0.396 | 8.12e-04 |
SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | 16 | 6.15e-03 | -0.396 | 1.14e-01 |
REGULATION OF INNATE IMMUNE RESPONSES TO CYTOSOLIC DNA | 13 | 1.89e-02 | 0.376 | 2.27e-01 |
RESPONSE OF EIF2AK4 GCN2 TO AMINO ACID DEFICIENCY | 94 | 3.75e-10 | 0.374 | 7.95e-08 |
ALPHA LINOLENIC OMEGA3 AND LINOLEIC OMEGA6 ACID METABOLISM | 12 | 2.77e-02 | 0.367 | 2.92e-01 |
COLLAGEN BIOSYNTHESIS AND MODIFYING ENZYMES | 63 | 9.65e-07 | 0.357 | 7.04e-05 |
NONSENSE MEDIATED DECAY NMD | 109 | 4.09e-10 | 0.347 | 7.95e-08 |
AGGREPHAGY | 35 | 5.20e-04 | 0.339 | 1.64e-02 |
ASSEMBLY OF ACTIVE LPL AND LIPC LIPASE COMPLEXES | 10 | 6.37e-02 | -0.339 | 4.49e-01 |
COMPLEMENT CASCADE | 22 | 6.03e-03 | 0.338 | 1.14e-01 |
ROLE OF PHOSPHOLIPIDS IN PHAGOCYTOSIS | 22 | 6.03e-03 | 0.338 | 1.14e-01 |
MECP2 REGULATES NEURONAL RECEPTORS AND CHANNELS | 18 | 1.32e-02 | -0.337 | 1.80e-01 |
CROSSLINKING OF COLLAGEN FIBRILS | 14 | 2.90e-02 | 0.337 | 2.96e-01 |
SEMA4D IN SEMAPHORIN SIGNALING | 24 | 4.68e-03 | 0.334 | 9.76e-02 |
ESTROGEN DEPENDENT NUCLEAR EVENTS DOWNSTREAM OF ESR MEMBRANE SIGNALING | 21 | 8.55e-03 | -0.332 | 1.39e-01 |
SELENOAMINO ACID METABOLISM | 108 | 2.69e-09 | 0.331 | 4.36e-07 |
P75NTR SIGNALS VIA NF KB | 16 | 2.50e-02 | 0.324 | 2.73e-01 |
ABERRANT REGULATION OF MITOTIC G1 S TRANSITION IN CANCER DUE TO RB1 DEFECTS | 17 | 2.25e-02 | -0.320 | 2.57e-01 |
CASPASE ACTIVATION VIA DEPENDENCE RECEPTORS IN THE ABSENCE OF LIGAND | 10 | 8.06e-02 | -0.319 | 4.80e-01 |
ASSEMBLY OF COLLAGEN FIBRILS AND OTHER MULTIMERIC STRUCTURES | 51 | 8.18e-05 | 0.319 | 3.54e-03 |
SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 106 | 1.55e-08 | 0.318 | 1.81e-06 |
FERTILIZATION | 12 | 5.67e-02 | 0.318 | 4.34e-01 |
POST CHAPERONIN TUBULIN FOLDING PATHWAY | 17 | 2.36e-02 | 0.317 | 2.62e-01 |
TRANSPORT OF CONNEXONS TO THE PLASMA MEMBRANE | 13 | 4.78e-02 | 0.317 | 3.87e-01 |
CD28 DEPENDENT VAV1 PATHWAY | 11 | 6.87e-02 | -0.317 | 4.49e-01 |
NOTCH2 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 11 | 7.08e-02 | -0.315 | 4.49e-01 |
INSULIN PROCESSING | 24 | 7.89e-03 | -0.313 | 1.32e-01 |
RHO GTPASES ACTIVATE ROCKS | 19 | 1.84e-02 | 0.313 | 2.27e-01 |
PEXOPHAGY | 11 | 7.55e-02 | 0.310 | 4.68e-01 |
TIGHT JUNCTION INTERACTIONS | 18 | 2.31e-02 | -0.309 | 2.60e-01 |
E2F MEDIATED REGULATION OF DNA REPLICATION | 19 | 2.05e-02 | -0.307 | 2.36e-01 |
P75NTR RECRUITS SIGNALLING COMPLEXES | 13 | 5.53e-02 | 0.307 | 4.27e-01 |
RNA POLYMERASE II TRANSCRIPTION TERMINATION | 65 | 1.88e-05 | 0.307 | 9.98e-04 |
REDUCTION OF CYTOSOLIC CA LEVELS | 11 | 8.04e-02 | -0.304 | 4.80e-01 |
COLLAGEN DEGRADATION | 51 | 1.87e-04 | 0.303 | 7.26e-03 |
LYSOSPHINGOLIPID AND LPA RECEPTORS | 12 | 7.02e-02 | -0.302 | 4.49e-01 |
CGMP EFFECTS | 15 | 4.32e-02 | -0.301 | 3.71e-01 |
SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | 13 | 6.02e-02 | 0.301 | 4.47e-01 |
set | setSize | pANOVA | s.dist | p.adjustANOVA |
---|---|---|---|---|
MET ACTIVATES RAP1 AND RAC1 | 11 | 1.04e-03 | -5.71e-01 | 2.96e-02 |
SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | 11 | 2.15e-03 | -5.34e-01 | 5.11e-02 |
ACTIVATION OF RAC1 | 13 | 1.76e-03 | -5.01e-01 | 4.48e-02 |
INITIAL TRIGGERING OF COMPLEMENT | 10 | 1.00e-02 | 4.70e-01 | 1.54e-01 |
CYTOSOLIC IRON SULFUR CLUSTER ASSEMBLY | 13 | 6.33e-03 | 4.37e-01 | 1.15e-01 |
EUKARYOTIC TRANSLATION ELONGATION | 87 | 1.86e-12 | 4.37e-01 | 2.18e-09 |
CREB1 PHOSPHORYLATION THROUGH THE ACTIVATION OF ADENYLATE CYCLASE | 11 | 1.22e-02 | -4.37e-01 | 1.71e-01 |
NF KB IS ACTIVATED AND SIGNALS SURVIVAL | 13 | 6.81e-03 | 4.33e-01 | 1.22e-01 |
ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | 16 | 2.78e-03 | 4.32e-01 | 6.36e-02 |
SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | 20 | 9.09e-04 | 4.28e-01 | 2.65e-02 |
SCAVENGING BY CLASS A RECEPTORS | 14 | 7.55e-03 | 4.12e-01 | 1.31e-01 |
SEROTONIN RECEPTORS | 10 | 2.92e-02 | -3.98e-01 | 2.96e-01 |
COLLAGEN CHAIN TRIMERIZATION | 40 | 1.46e-05 | 3.96e-01 | 8.12e-04 |
SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | 16 | 6.15e-03 | -3.96e-01 | 1.14e-01 |
REGULATION OF INNATE IMMUNE RESPONSES TO CYTOSOLIC DNA | 13 | 1.89e-02 | 3.76e-01 | 2.27e-01 |
RESPONSE OF EIF2AK4 GCN2 TO AMINO ACID DEFICIENCY | 94 | 3.75e-10 | 3.74e-01 | 7.95e-08 |
ALPHA LINOLENIC OMEGA3 AND LINOLEIC OMEGA6 ACID METABOLISM | 12 | 2.77e-02 | 3.67e-01 | 2.92e-01 |
COLLAGEN BIOSYNTHESIS AND MODIFYING ENZYMES | 63 | 9.65e-07 | 3.57e-01 | 7.04e-05 |
NONSENSE MEDIATED DECAY NMD | 109 | 4.09e-10 | 3.47e-01 | 7.95e-08 |
AGGREPHAGY | 35 | 5.20e-04 | 3.39e-01 | 1.64e-02 |
ASSEMBLY OF ACTIVE LPL AND LIPC LIPASE COMPLEXES | 10 | 6.37e-02 | -3.39e-01 | 4.49e-01 |
COMPLEMENT CASCADE | 22 | 6.03e-03 | 3.38e-01 | 1.14e-01 |
ROLE OF PHOSPHOLIPIDS IN PHAGOCYTOSIS | 22 | 6.03e-03 | 3.38e-01 | 1.14e-01 |
MECP2 REGULATES NEURONAL RECEPTORS AND CHANNELS | 18 | 1.32e-02 | -3.37e-01 | 1.80e-01 |
CROSSLINKING OF COLLAGEN FIBRILS | 14 | 2.90e-02 | 3.37e-01 | 2.96e-01 |
SEMA4D IN SEMAPHORIN SIGNALING | 24 | 4.68e-03 | 3.34e-01 | 9.76e-02 |
ESTROGEN DEPENDENT NUCLEAR EVENTS DOWNSTREAM OF ESR MEMBRANE SIGNALING | 21 | 8.55e-03 | -3.32e-01 | 1.39e-01 |
SELENOAMINO ACID METABOLISM | 108 | 2.69e-09 | 3.31e-01 | 4.36e-07 |
P75NTR SIGNALS VIA NF KB | 16 | 2.50e-02 | 3.24e-01 | 2.73e-01 |
ABERRANT REGULATION OF MITOTIC G1 S TRANSITION IN CANCER DUE TO RB1 DEFECTS | 17 | 2.25e-02 | -3.20e-01 | 2.57e-01 |
CASPASE ACTIVATION VIA DEPENDENCE RECEPTORS IN THE ABSENCE OF LIGAND | 10 | 8.06e-02 | -3.19e-01 | 4.80e-01 |
ASSEMBLY OF COLLAGEN FIBRILS AND OTHER MULTIMERIC STRUCTURES | 51 | 8.18e-05 | 3.19e-01 | 3.54e-03 |
SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 106 | 1.55e-08 | 3.18e-01 | 1.81e-06 |
FERTILIZATION | 12 | 5.67e-02 | 3.18e-01 | 4.34e-01 |
POST CHAPERONIN TUBULIN FOLDING PATHWAY | 17 | 2.36e-02 | 3.17e-01 | 2.62e-01 |
TRANSPORT OF CONNEXONS TO THE PLASMA MEMBRANE | 13 | 4.78e-02 | 3.17e-01 | 3.87e-01 |
CD28 DEPENDENT VAV1 PATHWAY | 11 | 6.87e-02 | -3.17e-01 | 4.49e-01 |
NOTCH2 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 11 | 7.08e-02 | -3.15e-01 | 4.49e-01 |
INSULIN PROCESSING | 24 | 7.89e-03 | -3.13e-01 | 1.32e-01 |
RHO GTPASES ACTIVATE ROCKS | 19 | 1.84e-02 | 3.13e-01 | 2.27e-01 |
PEXOPHAGY | 11 | 7.55e-02 | 3.10e-01 | 4.68e-01 |
TIGHT JUNCTION INTERACTIONS | 18 | 2.31e-02 | -3.09e-01 | 2.60e-01 |
E2F MEDIATED REGULATION OF DNA REPLICATION | 19 | 2.05e-02 | -3.07e-01 | 2.36e-01 |
P75NTR RECRUITS SIGNALLING COMPLEXES | 13 | 5.53e-02 | 3.07e-01 | 4.27e-01 |
RNA POLYMERASE II TRANSCRIPTION TERMINATION | 65 | 1.88e-05 | 3.07e-01 | 9.98e-04 |
REDUCTION OF CYTOSOLIC CA LEVELS | 11 | 8.04e-02 | -3.04e-01 | 4.80e-01 |
COLLAGEN DEGRADATION | 51 | 1.87e-04 | 3.03e-01 | 7.26e-03 |
LYSOSPHINGOLIPID AND LPA RECEPTORS | 12 | 7.02e-02 | -3.02e-01 | 4.49e-01 |
CGMP EFFECTS | 15 | 4.32e-02 | -3.01e-01 | 3.71e-01 |
SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | 13 | 6.02e-02 | 3.01e-01 | 4.47e-01 |
COLLAGEN FORMATION | 79 | 3.88e-06 | 3.01e-01 | 2.66e-04 |
ACTIVATION OF SMO | 16 | 3.76e-02 | 3.00e-01 | 3.48e-01 |
EUKARYOTIC TRANSLATION INITIATION | 114 | 3.30e-08 | 3.00e-01 | 3.20e-06 |
JOSEPHIN DOMAIN DUBS | 11 | 8.80e-02 | 2.97e-01 | 4.84e-01 |
CYTOSOLIC TRNA AMINOACYLATION | 24 | 1.18e-02 | 2.97e-01 | 1.71e-01 |
PROCESSING AND ACTIVATION OF SUMO | 10 | 1.05e-01 | -2.96e-01 | 5.28e-01 |
NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | 11 | 9.01e-02 | 2.95e-01 | 4.86e-01 |
REGULATION OF IFNG SIGNALING | 13 | 6.66e-02 | -2.94e-01 | 4.49e-01 |
INTERFERON ALPHA BETA SIGNALING | 52 | 2.54e-04 | -2.93e-01 | 9.25e-03 |
ECM PROTEOGLYCANS | 65 | 4.38e-05 | 2.93e-01 | 2.04e-03 |
GLUTAMATE AND GLUTAMINE METABOLISM | 13 | 6.74e-02 | 2.93e-01 | 4.49e-01 |
PYRIMIDINE SALVAGE | 10 | 1.12e-01 | -2.90e-01 | 5.39e-01 |
COMPLEX I BIOGENESIS | 56 | 1.82e-04 | 2.89e-01 | 7.26e-03 |
MET ACTIVATES PTK2 SIGNALING | 29 | 7.19e-03 | 2.88e-01 | 1.27e-01 |
SMOOTH MUSCLE CONTRACTION | 33 | 4.28e-03 | 2.87e-01 | 9.24e-02 |
INTERLEUKIN 37 SIGNALING | 19 | 3.17e-02 | 2.85e-01 | 3.05e-01 |
ACTIVATION OF BAD AND TRANSLOCATION TO MITOCHONDRIA | 15 | 5.89e-02 | -2.82e-01 | 4.40e-01 |
STING MEDIATED INDUCTION OF HOST IMMUNE RESPONSES | 14 | 6.86e-02 | 2.81e-01 | 4.49e-01 |
MOLECULES ASSOCIATED WITH ELASTIC FIBRES | 32 | 5.94e-03 | 2.81e-01 | 1.14e-01 |
THE CANONICAL RETINOID CYCLE IN RODS TWILIGHT VISION | 14 | 6.91e-02 | -2.81e-01 | 4.49e-01 |
MITOCHONDRIAL IRON SULFUR CLUSTER BIOGENESIS | 13 | 8.12e-02 | 2.79e-01 | 4.81e-01 |
FGFR2 LIGAND BINDING AND ACTIVATION | 12 | 9.80e-02 | 2.76e-01 | 5.06e-01 |
MRNA SPLICING | 188 | 8.46e-11 | 2.75e-01 | 2.47e-08 |
ELASTIC FIBRE FORMATION | 37 | 3.89e-03 | 2.74e-01 | 8.59e-02 |
CAMK IV MEDIATED PHOSPHORYLATION OF CREB | 10 | 1.35e-01 | -2.73e-01 | 5.60e-01 |
TICAM1 DEPENDENT ACTIVATION OF IRF3 IRF7 | 12 | 1.02e-01 | 2.72e-01 | 5.22e-01 |
NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | 20 | 3.56e-02 | -2.71e-01 | 3.32e-01 |
PYRIMIDINE CATABOLISM | 10 | 1.37e-01 | -2.71e-01 | 5.60e-01 |
REGULATION OF LOCALIZATION OF FOXO TRANSCRIPTION FACTORS | 12 | 1.05e-01 | -2.70e-01 | 5.28e-01 |
CS DS DEGRADATION | 14 | 8.37e-02 | 2.67e-01 | 4.84e-01 |
ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | 59 | 4.46e-04 | 2.64e-01 | 1.45e-02 |
CELL CELL JUNCTION ORGANIZATION | 50 | 1.31e-03 | -2.63e-01 | 3.56e-02 |
REGULATION OF EXPRESSION OF SLITS AND ROBOS | 160 | 1.22e-08 | 2.61e-01 | 1.59e-06 |
NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | 12 | 1.19e-01 | -2.60e-01 | 5.54e-01 |
SEALING OF THE NUCLEAR ENVELOPE NE BY ESCRT III | 23 | 3.15e-02 | 2.59e-01 | 3.05e-01 |
PROLONGED ERK ACTIVATION EVENTS | 14 | 9.57e-02 | -2.57e-01 | 4.99e-01 |
HSF1 DEPENDENT TRANSACTIVATION | 34 | 9.65e-03 | 2.57e-01 | 1.50e-01 |
P75NTR REGULATES AXONOGENESIS | 10 | 1.60e-01 | -2.56e-01 | 6.02e-01 |
CYTOCHROME C MEDIATED APOPTOTIC RESPONSE | 12 | 1.25e-01 | -2.56e-01 | 5.56e-01 |
GOLGI CISTERNAE PERICENTRIOLAR STACK REORGANIZATION | 11 | 1.48e-01 | -2.52e-01 | 5.78e-01 |
DISEASES OF DNA REPAIR | 11 | 1.53e-01 | 2.49e-01 | 5.87e-01 |
PHOSPHOLIPASE C MEDIATED CASCADE FGFR2 | 11 | 1.56e-01 | 2.47e-01 | 5.91e-01 |
RHO GTPASES ACTIVATE CIT | 18 | 7.04e-02 | 2.46e-01 | 4.49e-01 |
SYNDECAN INTERACTIONS | 26 | 3.06e-02 | 2.45e-01 | 3.05e-01 |
RMTS METHYLATE HISTONE ARGININES | 42 | 6.13e-03 | 2.44e-01 | 1.14e-01 |
RAP1 SIGNALLING | 15 | 1.01e-01 | -2.44e-01 | 5.18e-01 |
REGULATION OF COMMISSURAL AXON PATHFINDING BY SLIT AND ROBO | 10 | 1.82e-01 | -2.44e-01 | 6.38e-01 |
BIOTIN TRANSPORT AND METABOLISM | 11 | 1.64e-01 | 2.42e-01 | 6.08e-01 |
CELLULAR RESPONSE TO STARVATION | 145 | 5.19e-07 | 2.42e-01 | 4.33e-05 |
CHK1 CHK2 CDS1 MEDIATED INACTIVATION OF CYCLIN B CDK1 COMPLEX | 10 | 1.86e-01 | -2.42e-01 | 6.43e-01 |
CHAPERONE MEDIATED AUTOPHAGY | 20 | 6.19e-02 | 2.41e-01 | 4.49e-01 |
AMINE LIGAND BINDING RECEPTORS | 31 | 2.04e-02 | -2.41e-01 | 2.36e-01 |
ATTENUATION PHASE | 24 | 4.16e-02 | 2.40e-01 | 3.60e-01 |
SYNTHESIS OF BILE ACIDS AND BILE SALTS | 22 | 5.42e-02 | 2.37e-01 | 4.24e-01 |
MISCELLANEOUS TRANSPORT AND BINDING EVENTS | 20 | 6.66e-02 | -2.37e-01 | 4.49e-01 |
RAB GERANYLGERANYLATION | 57 | 2.00e-03 | -2.37e-01 | 4.96e-02 |
IRF3 MEDIATED INDUCTION OF TYPE I IFN | 11 | 1.75e-01 | 2.36e-01 | 6.24e-01 |
SIGNALING BY KIT IN DISEASE | 20 | 6.81e-02 | -2.36e-01 | 4.49e-01 |
POLO LIKE KINASE MEDIATED EVENTS | 13 | 1.44e-01 | 2.34e-01 | 5.71e-01 |
REPRESSION OF WNT TARGET GENES | 14 | 1.30e-01 | 2.34e-01 | 5.60e-01 |
SIGNALING BY FLT3 FUSION PROTEINS | 18 | 8.66e-02 | -2.33e-01 | 4.84e-01 |
ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | 34 | 1.88e-02 | -2.33e-01 | 2.27e-01 |
RRNA PROCESSING | 194 | 3.06e-08 | 2.31e-01 | 3.20e-06 |
HOMOLOGOUS DNA PAIRING AND STRAND EXCHANGE | 40 | 1.16e-02 | -2.31e-01 | 1.71e-01 |
DISEASES OF MITOTIC CELL CYCLE | 37 | 1.53e-02 | -2.31e-01 | 1.98e-01 |
REGULATION OF KIT SIGNALING | 16 | 1.14e-01 | -2.28e-01 | 5.39e-01 |
CD28 CO STIMULATION | 30 | 3.09e-02 | -2.28e-01 | 3.05e-01 |
G BETA GAMMA SIGNALLING THROUGH CDC42 | 18 | 9.45e-02 | -2.28e-01 | 4.97e-01 |
ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 12 | 19 | 8.60e-02 | -2.28e-01 | 4.84e-01 |
ATF6 ATF6 ALPHA ACTIVATES CHAPERONE GENES | 10 | 2.13e-01 | 2.27e-01 | 6.59e-01 |
DNA DAMAGE BYPASS | 46 | 7.61e-03 | -2.27e-01 | 1.31e-01 |
ACTIVATION OF THE PRE REPLICATIVE COMPLEX | 29 | 3.41e-02 | -2.27e-01 | 3.24e-01 |
GAP JUNCTION ASSEMBLY | 21 | 7.25e-02 | 2.26e-01 | 4.57e-01 |
TRANSLATION | 286 | 5.63e-11 | 2.26e-01 | 2.19e-08 |
REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | 15 | 1.33e-01 | -2.24e-01 | 5.60e-01 |
PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | 237 | 2.99e-09 | 2.24e-01 | 4.36e-07 |
MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | 31 | 3.11e-02 | -2.24e-01 | 3.05e-01 |
WNT LIGAND BIOGENESIS AND TRAFFICKING | 21 | 7.62e-02 | -2.24e-01 | 4.70e-01 |
NOTCH HLH TRANSCRIPTION PATHWAY | 28 | 4.15e-02 | 2.23e-01 | 3.60e-01 |
GRB2 EVENTS IN ERBB2 SIGNALING | 15 | 1.37e-01 | -2.22e-01 | 5.60e-01 |
INTERFERON GAMMA SIGNALING | 73 | 1.07e-03 | -2.22e-01 | 2.96e-02 |
SYNTHESIS OF ACTIVE UBIQUITIN ROLES OF E1 AND E2 ENZYMES | 29 | 3.89e-02 | -2.22e-01 | 3.54e-01 |
TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | 79 | 7.24e-04 | 2.20e-01 | 2.22e-02 |
SIGNALING BY HIPPO | 20 | 8.88e-02 | -2.20e-01 | 4.84e-01 |
UNWINDING OF DNA | 12 | 1.89e-01 | -2.19e-01 | 6.43e-01 |
IRE1ALPHA ACTIVATES CHAPERONES | 49 | 8.28e-03 | 2.18e-01 | 1.36e-01 |
ANCHORING FIBRIL FORMATION | 13 | 1.77e-01 | 2.16e-01 | 6.28e-01 |
REGULATION OF TP53 ACTIVITY THROUGH ASSOCIATION WITH CO FACTORS | 11 | 2.15e-01 | 2.16e-01 | 6.63e-01 |
SUMOYLATION OF INTRACELLULAR RECEPTORS | 26 | 5.73e-02 | -2.15e-01 | 4.34e-01 |
DISEASES ASSOCIATED WITH N GLYCOSYLATION OF PROTEINS | 17 | 1.24e-01 | -2.15e-01 | 5.56e-01 |
ADHERENS JUNCTIONS INTERACTIONS | 30 | 4.15e-02 | -2.15e-01 | 3.60e-01 |
PRE NOTCH PROCESSING IN GOLGI | 17 | 1.25e-01 | 2.15e-01 | 5.56e-01 |
MET ACTIVATES RAS SIGNALING | 10 | 2.42e-01 | -2.14e-01 | 6.78e-01 |
MITOCHONDRIAL TRANSLATION | 93 | 3.68e-04 | 2.14e-01 | 1.26e-02 |
SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | 15 | 1.52e-01 | -2.14e-01 | 5.84e-01 |
BINDING AND UPTAKE OF LIGANDS BY SCAVENGER RECEPTORS | 31 | 3.94e-02 | 2.14e-01 | 3.54e-01 |
MRNA SPLICING MINOR PATHWAY | 52 | 8.72e-03 | 2.10e-01 | 1.39e-01 |
SHC MEDIATED CASCADE FGFR3 | 12 | 2.09e-01 | 2.10e-01 | 6.56e-01 |
INFLUENZA INFECTION | 145 | 1.34e-05 | 2.10e-01 | 7.81e-04 |
BETA CATENIN PHOSPHORYLATION CASCADE | 16 | 1.47e-01 | -2.09e-01 | 5.77e-01 |
RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | 125 | 5.38e-05 | 2.09e-01 | 2.41e-03 |
IL 6 TYPE CYTOKINE RECEPTOR LIGAND INTERACTIONS | 13 | 1.93e-01 | 2.09e-01 | 6.45e-01 |
ADENYLATE CYCLASE ACTIVATING PATHWAY | 10 | 2.54e-01 | 2.08e-01 | 6.89e-01 |
RECEPTOR TYPE TYROSINE PROTEIN PHOSPHATASES | 20 | 1.07e-01 | -2.08e-01 | 5.33e-01 |
TP53 REGULATES TRANSCRIPTION OF SEVERAL ADDITIONAL CELL DEATH GENES WHOSE SPECIFIC ROLES IN P53 DEPENDENT APOPTOSIS REMAIN UNCERTAIN | 11 | 2.33e-01 | 2.08e-01 | 6.72e-01 |
DARPP 32 EVENTS | 23 | 8.77e-02 | -2.06e-01 | 4.84e-01 |
NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | 21 | 1.03e-01 | -2.05e-01 | 5.22e-01 |
KERATAN SULFATE DEGRADATION | 11 | 2.39e-01 | 2.05e-01 | 6.77e-01 |
RESPIRATORY ELECTRON TRANSPORT | 102 | 3.79e-04 | 2.04e-01 | 1.26e-02 |
TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX WITHIN TLR4 COMPLEX | 15 | 1.73e-01 | 2.03e-01 | 6.21e-01 |
CASPASE ACTIVATION VIA DEATH RECEPTORS IN THE PRESENCE OF LIGAND | 13 | 2.08e-01 | 2.02e-01 | 6.56e-01 |
GABA RECEPTOR ACTIVATION | 52 | 1.21e-02 | -2.01e-01 | 1.71e-01 |
NEGATIVE REGULATORS OF DDX58 IFIH1 SIGNALING | 33 | 4.57e-02 | -2.01e-01 | 3.84e-01 |
UNBLOCKING OF NMDA RECEPTORS GLUTAMATE BINDING AND ACTIVATION | 21 | 1.11e-01 | -2.01e-01 | 5.39e-01 |
CD28 DEPENDENT PI3K AKT SIGNALING | 20 | 1.20e-01 | -2.01e-01 | 5.56e-01 |
DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | 13 | 2.11e-01 | 2.00e-01 | 6.59e-01 |
GLYCOGEN METABOLISM | 25 | 8.59e-02 | 1.98e-01 | 4.84e-01 |
REGULATION OF IFNA SIGNALING | 12 | 2.34e-01 | -1.98e-01 | 6.72e-01 |
SIGNALING BY FGFR4 IN DISEASE | 10 | 2.81e-01 | -1.97e-01 | 7.03e-01 |
PROCESSING OF INTRONLESS PRE MRNAS | 19 | 1.38e-01 | 1.97e-01 | 5.60e-01 |
SIGNALING BY FLT3 ITD AND TKD MUTANTS | 15 | 1.90e-01 | -1.96e-01 | 6.43e-01 |
LYSINE CATABOLISM | 11 | 2.62e-01 | 1.95e-01 | 6.95e-01 |
POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | 59 | 9.49e-03 | -1.95e-01 | 1.50e-01 |
TRNA AMINOACYLATION | 42 | 2.86e-02 | 1.95e-01 | 2.95e-01 |
NF KB ACTIVATION THROUGH FADD RIP 1 PATHWAY MEDIATED BY CASPASE 8 AND 10 | 11 | 2.62e-01 | -1.95e-01 | 6.95e-01 |
TNFS BIND THEIR PHYSIOLOGICAL RECEPTORS | 13 | 2.23e-01 | 1.95e-01 | 6.69e-01 |
ABERRANT REGULATION OF MITOTIC EXIT IN CANCER DUE TO RB1 DEFECTS | 19 | 1.42e-01 | -1.94e-01 | 5.67e-01 |
SIGNALING BY CTNNB1 PHOSPHO SITE MUTANTS | 15 | 1.93e-01 | -1.94e-01 | 6.45e-01 |
INTERFERON SIGNALING | 160 | 2.26e-05 | -1.94e-01 | 1.10e-03 |
TRANSCRIPTIONAL REGULATION OF PLURIPOTENT STEM CELLS | 15 | 1.94e-01 | 1.94e-01 | 6.45e-01 |
RHO GTPASES ACTIVATE WASPS AND WAVES | 36 | 4.43e-02 | -1.94e-01 | 3.78e-01 |
SYNTHESIS OF PROSTAGLANDINS PG AND THROMBOXANES TX | 13 | 2.29e-01 | 1.93e-01 | 6.72e-01 |
DEACTIVATION OF THE BETA CATENIN TRANSACTIVATING COMPLEX | 41 | 3.31e-02 | 1.92e-01 | 3.16e-01 |
TERMINATION OF O GLYCAN BIOSYNTHESIS | 10 | 2.93e-01 | 1.92e-01 | 7.06e-01 |
SIGNALING BY FGFR3 FUSIONS IN CANCER | 10 | 2.94e-01 | -1.92e-01 | 7.07e-01 |
PYRUVATE METABOLISM | 27 | 8.61e-02 | -1.91e-01 | 4.84e-01 |
NON INTEGRIN MEMBRANE ECM INTERACTIONS | 55 | 1.45e-02 | 1.91e-01 | 1.91e-01 |
MITOTIC TELOPHASE CYTOKINESIS | 13 | 2.35e-01 | 1.90e-01 | 6.72e-01 |
DERMATAN SULFATE BIOSYNTHESIS | 11 | 2.80e-01 | 1.88e-01 | 7.03e-01 |
REGULATION OF GLYCOLYSIS BY FRUCTOSE 2 6 BISPHOSPHATE METABOLISM | 11 | 2.81e-01 | -1.88e-01 | 7.03e-01 |
NCAM1 INTERACTIONS | 40 | 4.00e-02 | 1.88e-01 | 3.54e-01 |
SIGNALING BY ACTIVIN | 12 | 2.62e-01 | -1.87e-01 | 6.95e-01 |
SHC1 EVENTS IN EGFR SIGNALING | 11 | 2.83e-01 | -1.87e-01 | 7.03e-01 |
RUNX2 REGULATES OSTEOBLAST DIFFERENTIATION | 23 | 1.22e-01 | -1.86e-01 | 5.56e-01 |
RNA POLYMERASE I TRANSCRIPTION INITIATION | 47 | 2.72e-02 | 1.86e-01 | 2.91e-01 |
LGI ADAM INTERACTIONS | 14 | 2.28e-01 | 1.86e-01 | 6.72e-01 |
IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | 10 | 3.10e-01 | -1.85e-01 | 7.33e-01 |
ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | 17 | 1.87e-01 | 1.85e-01 | 6.43e-01 |
DEPOLYMERISATION OF THE NUCLEAR LAMINA | 12 | 2.69e-01 | -1.84e-01 | 7.01e-01 |
GAP JUNCTION TRAFFICKING AND REGULATION | 33 | 6.86e-02 | 1.83e-01 | 4.49e-01 |
DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | 23 | 1.29e-01 | -1.83e-01 | 5.60e-01 |
ZBP1 DAI MEDIATED INDUCTION OF TYPE I IFNS | 18 | 1.79e-01 | 1.83e-01 | 6.34e-01 |
PI 3K CASCADE FGFR3 | 12 | 2.75e-01 | 1.82e-01 | 7.03e-01 |
PINK1 PRKN MEDIATED MITOPHAGY | 22 | 1.39e-01 | 1.82e-01 | 5.62e-01 |
METABOLISM OF AMINO ACIDS AND DERIVATIVES | 310 | 3.82e-08 | 1.82e-01 | 3.43e-06 |
GOLGI ASSOCIATED VESICLE BIOGENESIS | 55 | 2.01e-02 | -1.81e-01 | 2.36e-01 |
BILE ACID AND BILE SALT METABOLISM | 25 | 1.20e-01 | 1.80e-01 | 5.56e-01 |
GLYCOGEN STORAGE DISEASES | 12 | 2.81e-01 | 1.80e-01 | 7.03e-01 |
GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | 14 | 2.45e-01 | 1.80e-01 | 6.85e-01 |
DEFECTIVE B4GALT7 CAUSES EDS PROGEROID TYPE | 20 | 1.65e-01 | 1.79e-01 | 6.08e-01 |
SIGNALING BY PDGFRA TRANSMEMBRANE JUXTAMEMBRANE AND KINASE DOMAIN MUTANTS | 12 | 2.82e-01 | -1.79e-01 | 7.03e-01 |
ABORTIVE ELONGATION OF HIV 1 TRANSCRIPT IN THE ABSENCE OF TAT | 23 | 1.37e-01 | 1.79e-01 | 5.60e-01 |
TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN G2 CELL CYCLE ARREST | 15 | 2.32e-01 | 1.78e-01 | 6.72e-01 |
TERMINATION OF TRANSLESION DNA SYNTHESIS | 30 | 9.12e-02 | -1.78e-01 | 4.87e-01 |
G PROTEIN BETA GAMMA SIGNALLING | 30 | 9.14e-02 | -1.78e-01 | 4.87e-01 |
ACTIVATION OF MATRIX METALLOPROTEINASES | 14 | 2.50e-01 | -1.78e-01 | 6.88e-01 |
HDR THROUGH MMEJ ALT NHEJ | 10 | 3.31e-01 | 1.77e-01 | 7.42e-01 |
LATE ENDOSOMAL MICROAUTOPHAGY | 31 | 8.74e-02 | 1.77e-01 | 4.84e-01 |
PROCESSING OF SMDT1 | 16 | 2.19e-01 | -1.77e-01 | 6.68e-01 |
CYCLIN D ASSOCIATED EVENTS IN G1 | 45 | 3.98e-02 | -1.77e-01 | 3.54e-01 |
SIGNALING BY BMP | 24 | 1.33e-01 | -1.77e-01 | 5.60e-01 |
PLATELET CALCIUM HOMEOSTASIS | 25 | 1.26e-01 | -1.77e-01 | 5.57e-01 |
ACTIVATION OF BH3 ONLY PROTEINS | 28 | 1.08e-01 | -1.76e-01 | 5.34e-01 |
RESOLUTION OF D LOOP STRUCTURES THROUGH SYNTHESIS DEPENDENT STRAND ANNEALING SDSA | 24 | 1.37e-01 | -1.75e-01 | 5.60e-01 |
SODIUM CALCIUM EXCHANGERS | 10 | 3.38e-01 | -1.75e-01 | 7.42e-01 |
COPII MEDIATED VESICLE TRANSPORT | 66 | 1.40e-02 | -1.75e-01 | 1.86e-01 |
MATURATION OF SARS COV 2 SPIKE PROTEIN | 29 | 1.03e-01 | -1.75e-01 | 5.22e-01 |
INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | 13 | 2.76e-01 | -1.74e-01 | 7.03e-01 |
CELLULAR HEXOSE TRANSPORT | 11 | 3.17e-01 | -1.74e-01 | 7.36e-01 |
RHOA GTPASE CYCLE | 143 | 3.25e-04 | 1.74e-01 | 1.15e-02 |
SYNTHESIS OF IP3 AND IP4 IN THE CYTOSOL | 26 | 1.24e-01 | 1.74e-01 | 5.56e-01 |
DOWNSTREAM SIGNALING OF ACTIVATED FGFR3 | 19 | 1.89e-01 | 1.74e-01 | 6.43e-01 |
FGFR2 ALTERNATIVE SPLICING | 26 | 1.25e-01 | 1.74e-01 | 5.56e-01 |
SIGNALING BY ROBO RECEPTORS | 205 | 2.25e-05 | 1.72e-01 | 1.10e-03 |
TRISTETRAPROLIN TTP ZFP36 BINDS AND DESTABILIZES MRNA | 16 | 2.35e-01 | -1.72e-01 | 6.72e-01 |
INTERLEUKIN 27 SIGNALING | 10 | 3.50e-01 | 1.71e-01 | 7.50e-01 |
PHASE I FUNCTIONALIZATION OF COMPOUNDS | 60 | 2.27e-02 | 1.70e-01 | 2.57e-01 |
LONG TERM POTENTIATION | 23 | 1.59e-01 | -1.70e-01 | 6.00e-01 |
INTERLEUKIN RECEPTOR SHC SIGNALING | 20 | 1.89e-01 | 1.70e-01 | 6.43e-01 |
INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | 19 | 2.01e-01 | -1.69e-01 | 6.51e-01 |
ANTIMICROBIAL PEPTIDES | 13 | 2.91e-01 | 1.69e-01 | 7.05e-01 |
INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | 28 | 1.21e-01 | -1.69e-01 | 5.56e-01 |
SELECTIVE AUTOPHAGY | 72 | 1.32e-02 | 1.69e-01 | 1.80e-01 |
ENDOGENOUS STEROLS | 21 | 1.81e-01 | 1.69e-01 | 6.36e-01 |
O LINKED GLYCOSYLATION OF MUCINS | 41 | 6.31e-02 | -1.68e-01 | 4.49e-01 |
ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | 11 | 3.37e-01 | -1.67e-01 | 7.42e-01 |
PHASE 0 RAPID DEPOLARISATION | 31 | 1.07e-01 | -1.67e-01 | 5.33e-01 |
TRANSLESION SYNTHESIS BY Y FAMILY DNA POLYMERASES BYPASSES LESIONS ON DNA TEMPLATE | 37 | 7.85e-02 | -1.67e-01 | 4.77e-01 |
HSP90 CHAPERONE CYCLE FOR STEROID HORMONE RECEPTORS SHR | 48 | 4.52e-02 | 1.67e-01 | 3.82e-01 |
N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | 23 | 1.67e-01 | -1.66e-01 | 6.10e-01 |
EXTRA NUCLEAR ESTROGEN SIGNALING | 67 | 1.88e-02 | -1.66e-01 | 2.27e-01 |
PURINE CATABOLISM | 16 | 2.51e-01 | 1.66e-01 | 6.88e-01 |
COOPERATION OF PREFOLDIN AND TRIC CCT IN ACTIN AND TUBULIN FOLDING | 26 | 1.45e-01 | 1.65e-01 | 5.72e-01 |
MATURATION OF NUCLEOPROTEIN | 10 | 3.68e-01 | -1.64e-01 | 7.67e-01 |
EXTRACELLULAR MATRIX ORGANIZATION | 242 | 1.17e-05 | 1.64e-01 | 7.17e-04 |
REGULATION OF FOXO TRANSCRIPTIONAL ACTIVITY BY ACETYLATION | 10 | 3.70e-01 | -1.64e-01 | 7.67e-01 |
N GLYCAN ANTENNAE ELONGATION | 15 | 2.80e-01 | -1.61e-01 | 7.03e-01 |
PI3K EVENTS IN ERBB2 SIGNALING | 15 | 2.82e-01 | -1.60e-01 | 7.03e-01 |
TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | 13 | 3.18e-01 | 1.60e-01 | 7.37e-01 |
METABOLIC DISORDERS OF BIOLOGICAL OXIDATION ENZYMES | 21 | 2.05e-01 | 1.60e-01 | 6.53e-01 |
FORMATION OF APOPTOSOME | 10 | 3.82e-01 | -1.60e-01 | 7.74e-01 |
COMMON PATHWAY OF FIBRIN CLOT FORMATION | 11 | 3.62e-01 | 1.59e-01 | 7.63e-01 |
DISEASES ASSOCIATED WITH GLYCOSAMINOGLYCAN METABOLISM | 39 | 8.69e-02 | 1.58e-01 | 4.84e-01 |
LAMININ INTERACTIONS | 27 | 1.55e-01 | 1.58e-01 | 5.91e-01 |
G2 M DNA DAMAGE CHECKPOINT | 65 | 2.83e-02 | -1.57e-01 | 2.95e-01 |
CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | 34 | 1.14e-01 | 1.57e-01 | 5.39e-01 |
ACTIVATED NTRK2 SIGNALS THROUGH FRS2 AND FRS3 | 10 | 3.92e-01 | -1.56e-01 | 7.76e-01 |
FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | 19 | 2.38e-01 | 1.56e-01 | 6.75e-01 |
CYTOSOLIC SENSORS OF PATHOGEN ASSOCIATED DNA | 59 | 3.78e-02 | 1.56e-01 | 3.48e-01 |
METABOLISM OF RNA | 643 | 1.67e-11 | 1.56e-01 | 9.75e-09 |
SIALIC ACID METABOLISM | 32 | 1.27e-01 | -1.56e-01 | 5.60e-01 |
THE NLRP3 INFLAMMASOME | 15 | 3.00e-01 | -1.55e-01 | 7.16e-01 |
GROWTH HORMONE RECEPTOR SIGNALING | 20 | 2.32e-01 | -1.54e-01 | 6.72e-01 |
SYNTHESIS OF LEUKOTRIENES LT AND EOXINS EX | 13 | 3.37e-01 | 1.54e-01 | 7.42e-01 |
INTEGRIN CELL SURFACE INTERACTIONS | 69 | 2.75e-02 | 1.54e-01 | 2.92e-01 |
SHC1 EVENTS IN ERBB4 SIGNALING | 13 | 3.38e-01 | -1.53e-01 | 7.42e-01 |
RHO GTPASES ACTIVATE PAKS | 21 | 2.24e-01 | 1.53e-01 | 6.69e-01 |
PKA MEDIATED PHOSPHORYLATION OF CREB | 19 | 2.49e-01 | -1.53e-01 | 6.88e-01 |
RHOC GTPASE CYCLE | 73 | 2.46e-02 | 1.52e-01 | 2.70e-01 |
SYNTHESIS SECRETION AND INACTIVATION OF GLUCAGON LIKE PEPTIDE 1 GLP 1 | 12 | 3.63e-01 | -1.52e-01 | 7.63e-01 |
ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | 285 | 1.11e-05 | -1.52e-01 | 7.17e-04 |
ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | 73 | 2.56e-02 | -1.51e-01 | 2.76e-01 |
FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | 18 | 2.67e-01 | 1.51e-01 | 7.01e-01 |
ACYL CHAIN REMODELLING OF PS | 14 | 3.28e-01 | -1.51e-01 | 7.42e-01 |
NEGATIVE REGULATION OF TCF DEPENDENT SIGNALING BY WNT LIGAND ANTAGONISTS | 11 | 3.88e-01 | -1.50e-01 | 7.74e-01 |
REGULATION OF TP53 ACTIVITY THROUGH METHYLATION | 18 | 2.70e-01 | 1.50e-01 | 7.01e-01 |
INLB MEDIATED ENTRY OF LISTERIA MONOCYTOGENES INTO HOST CELL | 15 | 3.14e-01 | -1.50e-01 | 7.36e-01 |
GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | 16 | 2.99e-01 | -1.50e-01 | 7.16e-01 |
CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | 19 | 2.59e-01 | -1.50e-01 | 6.92e-01 |
PENTOSE PHOSPHATE PATHWAY | 13 | 3.50e-01 | -1.50e-01 | 7.50e-01 |
G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | 23 | 2.15e-01 | -1.49e-01 | 6.63e-01 |
HEME SIGNALING | 45 | 8.34e-02 | -1.49e-01 | 4.84e-01 |
CDC42 GTPASE CYCLE | 153 | 1.46e-03 | 1.49e-01 | 3.88e-02 |
RHOBTB2 GTPASE CYCLE | 23 | 2.16e-01 | 1.49e-01 | 6.63e-01 |
FORMATION OF THE CORNIFIED ENVELOPE | 29 | 1.66e-01 | 1.49e-01 | 6.08e-01 |
KERATINIZATION | 29 | 1.66e-01 | 1.49e-01 | 6.08e-01 |
TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | 17 | 2.90e-01 | -1.48e-01 | 7.05e-01 |
PREGNENOLONE BIOSYNTHESIS | 12 | 3.75e-01 | 1.48e-01 | 7.72e-01 |
LISTERIA MONOCYTOGENES ENTRY INTO HOST CELLS | 20 | 2.53e-01 | -1.48e-01 | 6.88e-01 |
ROLE OF LAT2 NTAL LAB ON CALCIUM MOBILIZATION | 14 | 3.39e-01 | -1.48e-01 | 7.42e-01 |
P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | 12 | 3.76e-01 | 1.48e-01 | 7.72e-01 |
AUF1 HNRNP D0 BINDS AND DESTABILIZES MRNA | 53 | 6.37e-02 | 1.47e-01 | 4.49e-01 |
ACTIVATION OF THE AP 1 FAMILY OF TRANSCRIPTION FACTORS | 10 | 4.21e-01 | -1.47e-01 | 7.94e-01 |
ERK MAPK TARGETS | 22 | 2.35e-01 | -1.46e-01 | 6.72e-01 |
HDACS DEACETYLATE HISTONES | 45 | 8.97e-02 | 1.46e-01 | 4.86e-01 |
FRS MEDIATED FGFR3 SIGNALING | 14 | 3.44e-01 | 1.46e-01 | 7.49e-01 |
TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | 16 | 3.12e-01 | 1.46e-01 | 7.33e-01 |
VOLTAGE GATED POTASSIUM CHANNELS | 40 | 1.11e-01 | -1.46e-01 | 5.39e-01 |
RHOBTB3 ATPASE CYCLE | 10 | 4.25e-01 | -1.46e-01 | 7.94e-01 |
DISEASES OF IMMUNE SYSTEM | 23 | 2.30e-01 | 1.45e-01 | 6.72e-01 |
BUTYRATE RESPONSE FACTOR 1 BRF1 BINDS AND DESTABILIZES MRNA | 16 | 3.17e-01 | -1.45e-01 | 7.36e-01 |
ERBB2 REGULATES CELL MOTILITY | 14 | 3.50e-01 | -1.44e-01 | 7.50e-01 |
RNA POLYMERASE I TRANSCRIPTION TERMINATION | 31 | 1.65e-01 | 1.44e-01 | 6.08e-01 |
INTERLEUKIN 10 SIGNALING | 18 | 2.90e-01 | -1.44e-01 | 7.05e-01 |
MITOPHAGY | 29 | 1.83e-01 | 1.43e-01 | 6.40e-01 |
COSTIMULATION BY THE CD28 FAMILY | 50 | 8.17e-02 | -1.42e-01 | 4.82e-01 |
CA DEPENDENT EVENTS | 36 | 1.40e-01 | -1.42e-01 | 5.62e-01 |
GLUTATHIONE SYNTHESIS AND RECYCLING | 11 | 4.14e-01 | 1.42e-01 | 7.92e-01 |
DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | 26 | 2.10e-01 | -1.42e-01 | 6.59e-01 |
TP53 REGULATES TRANSCRIPTION OF ADDITIONAL CELL CYCLE GENES WHOSE EXACT ROLE IN THE P53 PATHWAY REMAIN UNCERTAIN | 20 | 2.73e-01 | -1.42e-01 | 7.02e-01 |
CA2 PATHWAY | 56 | 6.69e-02 | -1.42e-01 | 4.49e-01 |
DEGRADATION OF THE EXTRACELLULAR MATRIX | 107 | 1.17e-02 | 1.41e-01 | 1.71e-01 |
DEADENYLATION OF MRNA | 25 | 2.22e-01 | -1.41e-01 | 6.69e-01 |
ANCHORING OF THE BASAL BODY TO THE PLASMA MEMBRANE | 96 | 1.70e-02 | 1.41e-01 | 2.15e-01 |
DAP12 SIGNALING | 24 | 2.32e-01 | -1.41e-01 | 6.72e-01 |
TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | 43 | 1.10e-01 | -1.41e-01 | 5.39e-01 |
CHEMOKINE RECEPTORS BIND CHEMOKINES | 15 | 3.45e-01 | -1.41e-01 | 7.50e-01 |
PROCESSING OF CAPPED INTRONLESS PRE MRNA | 28 | 1.97e-01 | 1.41e-01 | 6.45e-01 |
RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 1 PROMOTER | 28 | 1.99e-01 | 1.40e-01 | 6.46e-01 |
FOXO MEDIATED TRANSCRIPTION OF OXIDATIVE STRESS METABOLIC AND NEURONAL GENES | 25 | 2.26e-01 | -1.40e-01 | 6.71e-01 |
PLATELET ADHESION TO EXPOSED COLLAGEN | 12 | 4.04e-01 | 1.39e-01 | 7.85e-01 |
EPH EPHRIN MEDIATED REPULSION OF CELLS | 49 | 9.23e-02 | -1.39e-01 | 4.90e-01 |
INCRETIN SYNTHESIS SECRETION AND INACTIVATION | 13 | 3.86e-01 | -1.39e-01 | 7.74e-01 |
THE ROLE OF GTSE1 IN G2 M PROGRESSION AFTER G2 CHECKPOINT | 66 | 5.20e-02 | 1.38e-01 | 4.13e-01 |
PROTEIN UBIQUITINATION | 69 | 4.77e-02 | -1.38e-01 | 3.87e-01 |
NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | 59 | 6.80e-02 | -1.37e-01 | 4.49e-01 |
MET RECEPTOR RECYCLING | 10 | 4.52e-01 | -1.37e-01 | 8.10e-01 |
CELL EXTRACELLULAR MATRIX INTERACTIONS | 18 | 3.16e-01 | 1.36e-01 | 7.36e-01 |
THE ROLE OF NEF IN HIV 1 REPLICATION AND DISEASE PATHOGENESIS | 27 | 2.21e-01 | -1.36e-01 | 6.69e-01 |
SEMA3A PAK DEPENDENT AXON REPULSION | 16 | 3.47e-01 | -1.36e-01 | 7.50e-01 |
HEDGEHOG ON STATE | 82 | 3.48e-02 | 1.35e-01 | 3.27e-01 |
HEDGEHOG OFF STATE | 106 | 1.67e-02 | 1.35e-01 | 2.15e-01 |
POSITIVE EPIGENETIC REGULATION OF RRNA EXPRESSION | 62 | 6.77e-02 | 1.34e-01 | 4.49e-01 |
SIGNALING BY SCF KIT | 41 | 1.38e-01 | -1.34e-01 | 5.60e-01 |
ERKS ARE INACTIVATED | 13 | 4.03e-01 | -1.34e-01 | 7.85e-01 |
ERBB2 ACTIVATES PTK6 SIGNALING | 11 | 4.42e-01 | -1.34e-01 | 8.00e-01 |
CLEC7A DECTIN 1 INDUCES NFAT ACTIVATION | 11 | 4.42e-01 | -1.34e-01 | 8.00e-01 |
THE CITRIC ACID TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | 172 | 2.55e-03 | 1.34e-01 | 5.95e-02 |
CONSTITUTIVE SIGNALING BY OVEREXPRESSED ERBB2 | 11 | 4.44e-01 | -1.33e-01 | 8.02e-01 |
REGULATION OF TNFR1 SIGNALING | 34 | 1.80e-01 | 1.33e-01 | 6.36e-01 |
NGF STIMULATED TRANSCRIPTION | 37 | 1.63e-01 | -1.33e-01 | 6.08e-01 |
RUNX1 INTERACTS WITH CO FACTORS WHOSE PRECISE EFFECT ON RUNX1 TARGETS IS NOT KNOWN | 37 | 1.64e-01 | 1.32e-01 | 6.08e-01 |
RHO GTPASES ACTIVATE IQGAPS | 24 | 2.63e-01 | 1.32e-01 | 6.95e-01 |
SIGNALING BY WNT IN CANCER | 31 | 2.03e-01 | -1.32e-01 | 6.52e-01 |
ACYL CHAIN REMODELLING OF PE | 16 | 3.61e-01 | -1.32e-01 | 7.63e-01 |
HEME BIOSYNTHESIS | 13 | 4.10e-01 | -1.32e-01 | 7.90e-01 |
FORMATION OF THE BETA CATENIN TCF TRANSACTIVATING COMPLEX | 46 | 1.22e-01 | 1.32e-01 | 5.56e-01 |
HEDGEHOG LIGAND BIOGENESIS | 61 | 7.71e-02 | 1.31e-01 | 4.73e-01 |
ERCC6 CSB AND EHMT2 G9A POSITIVELY REGULATE RRNA EXPRESSION | 32 | 2.01e-01 | 1.31e-01 | 6.50e-01 |
INTERLEUKIN 6 FAMILY SIGNALING | 19 | 3.26e-01 | 1.30e-01 | 7.42e-01 |
CELL JUNCTION ORGANIZATION | 75 | 5.14e-02 | -1.30e-01 | 4.11e-01 |
RHOB GTPASE CYCLE | 67 | 6.63e-02 | 1.30e-01 | 4.49e-01 |
BLOOD GROUP SYSTEMS BIOSYNTHESIS | 13 | 4.18e-01 | -1.30e-01 | 7.93e-01 |
MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | 15 | 3.85e-01 | 1.30e-01 | 7.74e-01 |
HIV ELONGATION ARREST AND RECOVERY | 32 | 2.06e-01 | 1.29e-01 | 6.53e-01 |
CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | 46 | 1.30e-01 | 1.29e-01 | 5.60e-01 |
OLFACTORY SIGNALING PATHWAY | 26 | 2.57e-01 | 1.28e-01 | 6.92e-01 |
RNA POLYMERASE I TRANSCRIPTION | 67 | 7.08e-02 | 1.28e-01 | 4.49e-01 |
ACETYLCHOLINE REGULATES INSULIN SECRETION | 10 | 4.85e-01 | 1.28e-01 | 8.33e-01 |
INTRA GOLGI TRAFFIC | 43 | 1.48e-01 | -1.28e-01 | 5.78e-01 |
AKT PHOSPHORYLATES TARGETS IN THE NUCLEUS | 10 | 4.85e-01 | -1.28e-01 | 8.33e-01 |
TRANSCRIPTIONAL REGULATION BY MECP2 | 60 | 8.83e-02 | -1.27e-01 | 4.84e-01 |
DISEASES OF CARBOHYDRATE METABOLISM | 29 | 2.36e-01 | 1.27e-01 | 6.74e-01 |
SUMOYLATION OF CHROMATIN ORGANIZATION PROTEINS | 57 | 9.72e-02 | -1.27e-01 | 5.04e-01 |
CRISTAE FORMATION | 31 | 2.21e-01 | 1.27e-01 | 6.69e-01 |
RECOGNITION OF DNA DAMAGE BY PCNA CONTAINING REPLICATION COMPLEX | 29 | 2.40e-01 | -1.26e-01 | 6.77e-01 |
ACTIVATION OF NMDA RECEPTORS AND POSTSYNAPTIC EVENTS | 83 | 4.75e-02 | -1.26e-01 | 3.87e-01 |
HDR THROUGH HOMOLOGOUS RECOMBINATION HRR | 62 | 8.80e-02 | -1.25e-01 | 4.84e-01 |
PROCESSING OF DNA DOUBLE STRAND BREAK ENDS | 71 | 6.84e-02 | -1.25e-01 | 4.49e-01 |
METAL ION SLC TRANSPORTERS | 24 | 2.89e-01 | -1.25e-01 | 7.05e-01 |
RHOBTB GTPASE CYCLE | 35 | 2.03e-01 | 1.24e-01 | 6.52e-01 |
ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | 32 | 2.26e-01 | 1.24e-01 | 6.71e-01 |
CREB1 PHOSPHORYLATION THROUGH NMDA RECEPTOR MEDIATED ACTIVATION OF RAS SIGNALING | 28 | 2.58e-01 | -1.24e-01 | 6.92e-01 |
CARBOXYTERMINAL POST TRANSLATIONAL MODIFICATIONS OF TUBULIN | 34 | 2.12e-01 | 1.24e-01 | 6.59e-01 |
PHOSPHORYLATION OF THE APC C | 17 | 3.78e-01 | -1.24e-01 | 7.74e-01 |
SHC1 EVENTS IN ERBB2 SIGNALING | 21 | 3.28e-01 | -1.23e-01 | 7.42e-01 |
SIGNALING BY NTRK3 TRKC | 17 | 3.79e-01 | 1.23e-01 | 7.74e-01 |
RESOLUTION OF ABASIC SITES AP SITES | 37 | 1.95e-01 | 1.23e-01 | 6.45e-01 |
TRANSLATION OF SARS COV 2 STRUCTURAL PROTEINS | 44 | 1.58e-01 | -1.23e-01 | 6.00e-01 |
NEUROTRANSMITTER RECEPTORS AND POSTSYNAPTIC SIGNAL TRANSMISSION | 175 | 5.11e-03 | -1.23e-01 | 1.05e-01 |
IRAK1 RECRUITS IKK COMPLEX | 14 | 4.27e-01 | 1.23e-01 | 7.94e-01 |
SIGNALING BY HEDGEHOG | 141 | 1.20e-02 | 1.23e-01 | 1.71e-01 |
RIP MEDIATED NFKB ACTIVATION VIA ZBP1 | 15 | 4.12e-01 | 1.22e-01 | 7.90e-01 |
BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | 76 | 6.54e-02 | -1.22e-01 | 4.49e-01 |
SIGNALING BY PDGF | 56 | 1.13e-01 | 1.22e-01 | 5.39e-01 |
PLATELET HOMEOSTASIS | 76 | 6.57e-02 | -1.22e-01 | 4.49e-01 |
REGULATION OF INSULIN LIKE GROWTH FACTOR IGF TRANSPORT AND UPTAKE BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | 89 | 4.72e-02 | 1.22e-01 | 3.87e-01 |
MET PROMOTES CELL MOTILITY | 39 | 1.89e-01 | 1.22e-01 | 6.43e-01 |
NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | 17 | 3.85e-01 | 1.22e-01 | 7.74e-01 |
STRIATED MUSCLE CONTRACTION | 27 | 2.78e-01 | 1.21e-01 | 7.03e-01 |
INACTIVATION OF CSF3 G CSF SIGNALING | 24 | 3.08e-01 | -1.20e-01 | 7.28e-01 |
SIGNALING BY NOTCH1 HD DOMAIN MUTANTS IN CANCER | 15 | 4.21e-01 | 1.20e-01 | 7.94e-01 |
PLASMA LIPOPROTEIN REMODELING | 17 | 3.91e-01 | -1.20e-01 | 7.76e-01 |
METHYLATION | 11 | 4.91e-01 | 1.20e-01 | 8.40e-01 |
SIGNALING BY MET | 75 | 7.31e-02 | 1.20e-01 | 4.59e-01 |
CILIUM ASSEMBLY | 189 | 4.61e-03 | 1.20e-01 | 9.76e-02 |
DAP12 INTERACTIONS | 29 | 2.68e-01 | -1.19e-01 | 7.01e-01 |
INTERLEUKIN 15 SIGNALING | 12 | 4.76e-01 | -1.19e-01 | 8.26e-01 |
SIGNALING BY FGFR2 | 64 | 1.01e-01 | 1.19e-01 | 5.18e-01 |
SIGNALING BY NTRK2 TRKB | 24 | 3.15e-01 | -1.19e-01 | 7.36e-01 |
DEGRADATION OF DVL | 55 | 1.29e-01 | 1.18e-01 | 5.60e-01 |
REGULATION OF RUNX3 EXPRESSION AND ACTIVITY | 53 | 1.36e-01 | 1.18e-01 | 5.60e-01 |
NS1 MEDIATED EFFECTS ON HOST PATHWAYS | 37 | 2.17e-01 | -1.17e-01 | 6.63e-01 |
GLUCONEOGENESIS | 27 | 2.93e-01 | 1.17e-01 | 7.06e-01 |
GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | 18 | 3.91e-01 | 1.17e-01 | 7.76e-01 |
BBSOME MEDIATED CARGO TARGETING TO CILIUM | 23 | 3.33e-01 | 1.17e-01 | 7.42e-01 |
ACYL CHAIN REMODELLING OF PG | 10 | 5.23e-01 | -1.17e-01 | 8.60e-01 |
UNFOLDED PROTEIN RESPONSE UPR | 85 | 6.41e-02 | 1.16e-01 | 4.49e-01 |
NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | 43 | 1.87e-01 | -1.16e-01 | 6.43e-01 |
REGULATION OF TP53 ACTIVITY THROUGH ACETYLATION | 30 | 2.71e-01 | 1.16e-01 | 7.02e-01 |
CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | 342 | 2.29e-04 | -1.16e-01 | 8.62e-03 |
CARNITINE METABOLISM | 14 | 4.52e-01 | -1.16e-01 | 8.10e-01 |
TP53 REGULATES TRANSCRIPTION OF CASPASE ACTIVATORS AND CASPASES | 10 | 5.26e-01 | -1.16e-01 | 8.60e-01 |
SIGNALING BY CSF3 G CSF | 29 | 2.82e-01 | -1.15e-01 | 7.03e-01 |
KINESINS | 47 | 1.72e-01 | 1.15e-01 | 6.21e-01 |
EPHB MEDIATED FORWARD SIGNALING | 42 | 1.98e-01 | -1.15e-01 | 6.45e-01 |
AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | 25 | 3.22e-01 | -1.14e-01 | 7.41e-01 |
EARLY PHASE OF HIV LIFE CYCLE | 14 | 4.59e-01 | -1.14e-01 | 8.11e-01 |
RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | 85 | 6.92e-02 | 1.14e-01 | 4.49e-01 |
NRAGE SIGNALS DEATH THROUGH JNK | 56 | 1.41e-01 | 1.14e-01 | 5.65e-01 |
RAF ACTIVATION | 34 | 2.52e-01 | -1.14e-01 | 6.88e-01 |
PEPTIDE HORMONE METABOLISM | 59 | 1.34e-01 | -1.13e-01 | 5.60e-01 |
CARGO CONCENTRATION IN THE ER | 31 | 2.80e-01 | -1.12e-01 | 7.03e-01 |
NEPHRIN FAMILY INTERACTIONS | 22 | 3.64e-01 | 1.12e-01 | 7.63e-01 |
FORMATION OF RNA POL II ELONGATION COMPLEX | 57 | 1.45e-01 | 1.12e-01 | 5.72e-01 |
MICRORNA MIRNA BIOGENESIS | 24 | 3.45e-01 | 1.11e-01 | 7.50e-01 |
OTHER SEMAPHORIN INTERACTIONS | 19 | 4.00e-01 | -1.11e-01 | 7.83e-01 |
FOXO MEDIATED TRANSCRIPTION | 60 | 1.36e-01 | -1.11e-01 | 5.60e-01 |
POTASSIUM CHANNELS | 90 | 6.87e-02 | -1.11e-01 | 4.49e-01 |
RAC1 GTPASE CYCLE | 177 | 1.12e-02 | 1.11e-01 | 1.70e-01 |
SLC TRANSPORTER DISORDERS | 69 | 1.12e-01 | -1.11e-01 | 5.39e-01 |
RHOU GTPASE CYCLE | 33 | 2.72e-01 | -1.11e-01 | 7.02e-01 |
SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | 14 | 4.74e-01 | 1.10e-01 | 8.25e-01 |
IRON UPTAKE AND TRANSPORT | 51 | 1.73e-01 | -1.10e-01 | 6.21e-01 |
ADRENALINE NORADRENALINE INHIBITS INSULIN SECRETION | 26 | 3.33e-01 | -1.10e-01 | 7.42e-01 |
DCC MEDIATED ATTRACTIVE SIGNALING | 14 | 4.78e-01 | -1.09e-01 | 8.28e-01 |
NEGATIVE REGULATION OF FLT3 | 14 | 4.78e-01 | 1.09e-01 | 8.28e-01 |
HSF1 ACTIVATION | 26 | 3.35e-01 | 1.09e-01 | 7.42e-01 |
SUMOYLATION OF RNA BINDING PROTEINS | 45 | 2.05e-01 | -1.09e-01 | 6.53e-01 |
GLYOXYLATE METABOLISM AND GLYCINE DEGRADATION | 25 | 3.46e-01 | 1.09e-01 | 7.50e-01 |
NEDDYLATION | 217 | 5.82e-03 | -1.09e-01 | 1.14e-01 |
KILLING MECHANISMS | 10 | 5.52e-01 | 1.08e-01 | 8.72e-01 |
TNFR2 NON CANONICAL NF KB PATHWAY | 80 | 9.36e-02 | 1.08e-01 | 4.94e-01 |
RND1 GTPASE CYCLE | 38 | 2.48e-01 | -1.08e-01 | 6.88e-01 |
ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | 23 | 3.69e-01 | -1.08e-01 | 7.67e-01 |
RESOLUTION OF D LOOP STRUCTURES | 30 | 3.05e-01 | -1.08e-01 | 7.26e-01 |
PURINERGIC SIGNALING IN LEISHMANIASIS INFECTION | 22 | 3.80e-01 | -1.08e-01 | 7.74e-01 |
GAP JUNCTION DEGRADATION | 11 | 5.38e-01 | 1.07e-01 | 8.66e-01 |
INSULIN RECEPTOR RECYCLING | 20 | 4.09e-01 | -1.07e-01 | 7.89e-01 |
O LINKED GLYCOSYLATION | 86 | 8.77e-02 | -1.07e-01 | 4.84e-01 |
FLT3 SIGNALING | 36 | 2.69e-01 | -1.06e-01 | 7.01e-01 |
ALPHA PROTEIN KINASE 1 SIGNALING PATHWAY | 11 | 5.43e-01 | 1.06e-01 | 8.71e-01 |
SIGNALING BY ERBB2 IN CANCER | 25 | 3.59e-01 | -1.06e-01 | 7.62e-01 |
EGFR DOWNREGULATION | 28 | 3.34e-01 | -1.06e-01 | 7.42e-01 |
DDX58 IFIH1 MEDIATED INDUCTION OF INTERFERON ALPHA BETA | 63 | 1.50e-01 | -1.05e-01 | 5.79e-01 |
SENSORY PROCESSING OF SOUND BY OUTER HAIR CELLS OF THE COCHLEA | 41 | 2.45e-01 | 1.05e-01 | 6.85e-01 |
SIGNALING BY PDGFR IN DISEASE | 20 | 4.18e-01 | -1.05e-01 | 7.93e-01 |
E3 UBIQUITIN LIGASES UBIQUITINATE TARGET PROTEINS | 50 | 2.02e-01 | -1.04e-01 | 6.51e-01 |
TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | 30 | 3.25e-01 | 1.04e-01 | 7.42e-01 |
INTERLEUKIN 7 SIGNALING | 20 | 4.23e-01 | -1.03e-01 | 7.94e-01 |
COHESIN LOADING ONTO CHROMATIN | 10 | 5.73e-01 | 1.03e-01 | 8.80e-01 |
G ALPHA I SIGNALLING EVENTS | 193 | 1.39e-02 | -1.03e-01 | 1.86e-01 |
TICAM1 RIP1 MEDIATED IKK COMPLEX RECRUITMENT | 18 | 4.51e-01 | -1.03e-01 | 8.10e-01 |
ROLE OF SECOND MESSENGERS IN NETRIN 1 SIGNALING | 10 | 5.74e-01 | -1.03e-01 | 8.80e-01 |
MEIOTIC RECOMBINATION | 38 | 2.75e-01 | -1.02e-01 | 7.03e-01 |
RRNA MODIFICATION IN THE NUCLEUS AND CYTOSOL | 59 | 1.75e-01 | 1.02e-01 | 6.24e-01 |
STABILIZATION OF P53 | 54 | 1.95e-01 | 1.02e-01 | 6.45e-01 |
CYTOPROTECTION BY HMOX1 | 119 | 5.50e-02 | 1.02e-01 | 4.27e-01 |
METABOLISM OF FOLATE AND PTERINES | 15 | 4.95e-01 | 1.02e-01 | 8.44e-01 |
BASE EXCISION REPAIR | 56 | 1.89e-01 | 1.02e-01 | 6.43e-01 |
SIGNALING BY TGF BETA RECEPTOR COMPLEX | 72 | 1.37e-01 | -1.01e-01 | 5.60e-01 |
REGULATION OF PLK1 ACTIVITY AT G2 M TRANSITION | 84 | 1.09e-01 | 1.01e-01 | 5.36e-01 |
IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | 45 | 2.41e-01 | 1.01e-01 | 6.77e-01 |
DEGRADATION OF GLI1 BY THE PROTEASOME | 57 | 1.87e-01 | 1.01e-01 | 6.43e-01 |
HCMV EARLY EVENTS | 79 | 1.21e-01 | 1.01e-01 | 5.56e-01 |
SENSORY PROCESSING OF SOUND | 61 | 1.73e-01 | 1.01e-01 | 6.21e-01 |
TELOMERE C STRAND SYNTHESIS INITIATION | 13 | 5.29e-01 | 1.01e-01 | 8.61e-01 |
CARGO TRAFFICKING TO THE PERICILIARY MEMBRANE | 49 | 2.24e-01 | 1.00e-01 | 6.69e-01 |
ORGANELLE BIOGENESIS AND MAINTENANCE | 281 | 3.90e-03 | 1.00e-01 | 8.59e-02 |
INTEGRIN SIGNALING | 24 | 3.96e-01 | 1.00e-01 | 7.79e-01 |
FORMATION OF SENESCENCE ASSOCIATED HETEROCHROMATIN FOCI SAHF | 12 | 5.48e-01 | -1.00e-01 | 8.71e-01 |
METABOLISM OF ANGIOTENSINOGEN TO ANGIOTENSINS | 10 | 5.84e-01 | 1.00e-01 | 8.80e-01 |
PEROXISOMAL PROTEIN IMPORT | 57 | 1.93e-01 | -9.98e-02 | 6.45e-01 |
SIGNALING BY TGFB FAMILY MEMBERS | 96 | 9.58e-02 | -9.84e-02 | 4.99e-01 |
NOTCH4 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 12 | 5.55e-01 | -9.84e-02 | 8.73e-01 |
CHOLESTEROL BIOSYNTHESIS | 24 | 4.05e-01 | -9.83e-02 | 7.85e-01 |
SIGNALLING TO ERKS | 34 | 3.22e-01 | -9.82e-02 | 7.41e-01 |
RNA POLYMERASE III CHAIN ELONGATION | 18 | 4.71e-01 | 9.81e-02 | 8.21e-01 |
CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | 12 | 5.57e-01 | 9.80e-02 | 8.74e-01 |
CELLULAR RESPONSE TO CHEMICAL STRESS | 149 | 3.97e-02 | 9.77e-02 | 3.54e-01 |
ATF6 ATF6 ALPHA ACTIVATES CHAPERONES | 12 | 5.59e-01 | 9.73e-02 | 8.77e-01 |
THE PHOTOTRANSDUCTION CASCADE | 21 | 4.41e-01 | -9.71e-02 | 8.00e-01 |
PLASMA LIPOPROTEIN ASSEMBLY | 13 | 5.45e-01 | -9.71e-02 | 8.71e-01 |
SULFUR AMINO ACID METABOLISM | 22 | 4.32e-01 | 9.69e-02 | 7.94e-01 |
RHOBTB1 GTPASE CYCLE | 23 | 4.22e-01 | 9.67e-02 | 7.94e-01 |
INTERLEUKIN 17 SIGNALING | 66 | 1.75e-01 | -9.66e-02 | 6.24e-01 |
PLATELET AGGREGATION PLUG FORMATION | 33 | 3.38e-01 | 9.64e-02 | 7.42e-01 |
SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | 62 | 1.90e-01 | -9.62e-02 | 6.43e-01 |
OVARIAN TUMOR DOMAIN PROTEASES | 36 | 3.18e-01 | -9.61e-02 | 7.37e-01 |
GLYCOGEN SYNTHESIS | 14 | 5.36e-01 | 9.56e-02 | 8.66e-01 |
MITOTIC PROPHASE | 92 | 1.13e-01 | -9.56e-02 | 5.39e-01 |
CARGO RECOGNITION FOR CLATHRIN MEDIATED ENDOCYTOSIS | 93 | 1.13e-01 | -9.53e-02 | 5.39e-01 |
NETRIN 1 SIGNALING | 49 | 2.49e-01 | -9.51e-02 | 6.88e-01 |
POTENTIAL THERAPEUTICS FOR SARS | 76 | 1.53e-01 | 9.49e-02 | 5.86e-01 |
ASSEMBLY OF THE HIV VIRION | 16 | 5.13e-01 | 9.46e-02 | 8.55e-01 |
ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | 28 | 3.87e-01 | -9.45e-02 | 7.74e-01 |
RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | 78 | 1.49e-01 | 9.44e-02 | 5.79e-01 |
MITOCHONDRIAL PROTEIN IMPORT | 63 | 1.96e-01 | 9.43e-02 | 6.45e-01 |
POLYMERASE SWITCHING ON THE C STRAND OF THE TELOMERE | 25 | 4.15e-01 | 9.42e-02 | 7.93e-01 |
AUTOPHAGY | 138 | 5.71e-02 | 9.39e-02 | 4.34e-01 |
FGFR2 MUTANT RECEPTOR ACTIVATION | 26 | 4.08e-01 | 9.38e-02 | 7.89e-01 |
INWARDLY RECTIFYING K CHANNELS | 31 | 3.70e-01 | -9.30e-02 | 7.67e-01 |
A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | 26 | 4.13e-01 | 9.27e-02 | 7.92e-01 |
SUMOYLATION OF DNA DAMAGE RESPONSE AND REPAIR PROTEINS | 73 | 1.71e-01 | -9.27e-02 | 6.21e-01 |
DOWNSTREAM SIGNALING OF ACTIVATED FGFR4 | 17 | 5.09e-01 | 9.26e-02 | 8.52e-01 |
INSERTION OF TAIL ANCHORED PROTEINS INTO THE ENDOPLASMIC RETICULUM MEMBRANE | 22 | 4.52e-01 | -9.26e-02 | 8.10e-01 |
NUCLEOTIDE SALVAGE | 21 | 4.64e-01 | -9.24e-02 | 8.14e-01 |
HDR THROUGH SINGLE STRAND ANNEALING SSA | 36 | 3.38e-01 | -9.24e-02 | 7.42e-01 |
PROTEIN FOLDING | 89 | 1.33e-01 | 9.22e-02 | 5.60e-01 |
GAP FILLING DNA REPAIR SYNTHESIS AND LIGATION IN GG NER | 24 | 4.35e-01 | 9.22e-02 | 7.95e-01 |
CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | 12 | 5.81e-01 | -9.20e-02 | 8.80e-01 |
BIOLOGICAL OXIDATIONS | 123 | 7.89e-02 | 9.18e-02 | 4.77e-01 |
ZINC TRANSPORTERS | 15 | 5.39e-01 | -9.15e-02 | 8.67e-01 |
BASE EXCISION REPAIR AP SITE FORMATION | 29 | 3.95e-01 | 9.13e-02 | 7.79e-01 |
CELLULAR RESPONSES TO EXTERNAL STIMULI | 597 | 1.52e-04 | 9.11e-02 | 6.34e-03 |
DEGRADATION OF AXIN | 53 | 2.52e-01 | 9.10e-02 | 6.88e-01 |
TRANSLATION OF REPLICASE AND ASSEMBLY OF THE REPLICATION TRANSCRIPTION COMPLEX | 12 | 5.86e-01 | 9.08e-02 | 8.80e-01 |
FORMATION OF THE EARLY ELONGATION COMPLEX | 33 | 3.69e-01 | 9.04e-02 | 7.67e-01 |
MEIOTIC SYNAPSIS | 39 | 3.30e-01 | 9.02e-02 | 7.42e-01 |
INTERLEUKIN 1 FAMILY SIGNALING | 124 | 8.46e-02 | 8.98e-02 | 4.84e-01 |
TRANSFERRIN ENDOCYTOSIS AND RECYCLING | 26 | 4.29e-01 | -8.96e-02 | 7.94e-01 |
TRANSCRIPTION OF E2F TARGETS UNDER NEGATIVE CONTROL BY DREAM COMPLEX | 17 | 5.23e-01 | -8.95e-02 | 8.60e-01 |
SIGNALING BY NTRKS | 131 | 7.75e-02 | -8.94e-02 | 4.73e-01 |
ABC TRANSPORTER DISORDERS | 71 | 1.93e-01 | 8.94e-02 | 6.45e-01 |
NEGATIVE REGULATION OF FGFR3 SIGNALING | 23 | 4.59e-01 | 8.93e-02 | 8.11e-01 |
DUAL INCISION IN GG NER | 40 | 3.29e-01 | 8.93e-02 | 7.42e-01 |
CITRIC ACID CYCLE TCA CYCLE | 22 | 4.71e-01 | 8.88e-02 | 8.21e-01 |
SEMAPHORIN INTERACTIONS | 64 | 2.20e-01 | 8.87e-02 | 6.68e-01 |
AURKA ACTIVATION BY TPX2 | 71 | 1.97e-01 | 8.86e-02 | 6.45e-01 |
INTERLEUKIN 3 INTERLEUKIN 5 AND GM CSF SIGNALING | 41 | 3.28e-01 | 8.83e-02 | 7.42e-01 |
ANTIGEN PROCESSING CROSS PRESENTATION | 93 | 1.42e-01 | 8.81e-02 | 5.67e-01 |
CTLA4 INHIBITORY SIGNALING | 20 | 4.98e-01 | -8.76e-02 | 8.45e-01 |
GP1B IX V ACTIVATION SIGNALLING | 11 | 6.15e-01 | 8.75e-02 | 8.93e-01 |
PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | 16 | 5.45e-01 | -8.73e-02 | 8.71e-01 |
SUMOYLATION OF SUMOYLATION PROTEINS | 33 | 3.91e-01 | -8.63e-02 | 7.76e-01 |
NICOTINAMIDE SALVAGING | 15 | 5.66e-01 | 8.57e-02 | 8.79e-01 |
POST TRANSLATIONAL PROTEIN MODIFICATION | 1209 | 8.46e-07 | -8.49e-02 | 6.58e-05 |
MITOTIC G2 G2 M PHASES | 184 | 4.75e-02 | 8.48e-02 | 3.87e-01 |
ANTIGEN ACTIVATES B CELL RECEPTOR BCR LEADING TO GENERATION OF SECOND MESSENGERS | 26 | 4.55e-01 | -8.47e-02 | 8.10e-01 |
EPHRIN SIGNALING | 19 | 5.23e-01 | -8.46e-02 | 8.60e-01 |
POLYMERASE SWITCHING | 14 | 5.84e-01 | 8.46e-02 | 8.80e-01 |
NERVOUS SYSTEM DEVELOPMENT | 547 | 7.57e-04 | 8.45e-02 | 2.26e-02 |
COPI INDEPENDENT GOLGI TO ER RETROGRADE TRAFFIC | 44 | 3.33e-01 | 8.44e-02 | 7.42e-01 |
MUCOPOLYSACCHARIDOSES | 11 | 6.28e-01 | -8.44e-02 | 8.99e-01 |
NEGATIVE REGULATION OF NMDA RECEPTOR MEDIATED NEURONAL TRANSMISSION | 21 | 5.03e-01 | -8.44e-02 | 8.50e-01 |
SIGNALING BY INSULIN RECEPTOR | 61 | 2.56e-01 | -8.42e-02 | 6.90e-01 |
REGULATION OF HMOX1 EXPRESSION AND ACTIVITY | 63 | 2.49e-01 | 8.40e-02 | 6.88e-01 |
SUMOYLATION OF UBIQUITINYLATION PROTEINS | 37 | 3.77e-01 | -8.39e-02 | 7.74e-01 |
CARDIAC CONDUCTION | 108 | 1.34e-01 | -8.36e-02 | 5.60e-01 |
INTRINSIC PATHWAY FOR APOPTOSIS | 50 | 3.07e-01 | -8.36e-02 | 7.28e-01 |
CELL CELL COMMUNICATION | 107 | 1.36e-01 | -8.34e-02 | 5.60e-01 |
DEFECTIVE CFTR CAUSES CYSTIC FIBROSIS | 59 | 2.68e-01 | 8.34e-02 | 7.01e-01 |
TRANSMISSION ACROSS CHEMICAL SYNAPSES | 235 | 2.94e-02 | -8.26e-02 | 2.96e-01 |
WNT5A DEPENDENT INTERNALIZATION OF FZD4 | 15 | 5.81e-01 | 8.24e-02 | 8.80e-01 |
CRMPS IN SEMA3A SIGNALING | 16 | 5.69e-01 | -8.23e-02 | 8.80e-01 |
INSULIN RECEPTOR SIGNALLING CASCADE | 42 | 3.59e-01 | -8.19e-02 | 7.62e-01 |
SUMOYLATION OF IMMUNE RESPONSE PROTEINS | 11 | 6.38e-01 | -8.19e-02 | 9.01e-01 |
ASPARAGINE N LINKED GLYCOSYLATION | 283 | 1.84e-02 | -8.16e-02 | 2.27e-01 |
PLASMA LIPOPROTEIN ASSEMBLY REMODELING AND CLEARANCE | 51 | 3.15e-01 | -8.14e-02 | 7.36e-01 |
SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | 18 | 5.50e-01 | -8.13e-02 | 8.71e-01 |
CYTOSOLIC SULFONATION OF SMALL MOLECULES | 15 | 5.86e-01 | -8.13e-02 | 8.80e-01 |
NOTCH4 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 20 | 5.31e-01 | 8.10e-02 | 8.61e-01 |
SIGNALING BY ERBB2 ECD MUTANTS | 16 | 5.75e-01 | -8.09e-02 | 8.80e-01 |
DOWNSTREAM SIGNALING OF ACTIVATED FGFR2 | 23 | 5.02e-01 | 8.08e-02 | 8.49e-01 |
EGR2 AND SOX10 MEDIATED INITIATION OF SCHWANN CELL MYELINATION | 27 | 4.67e-01 | -8.08e-02 | 8.19e-01 |
TELOMERE EXTENSION BY TELOMERASE | 23 | 5.05e-01 | 8.04e-02 | 8.50e-01 |
DECTIN 1 MEDIATED NONCANONICAL NF KB SIGNALING | 59 | 2.88e-01 | 8.01e-02 | 7.05e-01 |
VISUAL PHOTOTRANSDUCTION | 61 | 2.81e-01 | -7.99e-02 | 7.03e-01 |
G1 S DNA DAMAGE CHECKPOINTS | 65 | 2.67e-01 | 7.97e-02 | 7.01e-01 |
METABOLISM OF PORPHYRINS | 19 | 5.49e-01 | -7.95e-02 | 8.71e-01 |
NCAM SIGNALING FOR NEURITE OUT GROWTH | 60 | 2.89e-01 | 7.91e-02 | 7.05e-01 |
DAG AND IP3 SIGNALING | 40 | 3.88e-01 | -7.90e-02 | 7.74e-01 |
OPIOID SIGNALLING | 86 | 2.09e-01 | -7.85e-02 | 6.56e-01 |
SHC MEDIATED CASCADE FGFR4 | 10 | 6.68e-01 | 7.83e-02 | 9.12e-01 |
METABOLISM OF NUCLEOTIDES | 91 | 1.98e-01 | -7.82e-02 | 6.45e-01 |
TNF SIGNALING | 43 | 3.76e-01 | 7.81e-02 | 7.72e-01 |
RECYCLING PATHWAY OF L1 | 40 | 3.94e-01 | 7.79e-02 | 7.79e-01 |
CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | 74 | 2.49e-01 | 7.75e-02 | 6.88e-01 |
SYNTHESIS OF PC | 25 | 5.05e-01 | 7.70e-02 | 8.50e-01 |
RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | 108 | 1.67e-01 | 7.70e-02 | 6.10e-01 |
ASYMMETRIC LOCALIZATION OF PCP PROTEINS | 62 | 2.95e-01 | 7.70e-02 | 7.08e-01 |
REGULATION OF FZD BY UBIQUITINATION | 19 | 5.61e-01 | -7.70e-02 | 8.78e-01 |
NEGATIVE REGULATION OF THE PI3K AKT NETWORK | 94 | 1.97e-01 | -7.70e-02 | 6.45e-01 |
SIGNALING BY FGFR | 74 | 2.53e-01 | 7.69e-02 | 6.88e-01 |
RNA POLYMERASE III TRANSCRIPTION | 41 | 3.94e-01 | 7.69e-02 | 7.79e-01 |
NEURONAL SYSTEM | 363 | 1.27e-02 | -7.64e-02 | 1.76e-01 |
ELEVATION OF CYTOSOLIC CA2 LEVELS | 14 | 6.22e-01 | -7.62e-02 | 8.93e-01 |
PCP CE PATHWAY | 90 | 2.13e-01 | 7.60e-02 | 6.59e-01 |
HDMS DEMETHYLATE HISTONES | 27 | 4.94e-01 | -7.60e-02 | 8.44e-01 |
DSCAM INTERACTIONS | 11 | 6.63e-01 | -7.58e-02 | 9.12e-01 |
O GLYCOSYLATION OF TSR DOMAIN CONTAINING PROTEINS | 36 | 4.32e-01 | -7.57e-02 | 7.94e-01 |
ADAPTIVE IMMUNE SYSTEM | 599 | 1.62e-03 | -7.57e-02 | 4.20e-02 |
DISEASES OF METABOLISM | 199 | 6.59e-02 | 7.57e-02 | 4.49e-01 |
NR1H3 NR1H2 REGULATE GENE EXPRESSION LINKED TO CHOLESTEROL TRANSPORT AND EFFLUX | 32 | 4.59e-01 | 7.56e-02 | 8.11e-01 |
TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | 169 | 9.04e-02 | -7.56e-02 | 4.86e-01 |
RHOV GTPASE CYCLE | 32 | 4.60e-01 | -7.55e-02 | 8.11e-01 |
PRESYNAPTIC FUNCTION OF KAINATE RECEPTORS | 19 | 5.70e-01 | -7.54e-02 | 8.80e-01 |
RUNX2 REGULATES BONE DEVELOPMENT | 29 | 4.85e-01 | -7.50e-02 | 8.33e-01 |
CD209 DC SIGN SIGNALING | 18 | 5.83e-01 | -7.48e-02 | 8.80e-01 |
CLATHRIN MEDIATED ENDOCYTOSIS | 133 | 1.37e-01 | -7.47e-02 | 5.60e-01 |
CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | 89 | 2.23e-01 | 7.47e-02 | 6.69e-01 |
IRS MEDIATED SIGNALLING | 37 | 4.32e-01 | -7.46e-02 | 7.94e-01 |
CELLULAR RESPONSE TO HYPOXIA | 71 | 2.80e-01 | 7.42e-02 | 7.03e-01 |
PTEN REGULATION | 134 | 1.39e-01 | 7.42e-02 | 5.62e-01 |
SEROTONIN NEUROTRANSMITTER RELEASE CYCLE | 18 | 5.86e-01 | 7.41e-02 | 8.80e-01 |
BASIGIN INTERACTIONS | 22 | 5.47e-01 | -7.41e-02 | 8.71e-01 |
CONSTITUTIVE SIGNALING BY EGFRVIII | 15 | 6.20e-01 | -7.40e-02 | 8.93e-01 |
INTRAFLAGELLAR TRANSPORT | 49 | 3.71e-01 | 7.40e-02 | 7.67e-01 |
SIGNALING BY NOTCH2 | 33 | 4.63e-01 | -7.39e-02 | 8.14e-01 |
ENOS ACTIVATION | 11 | 6.73e-01 | -7.36e-02 | 9.12e-01 |
REGULATION OF PTEN GENE TRANSCRIPTION | 59 | 3.28e-01 | 7.36e-02 | 7.42e-01 |
APOPTOTIC FACTOR MEDIATED RESPONSE | 18 | 5.90e-01 | -7.34e-02 | 8.83e-01 |
FORMATION OF FIBRIN CLOT CLOTTING CASCADE | 21 | 5.61e-01 | 7.34e-02 | 8.78e-01 |
INTERLEUKIN 20 FAMILY SIGNALING | 14 | 6.36e-01 | 7.31e-02 | 9.01e-01 |
GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | 23 | 5.45e-01 | 7.29e-02 | 8.71e-01 |
RAB GEFS EXCHANGE GTP FOR GDP ON RABS | 87 | 2.41e-01 | -7.28e-02 | 6.77e-01 |
TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | 11 | 6.77e-01 | 7.26e-02 | 9.13e-01 |
ION HOMEOSTASIS | 48 | 3.85e-01 | -7.25e-02 | 7.74e-01 |
FGFR1 MUTANT RECEPTOR ACTIVATION | 25 | 5.31e-01 | 7.23e-02 | 8.61e-01 |
NEGATIVE REGULATION OF NOTCH4 SIGNALING | 54 | 3.58e-01 | 7.23e-02 | 7.62e-01 |
GLUCAGON SIGNALING IN METABOLIC REGULATION | 29 | 5.01e-01 | -7.22e-02 | 8.49e-01 |
ASSEMBLY AND CELL SURFACE PRESENTATION OF NMDA RECEPTORS | 35 | 4.60e-01 | 7.21e-02 | 8.11e-01 |
COBALAMIN CBL VITAMIN B12 TRANSPORT AND METABOLISM | 13 | 6.53e-01 | 7.20e-02 | 9.12e-01 |
G1 S SPECIFIC TRANSCRIPTION | 26 | 5.26e-01 | -7.18e-02 | 8.60e-01 |
REGULATED PROTEOLYSIS OF P75NTR | 12 | 6.67e-01 | 7.18e-02 | 9.12e-01 |
METABOLISM OF POLYAMINES | 57 | 3.50e-01 | 7.16e-02 | 7.50e-01 |
RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | 28 | 5.12e-01 | 7.16e-02 | 8.55e-01 |
NR1H2 AND NR1H3 MEDIATED SIGNALING | 38 | 4.46e-01 | 7.15e-02 | 8.04e-01 |
RHOG GTPASE CYCLE | 73 | 2.91e-01 | 7.15e-02 | 7.05e-01 |
PHASE 4 RESTING MEMBRANE POTENTIAL | 14 | 6.47e-01 | -7.08e-02 | 9.06e-01 |
PIWI INTERACTING RNA PIRNA BIOGENESIS | 21 | 5.75e-01 | -7.07e-02 | 8.80e-01 |
CHONDROITIN SULFATE BIOSYNTHESIS | 19 | 5.95e-01 | -7.05e-02 | 8.86e-01 |
FOXO MEDIATED TRANSCRIPTION OF CELL DEATH GENES | 15 | 6.37e-01 | 7.04e-02 | 9.01e-01 |
REGULATION OF CHOLESTEROL BIOSYNTHESIS BY SREBP SREBF | 56 | 3.63e-01 | -7.03e-02 | 7.63e-01 |
REGULATION OF MECP2 EXPRESSION AND ACTIVITY | 30 | 5.06e-01 | -7.02e-02 | 8.51e-01 |
ESR MEDIATED SIGNALING | 163 | 1.25e-01 | -6.97e-02 | 5.56e-01 |
TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | 32 | 4.96e-01 | -6.95e-02 | 8.44e-01 |
G ALPHA 12 13 SIGNALLING EVENTS | 75 | 2.99e-01 | 6.93e-02 | 7.16e-01 |
RHO GTPASES ACTIVATE KTN1 | 11 | 6.91e-01 | 6.93e-02 | 9.17e-01 |
FORMATION OF INCISION COMPLEX IN GG NER | 43 | 4.33e-01 | -6.91e-02 | 7.94e-01 |
PI METABOLISM | 79 | 2.90e-01 | -6.90e-02 | 7.05e-01 |
ACTIVATED PKN1 STIMULATES TRANSCRIPTION OF AR ANDROGEN RECEPTOR REGULATED GENES KLK2 AND KLK3 | 21 | 5.86e-01 | -6.86e-02 | 8.80e-01 |
NUCLEAR ENVELOPE NE REASSEMBLY | 63 | 3.46e-01 | 6.86e-02 | 7.50e-01 |
ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | 28 | 5.30e-01 | -6.85e-02 | 8.61e-01 |
ADORA2B MEDIATED ANTI INFLAMMATORY CYTOKINES PRODUCTION | 90 | 2.64e-01 | -6.81e-02 | 6.98e-01 |
TP53 REGULATES METABOLIC GENES | 84 | 2.85e-01 | -6.76e-02 | 7.03e-01 |
EPIGENETIC REGULATION OF GENE EXPRESSION | 103 | 2.38e-01 | 6.74e-02 | 6.75e-01 |
MITOTIC PROMETAPHASE | 175 | 1.25e-01 | 6.72e-02 | 5.56e-01 |
RUNX1 REGULATES GENES INVOLVED IN MEGAKARYOCYTE DIFFERENTIATION AND PLATELET FUNCTION | 50 | 4.11e-01 | 6.72e-02 | 7.90e-01 |
G PROTEIN MEDIATED EVENTS | 52 | 4.02e-01 | -6.72e-02 | 7.85e-01 |
KSRP KHSRP BINDS AND DESTABILIZES MRNA | 16 | 6.43e-01 | 6.69e-02 | 9.03e-01 |
SUMOYLATION OF TRANSCRIPTION FACTORS | 17 | 6.34e-01 | -6.68e-02 | 9.01e-01 |
DEFECTS IN VITAMIN AND COFACTOR METABOLISM | 20 | 6.06e-01 | 6.67e-02 | 8.89e-01 |
INTERLEUKIN 35 SIGNALLING | 10 | 7.15e-01 | 6.66e-02 | 9.24e-01 |
SHC MEDIATED CASCADE FGFR1 | 15 | 6.57e-01 | 6.63e-02 | 9.12e-01 |
REGULATION OF TLR BY ENDOGENOUS LIGAND | 11 | 7.04e-01 | 6.63e-02 | 9.22e-01 |
UCH PROTEINASES | 88 | 2.86e-01 | 6.59e-02 | 7.04e-01 |
S PHASE | 153 | 1.60e-01 | -6.58e-02 | 6.02e-01 |
WNT5A DEPENDENT INTERNALIZATION OF FZD2 FZD5 AND ROR2 | 13 | 6.81e-01 | 6.58e-02 | 9.13e-01 |
TNFR1 INDUCED PROAPOPTOTIC SIGNALING | 12 | 6.94e-01 | 6.57e-02 | 9.18e-01 |
INTERLEUKIN 2 FAMILY SIGNALING | 33 | 5.14e-01 | 6.56e-02 | 8.55e-01 |
NICOTINATE METABOLISM | 24 | 5.78e-01 | 6.56e-02 | 8.80e-01 |
P75 NTR RECEPTOR MEDIATED SIGNALLING | 95 | 2.71e-01 | 6.53e-02 | 7.02e-01 |
PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | 51 | 4.21e-01 | -6.51e-02 | 7.94e-01 |
GLYCOSAMINOGLYCAN METABOLISM | 114 | 2.32e-01 | -6.49e-02 | 6.72e-01 |
SIGNAL REGULATORY PROTEIN FAMILY INTERACTIONS | 11 | 7.11e-01 | -6.45e-02 | 9.24e-01 |
VEGFR2 MEDIATED VASCULAR PERMEABILITY | 26 | 5.70e-01 | -6.44e-02 | 8.80e-01 |
DEVELOPMENTAL BIOLOGY | 811 | 2.12e-03 | 6.39e-02 | 5.11e-02 |
TRANSCRIPTIONAL REGULATION OF GRANULOPOIESIS | 43 | 4.70e-01 | -6.37e-02 | 8.21e-01 |
B WICH COMPLEX POSITIVELY REGULATES RRNA EXPRESSION | 47 | 4.50e-01 | 6.36e-02 | 8.10e-01 |
APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | 70 | 3.60e-01 | 6.33e-02 | 7.62e-01 |
TRANSCRIPTIONAL REGULATION BY RUNX1 | 176 | 1.49e-01 | 6.31e-02 | 5.79e-01 |
NEGATIVE EPIGENETIC REGULATION OF RRNA EXPRESSION | 65 | 3.81e-01 | 6.29e-02 | 7.74e-01 |
TRANSCRIPTIONAL REGULATION BY VENTX | 35 | 5.21e-01 | -6.27e-02 | 8.60e-01 |
REGULATION OF PTEN STABILITY AND ACTIVITY | 66 | 3.80e-01 | 6.25e-02 | 7.74e-01 |
DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | 38 | 5.08e-01 | 6.20e-02 | 8.52e-01 |
OTHER INTERLEUKIN SIGNALING | 20 | 6.32e-01 | 6.19e-02 | 9.00e-01 |
SIGNALING BY RETINOIC ACID | 33 | 5.38e-01 | -6.19e-02 | 8.66e-01 |
HCMV INFECTION | 102 | 2.81e-01 | 6.18e-02 | 7.03e-01 |
DETOXIFICATION OF REACTIVE OXYGEN SPECIES | 31 | 5.54e-01 | 6.15e-02 | 8.73e-01 |
GLUCAGON TYPE LIGAND RECEPTORS | 23 | 6.11e-01 | -6.14e-02 | 8.93e-01 |
SARS COV 1 INFECTION | 48 | 4.64e-01 | 6.11e-02 | 8.14e-01 |
RHOQ GTPASE CYCLE | 58 | 4.22e-01 | 6.10e-02 | 7.94e-01 |
SIGNALLING TO RAS | 20 | 6.37e-01 | 6.10e-02 | 9.01e-01 |
INTERLEUKIN 1 SIGNALING | 95 | 3.05e-01 | 6.09e-02 | 7.26e-01 |
NONHOMOLOGOUS END JOINING NHEJ | 43 | 4.90e-01 | -6.09e-02 | 8.40e-01 |
G2 M CHECKPOINTS | 133 | 2.29e-01 | -6.05e-02 | 6.72e-01 |
SIGNALING BY FGFR2 IIIA TM | 19 | 6.49e-01 | 6.04e-02 | 9.08e-01 |
GLUTATHIONE CONJUGATION | 29 | 5.75e-01 | 6.02e-02 | 8.80e-01 |
LAGGING STRAND SYNTHESIS | 20 | 6.42e-01 | 6.01e-02 | 9.02e-01 |
HOMOLOGY DIRECTED REPAIR | 107 | 2.84e-01 | -6.00e-02 | 7.03e-01 |
DEFECTIVE EXT2 CAUSES EXOSTOSES 2 | 14 | 6.98e-01 | 5.99e-02 | 9.21e-01 |
PI3K AKT SIGNALING IN CANCER | 89 | 3.31e-01 | -5.97e-02 | 7.42e-01 |
INITIATION OF NUCLEAR ENVELOPE NE REFORMATION | 16 | 6.80e-01 | -5.96e-02 | 9.13e-01 |
EXPORT OF VIRAL RIBONUCLEOPROTEINS FROM NUCLEUS | 31 | 5.66e-01 | -5.96e-02 | 8.79e-01 |
FORMATION OF TC NER PRE INCISION COMPLEX | 53 | 4.55e-01 | -5.93e-02 | 8.10e-01 |
VLDLR INTERNALISATION AND DEGRADATION | 12 | 7.23e-01 | -5.92e-02 | 9.27e-01 |
CHROMATIN MODIFYING ENZYMES | 217 | 1.34e-01 | 5.91e-02 | 5.60e-01 |
RHO GTPASES ACTIVATE NADPH OXIDASES | 18 | 6.67e-01 | 5.85e-02 | 9.12e-01 |
TRANS GOLGI NETWORK VESICLE BUDDING | 70 | 3.98e-01 | -5.85e-02 | 7.82e-01 |
BETA OXIDATION OF VERY LONG CHAIN FATTY ACIDS | 11 | 7.37e-01 | 5.84e-02 | 9.35e-01 |
RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | 24 | 6.21e-01 | 5.84e-02 | 8.93e-01 |
SIGNALING BY ERYTHROPOIETIN | 24 | 6.21e-01 | 5.84e-02 | 8.93e-01 |
IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | 21 | 6.44e-01 | 5.83e-02 | 9.03e-01 |
MITOCHONDRIAL BIOGENESIS | 92 | 3.34e-01 | 5.83e-02 | 7.42e-01 |
INOSITOL PHOSPHATE METABOLISM | 47 | 4.90e-01 | 5.82e-02 | 8.40e-01 |
SIGNAL AMPLIFICATION | 30 | 5.82e-01 | -5.81e-02 | 8.80e-01 |
CONSTITUTIVE SIGNALING BY ABERRANT PI3K IN CANCER | 62 | 4.31e-01 | -5.79e-02 | 7.94e-01 |
REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | 84 | 3.60e-01 | 5.79e-02 | 7.62e-01 |
PARASITE INFECTION | 55 | 4.60e-01 | -5.76e-02 | 8.11e-01 |
TRIGLYCERIDE CATABOLISM | 14 | 7.11e-01 | -5.72e-02 | 9.24e-01 |
SEPARATION OF SISTER CHROMATIDS | 165 | 2.06e-01 | 5.72e-02 | 6.53e-01 |
RESOLUTION OF SISTER CHROMATID COHESION | 100 | 3.25e-01 | 5.70e-02 | 7.42e-01 |
GPCR LIGAND BINDING | 261 | 1.17e-01 | -5.65e-02 | 5.50e-01 |
MITOTIC G1 PHASE AND G1 S TRANSITION | 140 | 2.55e-01 | -5.58e-02 | 6.90e-01 |
TRANSCRIPTIONAL REGULATION BY E2F6 | 34 | 5.75e-01 | -5.55e-02 | 8.80e-01 |
RHO GTPASE CYCLE | 427 | 5.05e-02 | 5.54e-02 | 4.06e-01 |
FCGAMMA RECEPTOR FCGR DEPENDENT PHAGOCYTOSIS | 82 | 3.87e-01 | 5.53e-02 | 7.74e-01 |
RAS PROCESSING | 24 | 6.39e-01 | 5.53e-02 | 9.01e-01 |
SIGNALING BY FGFR3 | 34 | 5.78e-01 | 5.51e-02 | 8.80e-01 |
SIGNALING BY RHO GTPASES MIRO GTPASES AND RHOBTB3 | 628 | 1.90e-02 | 5.51e-02 | 2.27e-01 |
CLASS B 2 SECRETIN FAMILY RECEPTORS | 69 | 4.32e-01 | -5.48e-02 | 7.94e-01 |
ARACHIDONIC ACID METABOLISM | 40 | 5.51e-01 | 5.45e-02 | 8.71e-01 |
ACTIVATION OF AMPK DOWNSTREAM OF NMDARS | 20 | 6.73e-01 | 5.45e-02 | 9.12e-01 |
CLASS A 1 RHODOPSIN LIKE RECEPTORS | 180 | 2.10e-01 | -5.42e-02 | 6.59e-01 |
TNFR1 INDUCED NFKAPPAB SIGNALING PATHWAY | 29 | 6.14e-01 | 5.42e-02 | 8.93e-01 |
REGULATION OF RUNX2 EXPRESSION AND ACTIVITY | 69 | 4.37e-01 | 5.42e-02 | 7.96e-01 |
TRANSCRIPTION OF E2F TARGETS UNDER NEGATIVE CONTROL BY P107 RBL1 AND P130 RBL2 IN COMPLEX WITH HDAC1 | 15 | 7.18e-01 | 5.39e-02 | 9.24e-01 |
NOTCH2 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 23 | 6.56e-01 | 5.37e-02 | 9.12e-01 |
HS GAG BIOSYNTHESIS | 29 | 6.18e-01 | -5.35e-02 | 8.93e-01 |
RAF INDEPENDENT MAPK1 3 ACTIVATION | 21 | 6.72e-01 | -5.35e-02 | 9.12e-01 |
GENERATION OF SECOND MESSENGER MOLECULES | 20 | 6.79e-01 | 5.34e-02 | 9.13e-01 |
DNA REPAIR | 291 | 1.18e-01 | -5.33e-02 | 5.54e-01 |
REGULATION OF RAS BY GAPS | 66 | 4.54e-01 | 5.33e-02 | 8.10e-01 |
NEGATIVE REGULATION OF MAPK PATHWAY | 43 | 5.46e-01 | -5.33e-02 | 8.71e-01 |
GABA B RECEPTOR ACTIVATION | 39 | 5.65e-01 | -5.32e-02 | 8.79e-01 |
CLASS I PEROXISOMAL MEMBRANE PROTEIN IMPORT | 20 | 6.81e-01 | -5.31e-02 | 9.13e-01 |
TRAF6 MEDIATED IRF7 ACTIVATION | 15 | 7.22e-01 | -5.30e-02 | 9.27e-01 |
RAS ACTIVATION UPON CA2 INFLUX THROUGH NMDA RECEPTOR | 20 | 6.82e-01 | -5.30e-02 | 9.13e-01 |
VASOPRESSIN REGULATES RENAL WATER HOMEOSTASIS VIA AQUAPORINS | 37 | 5.77e-01 | -5.30e-02 | 8.80e-01 |
NUCLEAR ENVELOPE BREAKDOWN | 47 | 5.31e-01 | -5.29e-02 | 8.61e-01 |
APC CDC20 MEDIATED DEGRADATION OF NEK2A | 24 | 6.54e-01 | -5.28e-02 | 9.12e-01 |
GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | 30 | 6.17e-01 | -5.28e-02 | 8.93e-01 |
SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | 11 | 7.63e-01 | 5.25e-02 | 9.45e-01 |
NUCLEAR PORE COMPLEX NPC DISASSEMBLY | 31 | 6.13e-01 | -5.25e-02 | 8.93e-01 |
SYNTHESIS OF PA | 29 | 6.26e-01 | 5.23e-02 | 8.97e-01 |
PLASMA LIPOPROTEIN CLEARANCE | 27 | 6.41e-01 | 5.19e-02 | 9.02e-01 |
GPVI MEDIATED ACTIVATION CASCADE | 31 | 6.17e-01 | 5.19e-02 | 8.93e-01 |
HIV TRANSCRIPTION ELONGATION | 42 | 5.62e-01 | 5.17e-02 | 8.78e-01 |
SUMOYLATION | 162 | 2.58e-01 | -5.15e-02 | 6.92e-01 |
FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | 117 | 3.36e-01 | 5.15e-02 | 7.42e-01 |
PYROPTOSIS | 20 | 6.91e-01 | -5.14e-02 | 9.17e-01 |
DEGRADATION OF BETA CATENIN BY THE DESTRUCTION COMPLEX | 82 | 4.23e-01 | 5.12e-02 | 7.94e-01 |
FCERI MEDIATED NF KB ACTIVATION | 76 | 4.41e-01 | 5.11e-02 | 8.00e-01 |
DOWNSTREAM SIGNALING OF ACTIVATED FGFR1 | 25 | 6.59e-01 | 5.10e-02 | 9.12e-01 |
MYOGENESIS | 25 | 6.59e-01 | -5.09e-02 | 9.12e-01 |
FATTY ACYL COA BIOSYNTHESIS | 32 | 6.19e-01 | 5.08e-02 | 8.93e-01 |
DEGRADATION OF CYSTEINE AND HOMOCYSTEINE | 12 | 7.61e-01 | 5.07e-02 | 9.45e-01 |
NOD1 2 SIGNALING PATHWAY | 35 | 6.04e-01 | 5.07e-02 | 8.89e-01 |
TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | 82 | 4.28e-01 | -5.07e-02 | 7.94e-01 |
TRANSCRIPTIONAL REGULATION BY RUNX3 | 92 | 4.05e-01 | 5.03e-02 | 7.85e-01 |
NUCLEOBASE BIOSYNTHESIS | 15 | 7.37e-01 | -5.02e-02 | 9.35e-01 |
DISEASES OF PROGRAMMED CELL DEATH | 54 | 5.25e-01 | 5.01e-02 | 8.60e-01 |
ABC FAMILY PROTEINS MEDIATED TRANSPORT | 95 | 3.99e-01 | 5.01e-02 | 7.83e-01 |
PROCESSIVE SYNTHESIS ON THE C STRAND OF THE TELOMERE | 19 | 7.06e-01 | -5.00e-02 | 9.22e-01 |
MAPK6 MAPK4 SIGNALING | 83 | 4.32e-01 | 4.99e-02 | 7.94e-01 |
TOLL LIKE RECEPTOR TLR1 TLR2 CASCADE | 92 | 4.10e-01 | -4.98e-02 | 7.90e-01 |
DNA DAMAGE TELOMERE STRESS INDUCED SENESCENCE | 42 | 5.78e-01 | -4.97e-02 | 8.80e-01 |
PLATELET SENSITIZATION BY LDL | 15 | 7.39e-01 | 4.96e-02 | 9.35e-01 |
TRANSPORT OF MATURE MRNAS DERIVED FROM INTRONLESS TRANSCRIPTS | 41 | 5.84e-01 | 4.95e-02 | 8.80e-01 |
MITOTIC METAPHASE AND ANAPHASE | 205 | 2.27e-01 | 4.90e-02 | 6.71e-01 |
PROTEIN PROTEIN INTERACTIONS AT SYNAPSES | 85 | 4.36e-01 | -4.89e-02 | 7.96e-01 |
CONSTITUTIVE SIGNALING BY LIGAND RESPONSIVE EGFR CANCER VARIANTS | 19 | 7.14e-01 | 4.86e-02 | 9.24e-01 |
TOLL LIKE RECEPTOR 9 TLR9 CASCADE | 91 | 4.24e-01 | -4.85e-02 | 7.94e-01 |
NUCLEAR IMPORT OF REV PROTEIN | 32 | 6.36e-01 | -4.84e-02 | 9.01e-01 |
RNA POLYMERASE II TRANSCRIPTION | 1084 | 7.84e-03 | -4.82e-02 | 1.32e-01 |
REGULATION OF BACH1 ACTIVITY | 11 | 7.82e-01 | -4.81e-02 | 9.50e-01 |
PHASE 2 PLATEAU PHASE | 13 | 7.64e-01 | -4.81e-02 | 9.45e-01 |
GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTEGRINS | 12 | 7.74e-01 | 4.78e-02 | 9.48e-01 |
SIGNALING BY GPCR | 478 | 7.42e-02 | -4.78e-02 | 4.63e-01 |
MTORC1 MEDIATED SIGNALLING | 24 | 6.87e-01 | 4.76e-02 | 9.17e-01 |
NEGATIVE REGULATION OF MET ACTIVITY | 21 | 7.07e-01 | -4.74e-02 | 9.22e-01 |
DNA REPLICATION | 121 | 3.68e-01 | -4.74e-02 | 7.67e-01 |
HCMV LATE EVENTS | 64 | 5.13e-01 | -4.73e-02 | 8.55e-01 |
NEUROTOXICITY OF CLOSTRIDIUM TOXINS | 10 | 7.96e-01 | 4.73e-02 | 9.53e-01 |
REGULATION OF LIPID METABOLISM BY PPARALPHA | 108 | 4.00e-01 | -4.69e-02 | 7.83e-01 |
ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | 38 | 6.17e-01 | 4.69e-02 | 8.93e-01 |
TRANSPORT OF SMALL MOLECULES | 568 | 5.77e-02 | -4.68e-02 | 4.34e-01 |
ER QUALITY CONTROL COMPARTMENT ERQC | 21 | 7.11e-01 | -4.68e-02 | 9.24e-01 |
PKA ACTIVATION IN GLUCAGON SIGNALLING | 16 | 7.46e-01 | 4.67e-02 | 9.40e-01 |
METALLOPROTEASE DUBS | 25 | 6.86e-01 | -4.67e-02 | 9.17e-01 |
SCF SKP2 MEDIATED DEGRADATION OF P27 P21 | 59 | 5.35e-01 | 4.67e-02 | 8.66e-01 |
PRC2 METHYLATES HISTONES AND DNA | 29 | 6.66e-01 | 4.64e-02 | 9.12e-01 |
MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | 15 | 7.56e-01 | -4.63e-02 | 9.43e-01 |
HYALURONAN UPTAKE AND DEGRADATION | 11 | 7.91e-01 | -4.63e-02 | 9.53e-01 |
RAB REGULATION OF TRAFFICKING | 118 | 3.87e-01 | -4.62e-02 | 7.74e-01 |
ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | 23 | 7.02e-01 | 4.61e-02 | 9.22e-01 |
TRNA MODIFICATION IN THE NUCLEUS AND CYTOSOL | 43 | 6.01e-01 | 4.61e-02 | 8.89e-01 |
PI 3K CASCADE FGFR2 | 16 | 7.49e-01 | 4.61e-02 | 9.40e-01 |
DEATH RECEPTOR SIGNALLING | 134 | 3.59e-01 | 4.60e-02 | 7.62e-01 |
ER TO GOLGI ANTEROGRADE TRANSPORT | 141 | 3.48e-01 | -4.58e-02 | 7.50e-01 |
RHO GTPASE EFFECTORS | 247 | 2.16e-01 | 4.58e-02 | 6.63e-01 |
PRESYNAPTIC DEPOLARIZATION AND CALCIUM CHANNEL OPENING | 11 | 7.93e-01 | -4.57e-02 | 9.53e-01 |
BUDDING AND MATURATION OF HIV VIRION | 27 | 6.81e-01 | 4.57e-02 | 9.13e-01 |
APOPTOTIC EXECUTION PHASE | 45 | 5.96e-01 | -4.57e-02 | 8.86e-01 |
APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | 21 | 7.17e-01 | -4.56e-02 | 9.24e-01 |
VXPX CARGO TARGETING TO CILIUM | 19 | 7.31e-01 | 4.55e-02 | 9.33e-01 |
SARS COV 2 INFECTION | 65 | 5.26e-01 | -4.55e-02 | 8.60e-01 |
SIGNALING BY CYTOSOLIC FGFR1 FUSION MUTANTS | 18 | 7.39e-01 | 4.54e-02 | 9.35e-01 |
PI 3K CASCADE FGFR4 | 10 | 8.04e-01 | 4.54e-02 | 9.55e-01 |
TRANSCRIPTION OF THE HIV GENOME | 67 | 5.24e-01 | 4.50e-02 | 8.60e-01 |
NOTCH3 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 26 | 6.92e-01 | 4.48e-02 | 9.18e-01 |
DNA STRAND ELONGATION | 32 | 6.62e-01 | -4.47e-02 | 9.12e-01 |
LYSOSOME VESICLE BIOGENESIS | 33 | 6.58e-01 | 4.45e-02 | 9.12e-01 |
SIGNALING BY LEPTIN | 10 | 8.08e-01 | 4.43e-02 | 9.56e-01 |
PI 3K CASCADE FGFR1 | 15 | 7.67e-01 | 4.43e-02 | 9.45e-01 |
CYTOKINE SIGNALING IN IMMUNE SYSTEM | 540 | 8.02e-02 | -4.42e-02 | 4.80e-01 |
NUCLEAR SIGNALING BY ERBB4 | 31 | 6.71e-01 | 4.41e-02 | 9.12e-01 |
SIGNALING BY NUCLEAR RECEPTORS | 220 | 2.61e-01 | -4.41e-02 | 6.95e-01 |
MITOCHONDRIAL FATTY ACID BETA OXIDATION | 33 | 6.63e-01 | 4.38e-02 | 9.12e-01 |
METABOLISM OF COFACTORS | 18 | 7.48e-01 | 4.37e-02 | 9.40e-01 |
ROS AND RNS PRODUCTION IN PHAGOCYTES | 28 | 6.90e-01 | 4.36e-02 | 9.17e-01 |
FANCONI ANEMIA PATHWAY | 36 | 6.53e-01 | 4.33e-02 | 9.12e-01 |
STIMULI SENSING CHANNELS | 74 | 5.20e-01 | -4.32e-02 | 8.60e-01 |
G ALPHA Z SIGNALLING EVENTS | 45 | 6.16e-01 | -4.32e-02 | 8.93e-01 |
TRIGLYCERIDE METABOLISM | 22 | 7.27e-01 | -4.30e-02 | 9.29e-01 |
SIGNALING BY PTK6 | 50 | 5.99e-01 | 4.29e-02 | 8.89e-01 |
L1CAM INTERACTIONS | 109 | 4.40e-01 | 4.28e-02 | 8.00e-01 |
PEROXISOMAL LIPID METABOLISM | 26 | 7.06e-01 | -4.28e-02 | 9.22e-01 |
TRANSCRIPTIONAL ACTIVATION OF MITOCHONDRIAL BIOGENESIS | 54 | 5.90e-01 | 4.24e-02 | 8.83e-01 |
DEREGULATED CDK5 TRIGGERS MULTIPLE NEURODEGENERATIVE PATHWAYS IN ALZHEIMER S DISEASE MODELS | 19 | 7.50e-01 | 4.23e-02 | 9.40e-01 |
HEPARAN SULFATE HEPARIN HS GAG METABOLISM | 51 | 6.01e-01 | -4.23e-02 | 8.89e-01 |
DISASSEMBLY OF THE DESTRUCTION COMPLEX AND RECRUITMENT OF AXIN TO THE MEMBRANE | 27 | 7.04e-01 | -4.23e-02 | 9.22e-01 |
INFECTIOUS DISEASE | 727 | 5.38e-02 | 4.22e-02 | 4.24e-01 |
PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | 12 | 8.00e-01 | -4.22e-02 | 9.54e-01 |
LDL CLEARANCE | 16 | 7.72e-01 | 4.18e-02 | 9.48e-01 |
MEMBRANE TRAFFICKING | 579 | 8.77e-02 | -4.17e-02 | 4.84e-01 |
GLYCEROPHOSPHOLIPID BIOSYNTHESIS | 108 | 4.54e-01 | 4.17e-02 | 8.10e-01 |
RESPONSE OF MTB TO PHAGOCYTOSIS | 21 | 7.41e-01 | -4.17e-02 | 9.36e-01 |
TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN G1 CELL CYCLE ARREST | 13 | 7.95e-01 | -4.16e-02 | 9.53e-01 |
APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | 35 | 6.71e-01 | 4.15e-02 | 9.12e-01 |
DEADENYLATION DEPENDENT MRNA DECAY | 55 | 5.95e-01 | -4.15e-02 | 8.86e-01 |
TCR SIGNALING | 102 | 4.70e-01 | 4.15e-02 | 8.21e-01 |
TCF DEPENDENT SIGNALING IN RESPONSE TO WNT | 177 | 3.42e-01 | 4.14e-02 | 7.48e-01 |
DOWNREGULATION OF ERBB2 SIGNALING | 28 | 7.05e-01 | 4.14e-02 | 9.22e-01 |
INTERACTIONS OF REV WITH HOST CELLULAR PROTEINS | 35 | 6.72e-01 | -4.13e-02 | 9.12e-01 |
THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | 28 | 7.10e-01 | -4.06e-02 | 9.24e-01 |
RHOH GTPASE CYCLE | 37 | 6.69e-01 | -4.06e-02 | 9.12e-01 |
G ALPHA S SIGNALLING EVENTS | 103 | 4.79e-01 | -4.04e-02 | 8.28e-01 |
MAP3K8 TPL2 DEPENDENT MAPK1 3 ACTIVATION | 16 | 7.80e-01 | 4.03e-02 | 9.50e-01 |
RAC2 GTPASE CYCLE | 86 | 5.21e-01 | 4.01e-02 | 8.60e-01 |
CELL CYCLE CHECKPOINTS | 241 | 2.85e-01 | -4.01e-02 | 7.03e-01 |
RETROGRADE TRANSPORT AT THE TRANS GOLGI NETWORK | 48 | 6.31e-01 | -4.00e-02 | 9.00e-01 |
INFLAMMASOMES | 19 | 7.64e-01 | -3.99e-02 | 9.45e-01 |
INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | 34 | 6.88e-01 | -3.98e-02 | 9.17e-01 |
SIGNALING BY ERBB4 | 57 | 6.04e-01 | -3.97e-02 | 8.89e-01 |
RNA POLYMERASE I PROMOTER ESCAPE | 47 | 6.38e-01 | 3.96e-02 | 9.01e-01 |
TNF RECEPTOR SUPERFAMILY TNFSF MEMBERS MEDIATING NON CANONICAL NF KB PATHWAY | 13 | 8.05e-01 | -3.96e-02 | 9.55e-01 |
SWITCHING OF ORIGINS TO A POST REPLICATIVE STATE | 86 | 5.28e-01 | -3.94e-02 | 8.61e-01 |
SUPPRESSION OF PHAGOSOMAL MATURATION | 12 | 8.13e-01 | 3.94e-02 | 9.58e-01 |
SIGNALING BY NOTCH4 | 83 | 5.37e-01 | 3.92e-02 | 8.66e-01 |
MYD88 INDEPENDENT TLR4 CASCADE | 93 | 5.14e-01 | -3.91e-02 | 8.55e-01 |
DNA DOUBLE STRAND BREAK REPAIR | 136 | 4.32e-01 | -3.91e-02 | 7.94e-01 |
EPH EPHRIN SIGNALING | 90 | 5.22e-01 | -3.90e-02 | 8.60e-01 |
SENSORY PERCEPTION | 146 | 4.16e-01 | 3.90e-02 | 7.93e-01 |
SYNTHESIS OF PYROPHOSPHATES IN THE CYTOSOL | 10 | 8.32e-01 | -3.88e-02 | 9.68e-01 |
SLC MEDIATED TRANSMEMBRANE TRANSPORT | 183 | 3.70e-01 | -3.85e-02 | 7.67e-01 |
PLATELET ACTIVATION SIGNALING AND AGGREGATION | 226 | 3.20e-01 | 3.84e-02 | 7.40e-01 |
NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | 17 | 7.87e-01 | 3.79e-02 | 9.52e-01 |
REGULATION OF SIGNALING BY CBL | 22 | 7.62e-01 | 3.73e-02 | 9.45e-01 |
RHOF GTPASE CYCLE | 40 | 6.84e-01 | -3.72e-02 | 9.15e-01 |
APC C MEDIATED DEGRADATION OF CELL CYCLE PROTEINS | 81 | 5.66e-01 | 3.69e-02 | 8.79e-01 |
RHO GTPASES ACTIVATE FORMINS | 118 | 4.92e-01 | 3.67e-02 | 8.40e-01 |
PD 1 SIGNALING | 10 | 8.42e-01 | 3.64e-02 | 9.69e-01 |
HYALURONAN METABOLISM | 15 | 8.08e-01 | -3.62e-02 | 9.56e-01 |
INTRINSIC PATHWAY OF FIBRIN CLOT FORMATION | 13 | 8.21e-01 | -3.62e-02 | 9.63e-01 |
TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN CYTOCHROME C RELEASE | 17 | 7.97e-01 | -3.61e-02 | 9.53e-01 |
DNA REPLICATION PRE INITIATION | 79 | 5.83e-01 | -3.58e-02 | 8.80e-01 |
SIGNALING BY NOTCH1 | 75 | 5.93e-01 | 3.57e-02 | 8.85e-01 |
TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | 31 | 7.33e-01 | -3.54e-02 | 9.33e-01 |
COOPERATION OF PDCL PHLP1 AND TRIC CCT IN G PROTEIN BETA FOLDING | 35 | 7.18e-01 | -3.53e-02 | 9.24e-01 |
CONSTITUTIVE SIGNALING BY AKT1 E17K IN CANCER | 26 | 7.56e-01 | -3.52e-02 | 9.43e-01 |
REPRODUCTION | 75 | 6.01e-01 | 3.49e-02 | 8.89e-01 |
ION CHANNEL TRANSPORT | 138 | 4.81e-01 | -3.48e-02 | 8.30e-01 |
MAPK FAMILY SIGNALING CASCADES | 288 | 3.12e-01 | 3.47e-02 | 7.33e-01 |
FCGR3A MEDIATED IL10 SYNTHESIS | 32 | 7.35e-01 | 3.45e-02 | 9.35e-01 |
JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | 22 | 7.80e-01 | -3.45e-02 | 9.50e-01 |
INTERLEUKIN 4 AND INTERLEUKIN 13 SIGNALING | 76 | 6.05e-01 | -3.43e-02 | 8.89e-01 |
REGULATION OF BETA CELL DEVELOPMENT | 24 | 7.71e-01 | -3.43e-02 | 9.48e-01 |
NEUREXINS AND NEUROLIGINS | 54 | 6.64e-01 | 3.42e-02 | 9.12e-01 |
HATS ACETYLATE HISTONES | 91 | 5.74e-01 | -3.41e-02 | 8.80e-01 |
SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | 52 | 6.71e-01 | -3.40e-02 | 9.12e-01 |
TP53 REGULATES TRANSCRIPTION OF CELL CYCLE GENES | 45 | 6.94e-01 | -3.39e-02 | 9.18e-01 |
ADENYLATE CYCLASE INHIBITORY PATHWAY | 13 | 8.33e-01 | 3.38e-02 | 9.68e-01 |
YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | 10 | 8.55e-01 | 3.35e-02 | 9.73e-01 |
FCERI MEDIATED MAPK ACTIVATION | 28 | 7.59e-01 | -3.34e-02 | 9.45e-01 |
DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | 23 | 7.82e-01 | 3.34e-02 | 9.50e-01 |
FRS MEDIATED FGFR2 SIGNALING | 18 | 8.07e-01 | 3.33e-02 | 9.56e-01 |
SIGNALING BY NOTCH | 188 | 4.34e-01 | 3.31e-02 | 7.95e-01 |
EFFECTS OF PIP2 HYDROLYSIS | 27 | 7.66e-01 | 3.31e-02 | 9.45e-01 |
NUCLEOTIDE EXCISION REPAIR | 109 | 5.55e-01 | -3.28e-02 | 8.73e-01 |
NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | 53 | 6.80e-01 | 3.28e-02 | 9.13e-01 |
EXTENSION OF TELOMERES | 50 | 6.91e-01 | 3.26e-02 | 9.17e-01 |
TRANSLOCATION OF SLC2A4 GLUT4 TO THE PLASMA MEMBRANE | 63 | 6.56e-01 | -3.25e-02 | 9.12e-01 |
SIGNALING BY TYPE 1 INSULIN LIKE GROWTH FACTOR 1 RECEPTOR IGF1R | 42 | 7.18e-01 | -3.22e-02 | 9.24e-01 |
G PROTEIN ACTIVATION | 22 | 7.96e-01 | -3.19e-02 | 9.53e-01 |
TBC RABGAPS | 43 | 7.18e-01 | -3.19e-02 | 9.24e-01 |
SPRY REGULATION OF FGF SIGNALING | 16 | 8.29e-01 | -3.11e-02 | 9.68e-01 |
GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR GG NER | 83 | 6.26e-01 | -3.10e-02 | 8.97e-01 |
FRS MEDIATED FGFR1 SIGNALING | 17 | 8.26e-01 | 3.09e-02 | 9.67e-01 |
SIGNALING BY INTERLEUKINS | 348 | 3.26e-01 | 3.07e-02 | 7.42e-01 |
TRANSCRIPTIONAL REGULATION BY THE AP 2 TFAP2 FAMILY OF TRANSCRIPTION FACTORS | 31 | 7.68e-01 | -3.06e-02 | 9.45e-01 |
NUCLEOTIDE LIKE PURINERGIC RECEPTORS | 13 | 8.49e-01 | 3.05e-02 | 9.72e-01 |
PROLACTIN RECEPTOR SIGNALING | 11 | 8.61e-01 | -3.05e-02 | 9.73e-01 |
DNA METHYLATION | 20 | 8.13e-01 | 3.05e-02 | 9.58e-01 |
GLYCOSPHINGOLIPID METABOLISM | 38 | 7.47e-01 | -3.02e-02 | 9.40e-01 |
NUCLEOBASE CATABOLISM | 31 | 7.72e-01 | -3.01e-02 | 9.48e-01 |
SYNTHESIS OF PE | 12 | 8.57e-01 | -3.00e-02 | 9.73e-01 |
INTERACTION BETWEEN L1 AND ANKYRINS | 29 | 7.80e-01 | 3.00e-02 | 9.50e-01 |
TOLL LIKE RECEPTOR CASCADES | 137 | 5.47e-01 | -2.98e-02 | 8.71e-01 |
CIRCADIAN CLOCK | 68 | 6.76e-01 | -2.94e-02 | 9.13e-01 |
THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | 22 | 8.12e-01 | -2.92e-02 | 9.58e-01 |
VESICLE MEDIATED TRANSPORT | 608 | 2.25e-01 | -2.90e-02 | 6.69e-01 |
INTERLEUKIN 12 FAMILY SIGNALING | 44 | 7.40e-01 | 2.89e-02 | 9.35e-01 |
CLEC7A DECTIN 1 SIGNALING | 94 | 6.30e-01 | 2.88e-02 | 9.00e-01 |
ABC TRANSPORTERS IN LIPID HOMEOSTASIS | 15 | 8.47e-01 | -2.87e-02 | 9.72e-01 |
TRANSCRIPTIONAL REGULATION BY RUNX2 | 110 | 6.05e-01 | -2.86e-02 | 8.89e-01 |
METABOLISM OF VITAMINS AND COFACTORS | 150 | 5.50e-01 | 2.83e-02 | 8.71e-01 |
DEFECTS IN COBALAMIN B12 METABOLISM | 12 | 8.65e-01 | 2.83e-02 | 9.73e-01 |
SIGNALING BY FGFR IN DISEASE | 55 | 7.17e-01 | 2.83e-02 | 9.24e-01 |
LEISHMANIA INFECTION | 193 | 5.02e-01 | -2.81e-02 | 8.49e-01 |
TRANSLATION OF SARS COV 1 STRUCTURAL PROTEINS | 28 | 7.98e-01 | 2.80e-02 | 9.53e-01 |
AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | 14 | 8.57e-01 | 2.78e-02 | 9.73e-01 |
M PHASE | 337 | 3.83e-01 | 2.77e-02 | 7.74e-01 |
OXIDATIVE STRESS INDUCED SENESCENCE | 78 | 6.72e-01 | 2.77e-02 | 9.12e-01 |
REGULATION OF GENE EXPRESSION IN LATE STAGE BRANCHING MORPHOGENESIS PANCREATIC BUD PRECURSOR CELLS | 13 | 8.64e-01 | 2.74e-02 | 9.73e-01 |
SIGNALING BY FGFR4 | 31 | 7.93e-01 | 2.73e-02 | 9.53e-01 |
TRNA PROCESSING | 105 | 6.30e-01 | 2.72e-02 | 9.00e-01 |
TRP CHANNELS | 19 | 8.37e-01 | -2.72e-02 | 9.69e-01 |
RRNA PROCESSING IN THE MITOCHONDRION | 10 | 8.82e-01 | 2.71e-02 | 9.77e-01 |
NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 48 | 7.49e-01 | 2.67e-02 | 9.40e-01 |
RA BIOSYNTHESIS PATHWAY | 13 | 8.68e-01 | -2.67e-02 | 9.73e-01 |
SARS COV INFECTIONS | 139 | 5.90e-01 | 2.65e-02 | 8.83e-01 |
MAP2K AND MAPK ACTIVATION | 36 | 7.85e-01 | 2.63e-02 | 9.52e-01 |
RNA POLYMERASE III TRANSCRIPTION TERMINATION | 23 | 8.27e-01 | 2.63e-02 | 9.68e-01 |
ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | 30 | 8.04e-01 | 2.62e-02 | 9.55e-01 |
FRS MEDIATED FGFR4 SIGNALING | 12 | 8.75e-01 | 2.62e-02 | 9.77e-01 |
DISEASES OF GLYCOSYLATION | 125 | 6.14e-01 | 2.62e-02 | 8.93e-01 |
TRAF6 MEDIATED NF KB ACTIVATION | 22 | 8.35e-01 | -2.56e-02 | 9.68e-01 |
REGULATION OF TP53 ACTIVITY | 148 | 5.92e-01 | 2.56e-02 | 8.84e-01 |
IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX | 10 | 8.89e-01 | 2.55e-02 | 9.77e-01 |
CELLULAR RESPONSE TO HEAT STRESS | 95 | 6.70e-01 | 2.53e-02 | 9.12e-01 |
INFECTION WITH MYCOBACTERIUM TUBERCULOSIS | 24 | 8.33e-01 | -2.49e-02 | 9.68e-01 |
MTOR SIGNALLING | 40 | 7.86e-01 | -2.48e-02 | 9.52e-01 |
ASSEMBLY OF THE PRE REPLICATIVE COMPLEX | 64 | 7.32e-01 | -2.47e-02 | 9.33e-01 |
HIV TRANSCRIPTION INITIATION | 45 | 7.74e-01 | -2.47e-02 | 9.48e-01 |
CASPASE ACTIVATION VIA EXTRINSIC APOPTOTIC SIGNALLING PATHWAY | 23 | 8.38e-01 | -2.47e-02 | 9.69e-01 |
NEUTROPHIL DEGRANULATION | 383 | 4.17e-01 | 2.42e-02 | 7.93e-01 |
CHROMOSOME MAINTENANCE | 103 | 6.71e-01 | 2.42e-02 | 9.12e-01 |
FATTY ACID METABOLISM | 146 | 6.14e-01 | 2.42e-02 | 8.93e-01 |
RAC3 GTPASE CYCLE | 88 | 6.95e-01 | -2.42e-02 | 9.19e-01 |
HEMOSTASIS | 472 | 3.71e-01 | 2.41e-02 | 7.67e-01 |
PTK6 REGULATES RHO GTPASES RAS GTPASE AND MAP KINASES | 13 | 8.81e-01 | -2.41e-02 | 9.77e-01 |
IRAK4 DEFICIENCY TLR2 4 | 12 | 8.87e-01 | 2.38e-02 | 9.77e-01 |
AQUAPORIN MEDIATED TRANSPORT | 40 | 7.95e-01 | -2.37e-02 | 9.53e-01 |
SYNAPTIC ADHESION LIKE MOLECULES | 21 | 8.51e-01 | -2.36e-02 | 9.72e-01 |
ACYL CHAIN REMODELLING OF PC | 17 | 8.67e-01 | 2.35e-02 | 9.73e-01 |
RECEPTOR MEDIATED MITOPHAGY | 11 | 8.94e-01 | 2.32e-02 | 9.77e-01 |
TRANSCRIPTIONAL REGULATION BY SMALL RNAS | 61 | 7.54e-01 | -2.32e-02 | 9.42e-01 |
HIV LIFE CYCLE | 143 | 6.38e-01 | 2.28e-02 | 9.01e-01 |
RETROGRADE NEUROTROPHIN SIGNALLING | 14 | 8.82e-01 | 2.28e-02 | 9.77e-01 |
ION TRANSPORT BY P TYPE ATPASES | 47 | 7.89e-01 | -2.25e-02 | 9.53e-01 |
TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | 13 | 8.88e-01 | -2.25e-02 | 9.77e-01 |
NEGATIVE REGULATION OF FGFR2 SIGNALING | 27 | 8.40e-01 | 2.24e-02 | 9.69e-01 |
TRANSLESION SYNTHESIS BY POLH | 19 | 8.66e-01 | 2.23e-02 | 9.73e-01 |
NEUROTRANSMITTER RELEASE CYCLE | 48 | 7.89e-01 | 2.23e-02 | 9.53e-01 |
METABOLISM OF WATER SOLUBLE VITAMINS AND COFACTORS | 100 | 7.01e-01 | 2.22e-02 | 9.22e-01 |
INTERLEUKIN 6 SIGNALING | 10 | 9.03e-01 | -2.22e-02 | 9.77e-01 |
SENESCENCE ASSOCIATED SECRETORY PHENOTYPE SASP | 63 | 7.61e-01 | -2.22e-02 | 9.45e-01 |
INTRA GOLGI AND RETROGRADE GOLGI TO ER TRAFFIC | 184 | 6.05e-01 | -2.21e-02 | 8.89e-01 |
N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | 35 | 8.21e-01 | 2.21e-02 | 9.63e-01 |
CYCLIN A CDK2 ASSOCIATED EVENTS AT S PHASE ENTRY | 84 | 7.30e-01 | 2.18e-02 | 9.32e-01 |
SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | 31 | 8.36e-01 | -2.15e-02 | 9.68e-01 |
REGULATION OF RUNX1 EXPRESSION AND ACTIVITY | 17 | 8.78e-01 | 2.15e-02 | 9.77e-01 |
AMYLOID FIBER FORMATION | 57 | 7.81e-01 | -2.13e-02 | 9.50e-01 |
RUNX1 REGULATES TRANSCRIPTION OF GENES INVOLVED IN DIFFERENTIATION OF HSCS | 81 | 7.43e-01 | 2.11e-02 | 9.38e-01 |
GAB1 SIGNALOSOME | 14 | 8.92e-01 | 2.10e-02 | 9.77e-01 |
REGULATION OF HSF1 MEDIATED HEAT SHOCK RESPONSE | 76 | 7.53e-01 | -2.09e-02 | 9.42e-01 |
ONCOGENE INDUCED SENESCENCE | 32 | 8.39e-01 | -2.08e-02 | 9.69e-01 |
C TYPE LECTIN RECEPTORS CLRS | 112 | 7.04e-01 | 2.08e-02 | 9.22e-01 |
SIGNALING BY BRAF AND RAF FUSIONS | 60 | 7.81e-01 | -2.07e-02 | 9.50e-01 |
SURFACTANT METABOLISM | 16 | 8.87e-01 | 2.06e-02 | 9.77e-01 |
G0 AND EARLY G1 | 24 | 8.63e-01 | -2.04e-02 | 9.73e-01 |
NEGATIVE REGULATION OF FGFR1 SIGNALING | 26 | 8.57e-01 | 2.04e-02 | 9.73e-01 |
PEPTIDE LIGAND BINDING RECEPTORS | 103 | 7.25e-01 | -2.01e-02 | 9.28e-01 |
PECAM1 INTERACTIONS | 12 | 9.07e-01 | 1.94e-02 | 9.77e-01 |
REGULATION OF TP53 EXPRESSION AND DEGRADATION | 34 | 8.46e-01 | -1.93e-02 | 9.72e-01 |
BIOSYNTHESIS OF SPECIALIZED PRORESOLVING MEDIATORS SPMS | 12 | 9.08e-01 | -1.92e-02 | 9.77e-01 |
MEIOSIS | 63 | 7.93e-01 | -1.91e-02 | 9.53e-01 |
INTERLEUKIN 12 SIGNALING | 37 | 8.41e-01 | -1.90e-02 | 9.69e-01 |
SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | 14 | 9.02e-01 | 1.90e-02 | 9.77e-01 |
METABOLISM OF LIPIDS | 611 | 4.28e-01 | -1.89e-02 | 7.94e-01 |
MITOCHONDRIAL TRNA AMINOACYLATION | 21 | 8.82e-01 | 1.88e-02 | 9.77e-01 |
FC EPSILON RECEPTOR FCERI SIGNALING | 123 | 7.21e-01 | -1.87e-02 | 9.26e-01 |
SYNTHESIS OF IP2 IP AND INS IN THE CYTOSOL | 13 | 9.07e-01 | -1.86e-02 | 9.77e-01 |
MITOTIC SPINDLE CHECKPOINT | 96 | 7.53e-01 | -1.86e-02 | 9.42e-01 |
REGULATED NECROSIS | 45 | 8.31e-01 | -1.84e-02 | 9.68e-01 |
PKMTS METHYLATE HISTONE LYSINES | 48 | 8.26e-01 | 1.83e-02 | 9.67e-01 |
PERK REGULATES GENE EXPRESSION | 28 | 8.67e-01 | -1.82e-02 | 9.73e-01 |
PCNA DEPENDENT LONG PATCH BASE EXCISION REPAIR | 20 | 8.88e-01 | -1.82e-02 | 9.77e-01 |
SUMOYLATION OF DNA METHYLATION PROTEINS | 16 | 9.00e-01 | 1.81e-02 | 9.77e-01 |
VIRAL MESSENGER RNA SYNTHESIS | 42 | 8.40e-01 | -1.80e-02 | 9.69e-01 |
METABOLISM OF CARBOHYDRATES | 258 | 6.20e-01 | -1.80e-02 | 8.93e-01 |
TELOMERE C STRAND LAGGING STRAND SYNTHESIS | 33 | 8.58e-01 | 1.79e-02 | 9.73e-01 |
LOSS OF FUNCTION OF MECP2 IN RETT SYNDROME | 13 | 9.11e-01 | -1.79e-02 | 9.78e-01 |
CYCLIN A B1 B2 ASSOCIATED EVENTS DURING G2 M TRANSITION | 21 | 8.88e-01 | 1.77e-02 | 9.77e-01 |
INTEGRATION OF ENERGY METABOLISM | 98 | 7.67e-01 | 1.73e-02 | 9.45e-01 |
TRANSLESION SYNTHESIS BY POLK | 17 | 9.02e-01 | -1.73e-02 | 9.77e-01 |
GLUCAGON LIKE PEPTIDE 1 GLP1 REGULATES INSULIN SECRETION | 38 | 8.54e-01 | -1.73e-02 | 9.73e-01 |
TP53 REGULATES TRANSCRIPTION OF DNA REPAIR GENES | 61 | 8.18e-01 | -1.70e-02 | 9.62e-01 |
MISMATCH REPAIR | 14 | 9.13e-01 | 1.69e-02 | 9.79e-01 |
HS GAG DEGRADATION | 20 | 8.97e-01 | -1.68e-02 | 9.77e-01 |
COPI DEPENDENT GOLGI TO ER RETROGRADE TRAFFIC | 85 | 7.97e-01 | -1.61e-02 | 9.53e-01 |
CONDENSATION OF PROPHASE CHROMOSOMES | 27 | 8.85e-01 | -1.60e-02 | 9.77e-01 |
DOWNSTREAM SIGNAL TRANSDUCTION | 29 | 8.81e-01 | -1.60e-02 | 9.77e-01 |
METABOLISM OF FAT SOLUBLE VITAMINS | 33 | 8.77e-01 | 1.56e-02 | 9.77e-01 |
NEGATIVE REGULATION OF FGFR4 SIGNALING | 21 | 9.04e-01 | 1.52e-02 | 9.77e-01 |
ESTROGEN DEPENDENT GENE EXPRESSION | 100 | 7.99e-01 | -1.48e-02 | 9.53e-01 |
UPTAKE AND ACTIONS OF BACTERIAL TOXINS | 29 | 8.94e-01 | 1.43e-02 | 9.77e-01 |
INNATE IMMUNE SYSTEM | 772 | 5.07e-01 | 1.41e-02 | 8.51e-01 |
RNA POLYMERASE II TRANSCRIBES SNRNA GENES | 74 | 8.35e-01 | 1.40e-02 | 9.68e-01 |
KERATAN SULFATE BIOSYNTHESIS | 24 | 9.08e-01 | -1.37e-02 | 9.77e-01 |
INHIBITION OF DNA RECOMBINATION AT TELOMERE | 35 | 8.89e-01 | -1.36e-02 | 9.77e-01 |
DEUBIQUITINATION | 241 | 7.18e-01 | -1.35e-02 | 9.24e-01 |
SIGNAL TRANSDUCTION BY L1 | 21 | 9.15e-01 | 1.34e-02 | 9.80e-01 |
ACTIVATION OF ANTERIOR HOX GENES IN HINDBRAIN DEVELOPMENT DURING EARLY EMBRYOGENESIS | 66 | 8.53e-01 | 1.32e-02 | 9.73e-01 |
GOLGI TO ER RETROGRADE TRANSPORT | 118 | 8.05e-01 | -1.32e-02 | 9.55e-01 |
REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | 29 | 9.02e-01 | -1.32e-02 | 9.77e-01 |
ERYTHROPOIETIN ACTIVATES PHOSPHOINOSITIDE 3 KINASE PI3K | 11 | 9.40e-01 | 1.31e-02 | 9.84e-01 |
SIGNALING BY FGFR2 IN DISEASE | 36 | 8.93e-01 | 1.30e-02 | 9.77e-01 |
ANTI INFLAMMATORY RESPONSE FAVOURING LEISHMANIA PARASITE INFECTION | 114 | 8.11e-01 | -1.30e-02 | 9.57e-01 |
SIGNALING BY NOTCH1 PEST DOMAIN MUTANTS IN CANCER | 59 | 8.63e-01 | 1.30e-02 | 9.73e-01 |
SPHINGOLIPID METABOLISM | 79 | 8.46e-01 | -1.27e-02 | 9.72e-01 |
VITAMIN B5 PANTOTHENATE METABOLISM | 14 | 9.35e-01 | -1.25e-02 | 9.83e-01 |
TRAFFICKING OF AMPA RECEPTORS | 31 | 9.04e-01 | 1.25e-02 | 9.77e-01 |
TICAM1 TRAF6 DEPENDENT INDUCTION OF TAK1 COMPLEX | 11 | 9.43e-01 | 1.25e-02 | 9.84e-01 |
TIE2 SIGNALING | 17 | 9.29e-01 | 1.25e-02 | 9.83e-01 |
SIGNALING BY VEGF | 102 | 8.30e-01 | 1.23e-02 | 9.68e-01 |
SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | 20 | 9.25e-01 | -1.22e-02 | 9.83e-01 |
GENE SILENCING BY RNA | 84 | 8.50e-01 | -1.20e-02 | 9.72e-01 |
REGULATION OF INSULIN SECRETION | 71 | 8.62e-01 | -1.20e-02 | 9.73e-01 |
RECOGNITION AND ASSOCIATION OF DNA GLYCOSYLASE WITH SITE CONTAINING AN AFFECTED PURINE | 22 | 9.23e-01 | 1.19e-02 | 9.83e-01 |
TRNA PROCESSING IN THE NUCLEUS | 56 | 8.80e-01 | -1.16e-02 | 9.77e-01 |
TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR TC NER | 77 | 8.60e-01 | -1.16e-02 | 9.73e-01 |
MUSCLE CONTRACTION | 163 | 8.01e-01 | 1.15e-02 | 9.54e-01 |
SIGNALING BY ERBB2 | 48 | 8.91e-01 | -1.14e-02 | 9.77e-01 |
RND3 GTPASE CYCLE | 38 | 9.03e-01 | -1.14e-02 | 9.77e-01 |
RHOJ GTPASE CYCLE | 54 | 8.89e-01 | 1.10e-02 | 9.77e-01 |
PROTEIN LOCALIZATION | 156 | 8.14e-01 | -1.09e-02 | 9.58e-01 |
SIGNALING BY THE B CELL RECEPTOR BCR | 103 | 8.50e-01 | -1.08e-02 | 9.72e-01 |
SIGNALING BY EGFR | 47 | 8.98e-01 | 1.08e-02 | 9.77e-01 |
DUAL INCISION IN TC NER | 64 | 8.83e-01 | -1.07e-02 | 9.77e-01 |
SNRNP ASSEMBLY | 51 | 8.97e-01 | -1.05e-02 | 9.77e-01 |
SIRT1 NEGATIVELY REGULATES RRNA EXPRESSION | 24 | 9.30e-01 | -1.04e-02 | 9.83e-01 |
SIGNALING BY RECEPTOR TYROSINE KINASES | 464 | 7.03e-01 | 1.04e-02 | 9.22e-01 |
VEGFR2 MEDIATED CELL PROLIFERATION | 19 | 9.38e-01 | 1.03e-02 | 9.84e-01 |
RHOD GTPASE CYCLE | 50 | 9.04e-01 | 9.81e-03 | 9.77e-01 |
MRNA CAPPING | 29 | 9.29e-01 | 9.62e-03 | 9.83e-01 |
TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | 77 | 8.84e-01 | 9.58e-03 | 9.77e-01 |
CALNEXIN CALRETICULIN CYCLE | 26 | 9.33e-01 | 9.55e-03 | 9.83e-01 |
CELL CYCLE MITOTIC | 471 | 7.24e-01 | 9.54e-03 | 9.27e-01 |
P38MAPK EVENTS | 13 | 9.53e-01 | 9.47e-03 | 9.84e-01 |
TRANSCRIPTIONAL REGULATION BY TP53 | 338 | 7.67e-01 | -9.41e-03 | 9.45e-01 |
DISORDERS OF TRANSMEMBRANE TRANSPORTERS | 140 | 8.51e-01 | -9.23e-03 | 9.72e-01 |
ERYTHROPOIETIN ACTIVATES RAS | 13 | 9.55e-01 | 9.04e-03 | 9.84e-01 |
DISEASES ASSOCIATED WITH O GLYCOSYLATION OF PROTEINS | 52 | 9.11e-01 | 8.97e-03 | 9.78e-01 |
ONCOGENIC MAPK SIGNALING | 77 | 8.93e-01 | -8.86e-03 | 9.77e-01 |
TRANSPORT OF THE SLBP DEPENDANT MATURE MRNA | 34 | 9.29e-01 | -8.80e-03 | 9.83e-01 |
DISEASES OF SIGNAL TRANSDUCTION BY GROWTH FACTOR RECEPTORS AND SECOND MESSENGERS | 366 | 7.78e-01 | -8.59e-03 | 9.50e-01 |
SIGNALING BY NOTCH3 | 48 | 9.19e-01 | 8.50e-03 | 9.82e-01 |
RIPK1 MEDIATED REGULATED NECROSIS | 25 | 9.44e-01 | 8.10e-03 | 9.84e-01 |
ASPARTATE AND ASPARAGINE METABOLISM | 10 | 9.65e-01 | 8.05e-03 | 9.87e-01 |
DISEASES ASSOCIATED WITH GLYCOSYLATION PRECURSOR BIOSYNTHESIS | 18 | 9.55e-01 | -7.68e-03 | 9.84e-01 |
GLUCOSE METABOLISM | 80 | 9.06e-01 | 7.61e-03 | 9.77e-01 |
SIGNALING BY FGFR1 IN DISEASE | 32 | 9.41e-01 | 7.53e-03 | 9.84e-01 |
SIGNALING BY MODERATE KINASE ACTIVITY BRAF MUTANTS | 41 | 9.36e-01 | 7.22e-03 | 9.83e-01 |
HIV INFECTION | 221 | 8.59e-01 | 6.93e-03 | 9.73e-01 |
DNA DOUBLE STRAND BREAK RESPONSE | 52 | 9.33e-01 | 6.79e-03 | 9.83e-01 |
PRE NOTCH EXPRESSION AND PROCESSING | 63 | 9.27e-01 | 6.66e-03 | 9.83e-01 |
UPTAKE AND FUNCTION OF ANTHRAX TOXINS | 11 | 9.70e-01 | 6.66e-03 | 9.87e-01 |
DNA DAMAGE RECOGNITION IN GG NER | 38 | 9.44e-01 | 6.64e-03 | 9.84e-01 |
ATF4 ACTIVATES GENES IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 23 | 9.56e-01 | -6.60e-03 | 9.84e-01 |
BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN GENE EXPRESSION | 26 | 9.55e-01 | 6.41e-03 | 9.84e-01 |
PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | 15 | 9.67e-01 | 6.18e-03 | 9.87e-01 |
COPI MEDIATED ANTEROGRADE TRANSPORT | 90 | 9.20e-01 | -6.09e-03 | 9.82e-01 |
GLYCOLYSIS | 66 | 9.34e-01 | -5.90e-03 | 9.83e-01 |
MITOCHONDRIAL CALCIUM ION TRANSPORT | 23 | 9.61e-01 | -5.89e-03 | 9.85e-01 |
TP53 REGULATES TRANSCRIPTION OF CELL DEATH GENES | 35 | 9.52e-01 | 5.83e-03 | 9.84e-01 |
REGULATION OF TP53 ACTIVITY THROUGH PHOSPHORYLATION | 87 | 9.26e-01 | -5.73e-03 | 9.83e-01 |
CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | 49 | 9.45e-01 | 5.72e-03 | 9.84e-01 |
METABOLISM OF NITRIC OXIDE NOS3 ACTIVATION AND REGULATION | 15 | 9.70e-01 | -5.68e-03 | 9.87e-01 |
MHC CLASS II ANTIGEN PRESENTATION | 103 | 9.21e-01 | 5.66e-03 | 9.82e-01 |
FLT3 SIGNALING IN DISEASE | 27 | 9.61e-01 | -5.51e-03 | 9.85e-01 |
RND2 GTPASE CYCLE | 38 | 9.54e-01 | 5.45e-03 | 9.84e-01 |
SIGNALING BY FGFR1 | 43 | 9.51e-01 | -5.41e-03 | 9.84e-01 |
RET SIGNALING | 37 | 9.56e-01 | -5.24e-03 | 9.84e-01 |
CELLULAR SENESCENCE | 140 | 9.16e-01 | 5.17e-03 | 9.80e-01 |
PHASE II CONJUGATION OF COMPOUNDS | 60 | 9.45e-01 | 5.11e-03 | 9.84e-01 |
HOST INTERACTIONS OF HIV FACTORS | 125 | 9.24e-01 | -4.94e-03 | 9.83e-01 |
UB SPECIFIC PROCESSING PROTEASES | 167 | 9.14e-01 | -4.87e-03 | 9.79e-01 |
RHO GTPASES ACTIVATE PKNS | 47 | 9.54e-01 | -4.84e-03 | 9.84e-01 |
ORC1 REMOVAL FROM CHROMATIN | 67 | 9.46e-01 | -4.80e-03 | 9.84e-01 |
KERATAN SULFATE KERATIN METABOLISM | 30 | 9.64e-01 | 4.74e-03 | 9.87e-01 |
RUNX3 REGULATES NOTCH SIGNALING | 13 | 9.77e-01 | 4.62e-03 | 9.91e-01 |
POSTMITOTIC NUCLEAR PORE COMPLEX NPC REFORMATION | 26 | 9.68e-01 | -4.49e-03 | 9.87e-01 |
METABOLISM OF STEROIDS | 112 | 9.35e-01 | 4.47e-03 | 9.83e-01 |
SUMOYLATION OF TRANSCRIPTION COFACTORS | 42 | 9.60e-01 | -4.46e-03 | 9.85e-01 |
INTRACELLULAR SIGNALING BY SECOND MESSENGERS | 282 | 9.01e-01 | 4.32e-03 | 9.77e-01 |
TELOMERE MAINTENANCE | 79 | 9.48e-01 | 4.25e-03 | 9.84e-01 |
AMINO ACIDS REGULATE MTORC1 | 51 | 9.58e-01 | -4.25e-03 | 9.85e-01 |
DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | 78 | 9.49e-01 | 4.23e-03 | 9.84e-01 |
SIGNALING BY NODAL | 15 | 9.79e-01 | 3.94e-03 | 9.91e-01 |
APOPTOSIS | 162 | 9.34e-01 | 3.79e-03 | 9.83e-01 |
RORA ACTIVATES GENE EXPRESSION | 18 | 9.78e-01 | -3.73e-03 | 9.91e-01 |
SPHINGOLIPID DE NOVO BIOSYNTHESIS | 41 | 9.68e-01 | 3.67e-03 | 9.87e-01 |
BRANCHED CHAIN AMINO ACID CATABOLISM | 21 | 9.77e-01 | -3.65e-03 | 9.91e-01 |
PHOSPHOLIPID METABOLISM | 186 | 9.32e-01 | -3.61e-03 | 9.83e-01 |
BETA CATENIN INDEPENDENT WNT SIGNALING | 138 | 9.43e-01 | 3.52e-03 | 9.84e-01 |
FREE FATTY ACIDS REGULATE INSULIN SECRETION | 10 | 9.86e-01 | -3.25e-03 | 9.94e-01 |
FOXO MEDIATED TRANSCRIPTION OF CELL CYCLE GENES | 17 | 9.82e-01 | 3.22e-03 | 9.92e-01 |
METABOLISM OF STEROID HORMONES | 20 | 9.80e-01 | 3.20e-03 | 9.91e-01 |
SUMOYLATION OF DNA REPLICATION PROTEINS | 42 | 9.76e-01 | -2.70e-03 | 9.91e-01 |
SIGNALING BY EGFR IN CANCER | 22 | 9.85e-01 | 2.29e-03 | 9.94e-01 |
PROTEIN METHYLATION | 17 | 9.88e-01 | -2.12e-03 | 9.94e-01 |
TRANSPORT OF BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | 62 | 9.79e-01 | 1.97e-03 | 9.91e-01 |
SIGNALING BY WNT | 266 | 9.60e-01 | -1.77e-03 | 9.85e-01 |
PURINE SALVAGE | 12 | 9.92e-01 | -1.64e-03 | 9.96e-01 |
CELL CYCLE | 589 | 9.47e-01 | 1.59e-03 | 9.84e-01 |
PROGRAMMED CELL DEATH | 184 | 9.71e-01 | -1.54e-03 | 9.88e-01 |
GENE AND PROTEIN EXPRESSION BY JAK STAT SIGNALING AFTER INTERLEUKIN 12 STIMULATION | 32 | 9.88e-01 | 1.51e-03 | 9.94e-01 |
ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 1 | 23 | 9.90e-01 | -1.44e-03 | 9.96e-01 |
ACTIVATION OF GENE EXPRESSION BY SREBF SREBP | 43 | 9.87e-01 | -1.39e-03 | 9.94e-01 |
RESPONSE OF EIF2AK1 HRI TO HEME DEFICIENCY | 14 | 9.93e-01 | 1.26e-03 | 9.96e-01 |
EPHA MEDIATED GROWTH CONE COLLAPSE | 27 | 9.92e-01 | 1.06e-03 | 9.96e-01 |
FCERI MEDIATED CA 2 MOBILIZATION | 26 | 9.96e-01 | 5.64e-04 | 9.97e-01 |
G ALPHA Q SIGNALLING EVENTS | 156 | 9.96e-01 | -2.31e-04 | 9.97e-01 |
NOTCH3 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 23 | 1.00e+00 | -1.55e-05 | 1.00e+00 |
MET ACTIVATES RAP1 AND RAC1
534 | |
---|---|
set | MET ACTIVATES RAP1 AND RAC1 |
setSize | 11 |
pANOVA | 0.00104 |
s.dist | -0.571 |
p.adjustANOVA | 0.0296 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Rap1b | -8382 |
Met | -7793 |
Hgf | -7787 |
Rac1 | -7094 |
Dock7 | -6822 |
Crkl | -5515 |
Rap1a | -5254 |
Crk | -5197 |
Gab1 | -4850 |
Grb2 | -3233 |
Rapgef1 | 4681 |
GeneID | Gene Rank |
---|---|
Rap1b | -8382 |
Met | -7793 |
Hgf | -7787 |
Rac1 | -7094 |
Dock7 | -6822 |
Crkl | -5515 |
Rap1a | -5254 |
Crk | -5197 |
Gab1 | -4850 |
Grb2 | -3233 |
Rapgef1 | 4681 |
SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE
1039 | |
---|---|
set | SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE |
setSize | 11 |
pANOVA | 0.00215 |
s.dist | -0.534 |
p.adjustANOVA | 0.0511 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Pikfyve | -8077 |
Pik3c2a | -7961 |
Mtmr2 | -7642 |
Pik3c3 | -6280 |
Mtmr9 | -5965 |
Mtmr7 | -5768 |
Mtmr4 | -5613 |
Fig4 | -4289 |
Pik3r4 | -3300 |
Mtm1 | 393 |
Vac14 | 638 |
GeneID | Gene Rank |
---|---|
Pikfyve | -8077 |
Pik3c2a | -7961 |
Mtmr2 | -7642 |
Pik3c3 | -6280 |
Mtmr9 | -5965 |
Mtmr7 | -5768 |
Mtmr4 | -5613 |
Fig4 | -4289 |
Pik3r4 | -3300 |
Mtm1 | 393 |
Vac14 | 638 |
ACTIVATION OF RAC1
24 | |
---|---|
set | ACTIVATION OF RAC1 |
setSize | 13 |
pANOVA | 0.00176 |
s.dist | -0.501 |
p.adjustANOVA | 0.0448 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Slit2 | -8763 |
Pak1 | -7266 |
Robo1 | -7152 |
Rac1 | -7094 |
Sos2 | -6283 |
Sos1 | -5957 |
Pak5 | -5255 |
Pak3 | -3689 |
Pak6 | -2724 |
Pak2 | -2269 |
Pak4 | -1910 |
Nck2 | -1100 |
Nck1 | -530 |
GeneID | Gene Rank |
---|---|
Slit2 | -8763 |
Pak1 | -7266 |
Robo1 | -7152 |
Rac1 | -7094 |
Sos2 | -6283 |
Sos1 | -5957 |
Pak5 | -5255 |
Pak3 | -3689 |
Pak6 | -2724 |
Pak2 | -2269 |
Pak4 | -1910 |
Nck2 | -1100 |
Nck1 | -530 |
INITIAL TRIGGERING OF COMPLEMENT
443 | |
---|---|
set | INITIAL TRIGGERING OF COMPLEMENT |
setSize | 10 |
pANOVA | 0.01 |
s.dist | 0.47 |
p.adjustANOVA | 0.154 |
Top enriched genes
GeneID | Gene Rank |
---|---|
C2 | 7830 |
Cfp | 7752 |
C1qb | 6966 |
Masp2 | 5994 |
C4b | 4905 |
C1qc | 4382 |
C1qa | 3001 |
Masp1 | 2826 |
Gzmm | -547 |
Cfb | -7716 |
GeneID | Gene Rank |
---|---|
C2 | 7830 |
Cfp | 7752 |
C1qb | 6966 |
Masp2 | 5994 |
C4b | 4905 |
C1qc | 4382 |
C1qa | 3001 |
Masp1 | 2826 |
Gzmm | -547 |
Cfb | -7716 |
CYTOSOLIC IRON SULFUR CLUSTER ASSEMBLY
199 | |
---|---|
set | CYTOSOLIC IRON SULFUR CLUSTER ASSEMBLY |
setSize | 13 |
pANOVA | 0.00633 |
s.dist | 0.437 |
p.adjustANOVA | 0.115 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Ercc2 | 7653 |
Ciao2b | 7479 |
Ndor1 | 7409 |
Pold1 | 6726 |
Ciapin1 | 5074 |
Ciao3 | 5063 |
Rtel1 | 4820 |
Brip1 | 4238 |
Nubp1 | 3460 |
Abcb7 | -1266 |
Mms19 | -1589 |
Nubp2 | -3102 |
Ciao1 | -3545 |
GeneID | Gene Rank |
---|---|
Ercc2 | 7653 |
Ciao2b | 7479 |
Ndor1 | 7409 |
Pold1 | 6726 |
Ciapin1 | 5074 |
Ciao3 | 5063 |
Rtel1 | 4820 |
Brip1 | 4238 |
Nubp1 | 3460 |
Abcb7 | -1266 |
Mms19 | -1589 |
Nubp2 | -3102 |
Ciao1 | -3545 |
EUKARYOTIC TRANSLATION ELONGATION
301 | |
---|---|
set | EUKARYOTIC TRANSLATION ELONGATION |
setSize | 87 |
pANOVA | 1.86e-12 |
s.dist | 0.437 |
p.adjustANOVA | 2.18e-09 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Rps28 | 7597 |
Rps8 | 7450 |
Rpl26 | 7359 |
Rpl28 | 7124 |
Eef1d | 6824 |
Rpl38 | 6634 |
Rplp2 | 6619 |
Rps29 | 6609 |
Eef1a2 | 6277 |
Rpl35 | 6264 |
Eef2 | 6157 |
Rpl23a | 6154 |
Rps13 | 5967 |
Rps27a | 5852 |
Rps21 | 5714 |
Rps2 | 5693 |
Rpl23 | 5633 |
Rps9 | 5593 |
Rpl37a | 5545 |
Rps4x | 5533 |
GeneID | Gene Rank |
---|---|
Rps28 | 7597 |
Rps8 | 7450 |
Rpl26 | 7359 |
Rpl28 | 7124 |
Eef1d | 6824 |
Rpl38 | 6634 |
Rplp2 | 6619 |
Rps29 | 6609 |
Eef1a2 | 6277 |
Rpl35 | 6264 |
Eef2 | 6157 |
Rpl23a | 6154 |
Rps13 | 5967 |
Rps27a | 5852 |
Rps21 | 5714 |
Rps2 | 5693 |
Rpl23 | 5633 |
Rps9 | 5593 |
Rpl37a | 5545 |
Rps4x | 5533 |
Rps26 | 5531 |
Rpl37 | 5530 |
Rps19 | 5400 |
Rpl6 | 5381 |
Rps18 | 5259 |
Rpl8 | 5182 |
Rps27l | 4781 |
Rpl35a | 4749 |
Eef1g | 4670 |
Rplp1 | 4497 |
Rpl7a | 4489 |
Rpl24 | 4485 |
Rps25 | 4349 |
Rps3a1 | 4211 |
Rpl14 | 4027 |
Rpl32 | 4021 |
Rpl13 | 3983 |
Rps17 | 3940 |
Rps11 | 3934 |
Rpl18a | 3929 |
Uba52 | 3876 |
Rpl12 | 3790 |
Rpl10 | 3755 |
Rps6 | 3747 |
Fau | 3714 |
Rpl30 | 3435 |
Rps16 | 3425 |
Rpl31 | 3267 |
Rps14 | 3149 |
Rps24 | 3077 |
Rps15 | 3027 |
Rpl21 | 3024 |
Rps10 | 2979 |
Rpl27a | 2892 |
Eef1b2 | 2808 |
Rpl36al | 2751 |
Rps7 | 2731 |
Rpl19 | 2668 |
Rpl3 | 2654 |
Rpsa | 2614 |
Rpl36 | 2443 |
Rpl11 | 2320 |
Rps5 | 2249 |
Rpl18 | 1869 |
Rps27 | 1669 |
Rpl9 | 1493 |
Rpl5 | 1297 |
Rps12 | 1217 |
Rpl36a | 927 |
Rpl10a | 895 |
Rpl4 | 873 |
Rps23 | 872 |
Rpl22 | 732 |
Rpl27 | 529 |
Rpl13a | 406 |
Rps20 | -240 |
Rplp0 | -309 |
Rpl29 | -312 |
Rpl34 | -373 |
Rps3 | -775 |
Rpl7 | -1359 |
Rps15a | -1947 |
Rpl39 | -2430 |
Rpl17 | -2699 |
Eef1a1 | -2849 |
Rpl15 | -3330 |
Rpl22l1 | -3372 |
CREB1 PHOSPHORYLATION THROUGH THE ACTIVATION OF ADENYLATE CYCLASE
185 | |
---|---|
set | CREB1 PHOSPHORYLATION THROUGH THE ACTIVATION OF ADENYLATE CYCLASE |
setSize | 11 |
pANOVA | 0.0122 |
s.dist | -0.437 |
p.adjustANOVA | 0.171 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Prkacb | -8544 |
Prkar2b | -8346 |
Prkar1a | -7991 |
Creb1 | -7647 |
Prkx | -7158 |
Calm1 | -6803 |
Adcy1 | -4571 |
Prkar1b | -546 |
Adcy8 | 661 |
Prkaca | 1782 |
Prkar2a | 4341 |
GeneID | Gene Rank |
---|---|
Prkacb | -8544 |
Prkar2b | -8346 |
Prkar1a | -7991 |
Creb1 | -7647 |
Prkx | -7158 |
Calm1 | -6803 |
Adcy1 | -4571 |
Prkar1b | -546 |
Adcy8 | 661 |
Prkaca | 1782 |
Prkar2a | 4341 |
NF KB IS ACTIVATED AND SIGNALS SURVIVAL
621 | |
---|---|
set | NF KB IS ACTIVATED AND SIGNALS SURVIVAL |
setSize | 13 |
pANOVA | 0.00681 |
s.dist | 0.433 |
p.adjustANOVA | 0.122 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Ikbkb | 6593 |
Nfkb1 | 6575 |
Irak1 | 6335 |
Rps27a | 5852 |
Ngfr | 5541 |
Uba52 | 3876 |
Ubc | 3089 |
Ubb | 2615 |
Ngf | 2468 |
Nfkbia | 2118 |
Sqstm1 | 727 |
Rela | 29 |
Traf6 | -3825 |
GeneID | Gene Rank |
---|---|
Ikbkb | 6593 |
Nfkb1 | 6575 |
Irak1 | 6335 |
Rps27a | 5852 |
Ngfr | 5541 |
Uba52 | 3876 |
Ubc | 3089 |
Ubb | 2615 |
Ngf | 2468 |
Nfkbia | 2118 |
Sqstm1 | 727 |
Rela | 29 |
Traf6 | -3825 |
ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON
20 | |
---|---|
set | ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON |
setSize | 16 |
pANOVA | 0.00278 |
s.dist | 0.432 |
p.adjustANOVA | 0.0636 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Irf3 | 7213 |
Ticam2 | 6835 |
Cd14 | 6545 |
Rps27a | 5852 |
Ikbke | 4960 |
Ptpn11 | 4357 |
Ticam1 | 4298 |
Tlr4 | 3893 |
Uba52 | 3876 |
Traf3 | 3513 |
Ubc | 3089 |
Tank | 2755 |
Ubb | 2615 |
Tbk1 | 643 |
Sarm1 | -166 |
Irf7 | -8811 |
GeneID | Gene Rank |
---|---|
Irf3 | 7213 |
Ticam2 | 6835 |
Cd14 | 6545 |
Rps27a | 5852 |
Ikbke | 4960 |
Ptpn11 | 4357 |
Ticam1 | 4298 |
Tlr4 | 3893 |
Uba52 | 3876 |
Traf3 | 3513 |
Ubc | 3089 |
Tank | 2755 |
Ubb | 2615 |
Tbk1 | 643 |
Sarm1 | -166 |
Irf7 | -8811 |
SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE
909 | |
---|---|
set | SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE |
setSize | 20 |
pANOVA | 0.000909 |
s.dist | 0.428 |
p.adjustANOVA | 0.0265 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Myl9 | 7852 |
Myh11 | 7708 |
Myh14 | 7493 |
Limk2 | 7421 |
Plxnb1 | 6902 |
Limk1 | 6628 |
Myh9 | 6341 |
Rhoc | 5770 |
Rnd1 | 5407 |
Myl6 | 4895 |
Myl12b | 4330 |
Myh10 | 3504 |
Arhgef11 | 2057 |
Erbb2 | 8 |
Sema4d | -257 |
Rock2 | -657 |
Rock1 | -1112 |
Arhgef12 | -2059 |
Rhoa | -3484 |
Rhob | -5010 |
GeneID | Gene Rank |
---|---|
Myl9 | 7852 |
Myh11 | 7708 |
Myh14 | 7493 |
Limk2 | 7421 |
Plxnb1 | 6902 |
Limk1 | 6628 |
Myh9 | 6341 |
Rhoc | 5770 |
Rnd1 | 5407 |
Myl6 | 4895 |
Myl12b | 4330 |
Myh10 | 3504 |
Arhgef11 | 2057 |
Erbb2 | 8 |
Sema4d | -257 |
Rock2 | -657 |
Rock1 | -1112 |
Arhgef12 | -2059 |
Rhoa | -3484 |
Rhob | -5010 |
SCAVENGING BY CLASS A RECEPTORS
901 | |
---|---|
set | SCAVENGING BY CLASS A RECEPTORS |
setSize | 14 |
pANOVA | 0.00755 |
s.dist | 0.412 |
p.adjustANOVA | 0.131 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Calr | 7889 |
Col1a2 | 7492 |
Colec12 | 7328 |
Apoe | 6023 |
Col3a1 | 5984 |
Col4a2 | 5670 |
Masp1 | 2826 |
Col1a1 | 2599 |
Hsp90b1 | 2547 |
Ftl1 | 1744 |
Apoa1 | -74 |
Fth1 | -278 |
Col4a1 | -844 |
Scara5 | -6165 |
GeneID | Gene Rank |
---|---|
Calr | 7889 |
Col1a2 | 7492 |
Colec12 | 7328 |
Apoe | 6023 |
Col3a1 | 5984 |
Col4a2 | 5670 |
Masp1 | 2826 |
Col1a1 | 2599 |
Hsp90b1 | 2547 |
Ftl1 | 1744 |
Apoa1 | -74 |
Fth1 | -278 |
Col4a1 | -844 |
Scara5 | -6165 |
SEROTONIN RECEPTORS
917 | |
---|---|
set | SEROTONIN RECEPTORS |
setSize | 10 |
pANOVA | 0.0292 |
s.dist | -0.398 |
p.adjustANOVA | 0.296 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Htr4 | -8729 |
Htr5a | -7227 |
Htr2a | -7180 |
Htr2c | -6735 |
Htr1d | -5086 |
Htr6 | -2887 |
Htr1f | -2717 |
Htr1a | 57 |
Htr1b | 1192 |
Htr7 | 1775 |
GeneID | Gene Rank |
---|---|
Htr4 | -8729 |
Htr5a | -7227 |
Htr2a | -7180 |
Htr2c | -6735 |
Htr1d | -5086 |
Htr6 | -2887 |
Htr1f | -2717 |
Htr1a | 57 |
Htr1b | 1192 |
Htr7 | 1775 |
COLLAGEN CHAIN TRIMERIZATION
164 | |
---|---|
set | COLLAGEN CHAIN TRIMERIZATION |
setSize | 40 |
pANOVA | 1.46e-05 |
s.dist | 0.396 |
p.adjustANOVA | 0.000812 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Col13a1 | 7899 |
Col26a1 | 7772 |
Col9a2 | 7757 |
Col27a1 | 7737 |
Col11a2 | 7685 |
Col12a1 | 7671 |
Col1a2 | 7492 |
Col16a1 | 7367 |
Col2a1 | 7012 |
Col5a2 | 6994 |
Col7a1 | 6814 |
Col5a3 | 6711 |
Col6a2 | 6291 |
Col3a1 | 5984 |
Col6a1 | 5959 |
Col4a2 | 5670 |
Col28a1 | 4763 |
Col6a3 | 4621 |
Col15a1 | 4606 |
Col9a3 | 3789 |
GeneID | Gene Rank |
---|---|
Col13a1 | 7899 |
Col26a1 | 7772 |
Col9a2 | 7757 |
Col27a1 | 7737 |
Col11a2 | 7685 |
Col12a1 | 7671 |
Col1a2 | 7492 |
Col16a1 | 7367 |
Col2a1 | 7012 |
Col5a2 | 6994 |
Col7a1 | 6814 |
Col5a3 | 6711 |
Col6a2 | 6291 |
Col3a1 | 5984 |
Col6a1 | 5959 |
Col4a2 | 5670 |
Col28a1 | 4763 |
Col6a3 | 4621 |
Col15a1 | 4606 |
Col9a3 | 3789 |
Col18a1 | 3050 |
Col24a1 | 2997 |
Col1a1 | 2599 |
Col4a5 | 2486 |
Col17a1 | 2390 |
Col6a5 | 2356 |
Col20a1 | 1863 |
Col4a3 | 1850 |
Col11a1 | 1221 |
Col14a1 | -449 |
Col19a1 | -590 |
Col8a1 | -758 |
Col4a1 | -844 |
Col5a1 | -939 |
Col23a1 | -3675 |
Col9a1 | -4500 |
Col6a6 | -5128 |
Col25a1 | -5179 |
Col22a1 | -5346 |
Col8a2 | -7555 |
SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE
1037 | |
---|---|
set | SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE |
setSize | 16 |
pANOVA | 0.00615 |
s.dist | -0.396 |
p.adjustANOVA | 0.114 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Pikfyve | -8077 |
Pik3c2a | -7961 |
Mtmr2 | -7642 |
Pik3c3 | -6280 |
Mtmr12 | -5786 |
Mtmr4 | -5613 |
Fig4 | -4289 |
Inpp5f | -4102 |
Inpp4a | -3940 |
Pi4k2b | -3897 |
Pik3r4 | -3300 |
Mtmr10 | -1072 |
Mtm1 | 393 |
Inpp4b | 582 |
Vac14 | 638 |
Pi4k2a | 669 |
GeneID | Gene Rank |
---|---|
Pikfyve | -8077 |
Pik3c2a | -7961 |
Mtmr2 | -7642 |
Pik3c3 | -6280 |
Mtmr12 | -5786 |
Mtmr4 | -5613 |
Fig4 | -4289 |
Inpp5f | -4102 |
Inpp4a | -3940 |
Pi4k2b | -3897 |
Pik3r4 | -3300 |
Mtmr10 | -1072 |
Mtm1 | 393 |
Inpp4b | 582 |
Vac14 | 638 |
Pi4k2a | 669 |
REGULATION OF INNATE IMMUNE RESPONSES TO CYTOSOLIC DNA
798 | |
---|---|
set | REGULATION OF INNATE IMMUNE RESPONSES TO CYTOSOLIC DNA |
setSize | 13 |
pANOVA | 0.0189 |
s.dist | 0.376 |
p.adjustANOVA | 0.227 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Irf3 | 7213 |
Rps27a | 5852 |
Sting1 | 5286 |
Ddx41 | 4210 |
Uba52 | 3876 |
Dtx4 | 3119 |
Ubc | 3089 |
Ubb | 2615 |
Trim56 | 1619 |
Tbk1 | 643 |
Trim32 | -53 |
Trex1 | -238 |
Trim21 | -1495 |
GeneID | Gene Rank |
---|---|
Irf3 | 7213 |
Rps27a | 5852 |
Sting1 | 5286 |
Ddx41 | 4210 |
Uba52 | 3876 |
Dtx4 | 3119 |
Ubc | 3089 |
Ubb | 2615 |
Trim56 | 1619 |
Tbk1 | 643 |
Trim32 | -53 |
Trex1 | -238 |
Trim21 | -1495 |
RESPONSE OF EIF2AK4 GCN2 TO AMINO ACID DEFICIENCY
833 | |
---|---|
set | RESPONSE OF EIF2AK4 GCN2 TO AMINO ACID DEFICIENCY |
setSize | 94 |
pANOVA | 3.75e-10 |
s.dist | 0.374 |
p.adjustANOVA | 7.95e-08 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Ddit3 | 7639 |
Rps28 | 7597 |
Rps8 | 7450 |
Rpl26 | 7359 |
Rpl28 | 7124 |
Rpl38 | 6634 |
Rplp2 | 6619 |
Rps29 | 6609 |
Rpl35 | 6264 |
Gcn1 | 6172 |
Rpl23a | 6154 |
Rps13 | 5967 |
Rps27a | 5852 |
Rps21 | 5714 |
Rps2 | 5693 |
Rpl23 | 5633 |
Rps9 | 5593 |
Rpl37a | 5545 |
Rps4x | 5533 |
Rps26 | 5531 |
GeneID | Gene Rank |
---|---|
Ddit3 | 7639 |
Rps28 | 7597 |
Rps8 | 7450 |
Rpl26 | 7359 |
Rpl28 | 7124 |
Rpl38 | 6634 |
Rplp2 | 6619 |
Rps29 | 6609 |
Rpl35 | 6264 |
Gcn1 | 6172 |
Rpl23a | 6154 |
Rps13 | 5967 |
Rps27a | 5852 |
Rps21 | 5714 |
Rps2 | 5693 |
Rpl23 | 5633 |
Rps9 | 5593 |
Rpl37a | 5545 |
Rps4x | 5533 |
Rps26 | 5531 |
Rpl37 | 5530 |
Rps19 | 5400 |
Rpl6 | 5381 |
Rps18 | 5259 |
Rpl8 | 5182 |
Rps27l | 4781 |
Rpl35a | 4749 |
Rplp1 | 4497 |
Rpl7a | 4489 |
Rpl24 | 4485 |
Rps25 | 4349 |
Rps3a1 | 4211 |
Rpl14 | 4027 |
Rpl32 | 4021 |
Rpl13 | 3983 |
Rps17 | 3940 |
Rps11 | 3934 |
Rpl18a | 3929 |
Uba52 | 3876 |
Atf4 | 3827 |
Rpl12 | 3790 |
Rpl10 | 3755 |
Rps6 | 3747 |
Fau | 3714 |
Rpl30 | 3435 |
Rps16 | 3425 |
Rpl31 | 3267 |
Rps14 | 3149 |
Rps24 | 3077 |
Rps15 | 3027 |
Rpl21 | 3024 |
Rps10 | 2979 |
Rpl27a | 2892 |
Rpl36al | 2751 |
Rps7 | 2731 |
Rpl19 | 2668 |
Rpl3 | 2654 |
Atf3 | 2633 |
Rpsa | 2614 |
Rpl36 | 2443 |
Rpl11 | 2320 |
Rps5 | 2249 |
Rpl18 | 1869 |
Rps27 | 1669 |
Rpl9 | 1493 |
Rpl5 | 1297 |
Rps12 | 1217 |
Rpl36a | 927 |
Rpl10a | 895 |
Impact | 879 |
Rpl4 | 873 |
Rps23 | 872 |
Eif2ak4 | 840 |
Rpl22 | 732 |
Rpl27 | 529 |
Rpl13a | 406 |
Rps20 | -240 |
Rplp0 | -309 |
Rpl29 | -312 |
Rpl34 | -373 |
Rps3 | -775 |
Eif2s1 | -1087 |
Rpl7 | -1359 |
Eif2s2 | -1396 |
Cebpg | -1746 |
Eif2s3x | -1929 |
Rps15a | -1947 |
Rpl39 | -2430 |
Rpl17 | -2699 |
Rpl15 | -3330 |
Rpl22l1 | -3372 |
Cebpb | -4230 |
Asns | -6276 |
Atf2 | -8357 |
ALPHA LINOLENIC OMEGA3 AND LINOLEIC OMEGA6 ACID METABOLISM
45 | |
---|---|
set | ALPHA LINOLENIC OMEGA3 AND LINOLEIC OMEGA6 ACID METABOLISM |
setSize | 12 |
pANOVA | 0.0277 |
s.dist | 0.367 |
p.adjustANOVA | 0.292 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Elovl1 | 7986 |
Acaa1a | 6080 |
Acot8 | 5801 |
Abcd1 | 5702 |
Fads1 | 5189 |
Hsd17b4 | 4959 |
Fads2 | 4816 |
Scp2 | 1613 |
Elovl5 | 404 |
Elovl2 | -903 |
Acsl1 | -4238 |
Acox1 | -5344 |
GeneID | Gene Rank |
---|---|
Elovl1 | 7986 |
Acaa1a | 6080 |
Acot8 | 5801 |
Abcd1 | 5702 |
Fads1 | 5189 |
Hsd17b4 | 4959 |
Fads2 | 4816 |
Scp2 | 1613 |
Elovl5 | 404 |
Elovl2 | -903 |
Acsl1 | -4238 |
Acox1 | -5344 |
COLLAGEN BIOSYNTHESIS AND MODIFYING ENZYMES
163 | |
---|---|
set | COLLAGEN BIOSYNTHESIS AND MODIFYING ENZYMES |
setSize | 63 |
pANOVA | 9.65e-07 |
s.dist | 0.357 |
p.adjustANOVA | 7.04e-05 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Col13a1 | 7899 |
Bmp1 | 7814 |
Col26a1 | 7772 |
Col9a2 | 7757 |
Col27a1 | 7737 |
Col11a2 | 7685 |
Col12a1 | 7671 |
P4ha2 | 7608 |
Col1a2 | 7492 |
Col16a1 | 7367 |
Plod3 | 7307 |
P3h3 | 7256 |
Colgalt1 | 7126 |
Col2a1 | 7012 |
Col5a2 | 6994 |
Col7a1 | 6814 |
Col5a3 | 6711 |
Serpinh1 | 6688 |
Col6a2 | 6291 |
Col3a1 | 5984 |
GeneID | Gene Rank |
---|---|
Col13a1 | 7899 |
Bmp1 | 7814 |
Col26a1 | 7772 |
Col9a2 | 7757 |
Col27a1 | 7737 |
Col11a2 | 7685 |
Col12a1 | 7671 |
P4ha2 | 7608 |
Col1a2 | 7492 |
Col16a1 | 7367 |
Plod3 | 7307 |
P3h3 | 7256 |
Colgalt1 | 7126 |
Col2a1 | 7012 |
Col5a2 | 6994 |
Col7a1 | 6814 |
Col5a3 | 6711 |
Serpinh1 | 6688 |
Col6a2 | 6291 |
Col3a1 | 5984 |
Col6a1 | 5959 |
P4ha3 | 5888 |
Col4a2 | 5670 |
P3h1 | 5214 |
P4ha1 | 4858 |
Col28a1 | 4763 |
Pcolce | 4733 |
Col6a3 | 4621 |
Col15a1 | 4606 |
Plod1 | 4559 |
Col9a3 | 3789 |
Ppib | 3226 |
Col18a1 | 3050 |
Col24a1 | 2997 |
Col1a1 | 2599 |
Col4a5 | 2486 |
Col17a1 | 2390 |
Col6a5 | 2356 |
Col20a1 | 1863 |
Col4a3 | 1850 |
Pcolce2 | 1603 |
Col11a1 | 1221 |
Tll2 | 1166 |
Plod2 | 558 |
Adamts14 | 546 |
Col14a1 | -449 |
Col19a1 | -590 |
Col8a1 | -758 |
Col4a1 | -844 |
Col5a1 | -939 |
P4hb | -1563 |
Crtap | -3463 |
Col23a1 | -3675 |
Tll1 | -3733 |
Colgalt2 | -3764 |
Col9a1 | -4500 |
Col6a6 | -5128 |
Col25a1 | -5179 |
Col22a1 | -5346 |
Adamts2 | -5585 |
P3h2 | -5829 |
Adamts3 | -6206 |
Col8a2 | -7555 |
NONSENSE MEDIATED DECAY NMD
629 | |
---|---|
set | NONSENSE MEDIATED DECAY NMD |
setSize | 109 |
pANOVA | 4.09e-10 |
s.dist | 0.347 |
p.adjustANOVA | 7.95e-08 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Rps28 | 7597 |
Upf3a | 7470 |
Rps8 | 7450 |
Rpl26 | 7359 |
Rpl28 | 7124 |
Rpl38 | 6634 |
Rplp2 | 6619 |
Rps29 | 6609 |
Rpl35 | 6264 |
Rpl23a | 6154 |
Rps13 | 5967 |
Upf2 | 5920 |
Rps27a | 5852 |
Upf3b | 5809 |
Eif4g1 | 5754 |
Rps21 | 5714 |
Rps2 | 5693 |
Rpl23 | 5633 |
Rps9 | 5593 |
Rpl37a | 5545 |
GeneID | Gene Rank |
---|---|
Rps28 | 7597 |
Upf3a | 7470 |
Rps8 | 7450 |
Rpl26 | 7359 |
Rpl28 | 7124 |
Rpl38 | 6634 |
Rplp2 | 6619 |
Rps29 | 6609 |
Rpl35 | 6264 |
Rpl23a | 6154 |
Rps13 | 5967 |
Upf2 | 5920 |
Rps27a | 5852 |
Upf3b | 5809 |
Eif4g1 | 5754 |
Rps21 | 5714 |
Rps2 | 5693 |
Rpl23 | 5633 |
Rps9 | 5593 |
Rpl37a | 5545 |
Rps4x | 5533 |
Rps26 | 5531 |
Rpl37 | 5530 |
Rps19 | 5400 |
Rpl6 | 5381 |
Rbm8a | 5293 |
Rps18 | 5259 |
Rpl8 | 5182 |
Casc3 | 5113 |
Rps27l | 4781 |
Eif4a3 | 4762 |
Rpl35a | 4749 |
Upf1 | 4646 |
Rplp1 | 4497 |
Rpl7a | 4489 |
Rpl24 | 4485 |
Rps25 | 4349 |
Rps3a1 | 4211 |
Rpl14 | 4027 |
Rpl32 | 4021 |
Rpl13 | 3983 |
Rps17 | 3940 |
Rps11 | 3934 |
Rpl18a | 3929 |
Uba52 | 3876 |
Rpl12 | 3790 |
Rpl10 | 3755 |
Rps6 | 3747 |
Fau | 3714 |
Rpl30 | 3435 |
Rps16 | 3425 |
Rpl31 | 3267 |
Magohb | 3263 |
Rps14 | 3149 |
Rps24 | 3077 |
Rps15 | 3027 |
Rpl21 | 3024 |
Rps10 | 2979 |
Rpl27a | 2892 |
Rpl36al | 2751 |
Rps7 | 2731 |
Rpl19 | 2668 |
Rpl3 | 2654 |
Rpsa | 2614 |
Rpl36 | 2443 |
Rpl11 | 2320 |
Rps5 | 2249 |
Smg5 | 2199 |
Rnps1 | 1880 |
Rpl18 | 1869 |
Ncbp2 | 1712 |
Smg9 | 1705 |
Rps27 | 1669 |
Rpl9 | 1493 |
Gspt2 | 1418 |
Rpl5 | 1297 |
Rps12 | 1217 |
Rpl36a | 927 |
Rpl10a | 895 |
Rpl4 | 873 |
Rps23 | 872 |
Rpl22 | 732 |
Ncbp1 | 630 |
Rpl27 | 529 |
Rpl13a | 406 |
Ppp2r1a | 137 |
Rps20 | -240 |
Rplp0 | -309 |
Rpl29 | -312 |
Rpl34 | -373 |
Rps3 | -775 |
Pabpc1 | -1124 |
Rpl7 | -1359 |
Rps15a | -1947 |
Magoh | -2121 |
Smg8 | -2131 |
Rpl39 | -2430 |
Smg1 | -2440 |
Ppp2ca | -2528 |
Rpl17 | -2699 |
Dcp1a | -2707 |
Rpl15 | -3330 |
Rpl22l1 | -3372 |
Smg7 | -3557 |
Smg6 | -4273 |
Ppp2r2a | -4883 |
Gspt1 | -5233 |
Etf1 | -6408 |
Pnrc2 | -7733 |
AGGREPHAGY
42 | |
---|---|
set | AGGREPHAGY |
setSize | 35 |
pANOVA | 0.00052 |
s.dist | 0.339 |
p.adjustANOVA | 0.0164 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Hsf1 | 7863 |
Prkn | 7558 |
Tubb4a | 7514 |
Vim | 7137 |
Tubb3 | 7125 |
Dynll2 | 6857 |
Hdac6 | 6801 |
Rps27a | 5852 |
Tubb6 | 5562 |
Cftr | 4729 |
Vcp | 4709 |
Park7 | 4550 |
Dync1h1 | 4204 |
Uba52 | 3876 |
Tuba1b | 3388 |
Ubc | 3089 |
Tuba4a | 2983 |
Pcnt | 2632 |
Ubb | 2615 |
Arl13b | 1722 |
GeneID | Gene Rank |
---|---|
Hsf1 | 7863 |
Prkn | 7558 |
Tubb4a | 7514 |
Vim | 7137 |
Tubb3 | 7125 |
Dynll2 | 6857 |
Hdac6 | 6801 |
Rps27a | 5852 |
Tubb6 | 5562 |
Cftr | 4729 |
Vcp | 4709 |
Park7 | 4550 |
Dync1h1 | 4204 |
Uba52 | 3876 |
Tuba1b | 3388 |
Ubc | 3089 |
Tuba4a | 2983 |
Pcnt | 2632 |
Ubb | 2615 |
Arl13b | 1722 |
Tubb4b | 1266 |
Dync1li1 | 1232 |
Tubb2a | 982 |
Tuba8 | 723 |
Tubb2b | 597 |
Dync1i1 | 565 |
Ift88 | 268 |
Ube2v1 | -76 |
Tuba1c | -502 |
Tuba1a | -1498 |
Dynll1 | -2176 |
Dync1i2 | -2459 |
Dync1li2 | -3015 |
Hsp90aa1 | -5314 |
Ube2n | -6198 |
ASSEMBLY OF ACTIVE LPL AND LIPC LIPASE COMPLEXES
73 | |
---|---|
set | ASSEMBLY OF ACTIVE LPL AND LIPC LIPASE COMPLEXES |
setSize | 10 |
pANOVA | 0.0637 |
s.dist | -0.339 |
p.adjustANOVA | 0.449 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Angptl4 | -8438 |
Lpl | -8375 |
Creb3l3 | -7989 |
Mbtps2 | -7343 |
Pcsk5 | -5807 |
Mbtps1 | -2771 |
Lmf2 | 1837 |
Lmf1 | 1892 |
Furin | 2198 |
Pcsk6 | 2268 |
GeneID | Gene Rank |
---|---|
Angptl4 | -8438 |
Lpl | -8375 |
Creb3l3 | -7989 |
Mbtps2 | -7343 |
Pcsk5 | -5807 |
Mbtps1 | -2771 |
Lmf2 | 1837 |
Lmf1 | 1892 |
Furin | 2198 |
Pcsk6 | 2268 |
COMPLEMENT CASCADE
168 | |
---|---|
set | COMPLEMENT CASCADE |
setSize | 22 |
pANOVA | 0.00603 |
s.dist | 0.338 |
p.adjustANOVA | 0.114 |
Top enriched genes
GeneID | Gene Rank |
---|---|
C2 | 7830 |
Cfp | 7752 |
C1qb | 6966 |
Serping1 | 6861 |
Masp2 | 5994 |
C4b | 4905 |
Clu | 4790 |
C1qc | 4382 |
Cd46 | 4241 |
C8g | 3014 |
C1qa | 3001 |
Masp1 | 2826 |
Cfh | 2570 |
Cr1l | 1928 |
Pros1 | 1027 |
Cd81 | 869 |
Cd55 | 766 |
Gzmm | -547 |
Cd59b | -1263 |
C3ar1 | -2345 |
GeneID | Gene Rank |
---|---|
C2 | 7830 |
Cfp | 7752 |
C1qb | 6966 |
Serping1 | 6861 |
Masp2 | 5994 |
C4b | 4905 |
Clu | 4790 |
C1qc | 4382 |
Cd46 | 4241 |
C8g | 3014 |
C1qa | 3001 |
Masp1 | 2826 |
Cfh | 2570 |
Cr1l | 1928 |
Pros1 | 1027 |
Cd81 | 869 |
Cd55 | 766 |
Gzmm | -547 |
Cd59b | -1263 |
C3ar1 | -2345 |
Vtn | -4402 |
Cfb | -7716 |
ROLE OF PHOSPHOLIPIDS IN PHAGOCYTOSIS
884 | |
---|---|
set | ROLE OF PHOSPHOLIPIDS IN PHAGOCYTOSIS |
setSize | 22 |
pANOVA | 0.00603 |
s.dist | 0.338 |
p.adjustANOVA | 0.114 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Pla2g6 | 7864 |
Plpp4 | 7854 |
Itpr3 | 7751 |
Prkcd | 7667 |
Plcg1 | 7468 |
Pld1 | 6608 |
Fcgr3 | 5696 |
Itpr2 | 5108 |
Fcgr1 | 5036 |
Pld2 | 5001 |
Plpp5 | 3070 |
Plcg2 | 2455 |
Pik3r2 | 1777 |
Pik3ca | 1397 |
Pld3 | 488 |
Ahcyl1 | -536 |
Pld4 | -741 |
Pik3r1 | -2773 |
Syk | -2933 |
Pik3cb | -3280 |
GeneID | Gene Rank |
---|---|
Pla2g6 | 7864 |
Plpp4 | 7854 |
Itpr3 | 7751 |
Prkcd | 7667 |
Plcg1 | 7468 |
Pld1 | 6608 |
Fcgr3 | 5696 |
Itpr2 | 5108 |
Fcgr1 | 5036 |
Pld2 | 5001 |
Plpp5 | 3070 |
Plcg2 | 2455 |
Pik3r2 | 1777 |
Pik3ca | 1397 |
Pld3 | 488 |
Ahcyl1 | -536 |
Pld4 | -741 |
Pik3r1 | -2773 |
Syk | -2933 |
Pik3cb | -3280 |
Itpr1 | -3732 |
Prkce | -7798 |
MECP2 REGULATES NEURONAL RECEPTORS AND CHANNELS
528 | |
---|---|
set | MECP2 REGULATES NEURONAL RECEPTORS AND CHANNELS |
setSize | 18 |
pANOVA | 0.0132 |
s.dist | -0.337 |
p.adjustANOVA | 0.18 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Ptpn4 | -8441 |
Slc2a3 | -8428 |
Oprk1 | -8305 |
Met | -7793 |
Creb1 | -7647 |
Gria2 | -7584 |
Grin2a | -7389 |
Grin2b | -6592 |
Mecp2 | -5261 |
Hdac2 | -4517 |
Trpc3 | -3236 |
Gprin1 | -2848 |
Sin3a | -516 |
Oprm1 | -230 |
Notch1 | 4059 |
Ptpn1 | 4215 |
Hdac1 | 4224 |
Fkbp5 | 7973 |
GeneID | Gene Rank |
---|---|
Ptpn4 | -8441 |
Slc2a3 | -8428 |
Oprk1 | -8305 |
Met | -7793 |
Creb1 | -7647 |
Gria2 | -7584 |
Grin2a | -7389 |
Grin2b | -6592 |
Mecp2 | -5261 |
Hdac2 | -4517 |
Trpc3 | -3236 |
Gprin1 | -2848 |
Sin3a | -516 |
Oprm1 | -230 |
Notch1 | 4059 |
Ptpn1 | 4215 |
Hdac1 | 4224 |
Fkbp5 | 7973 |
CROSSLINKING OF COLLAGEN FIBRILS
189 | |
---|---|
set | CROSSLINKING OF COLLAGEN FIBRILS |
setSize | 14 |
pANOVA | 0.029 |
s.dist | 0.337 |
p.adjustANOVA | 0.296 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Bmp1 | 7814 |
Col1a2 | 7492 |
Loxl3 | 7065 |
Col4a2 | 5670 |
Pcolce | 4733 |
Col1a1 | 2599 |
Col4a5 | 2486 |
Col4a3 | 1850 |
Loxl1 | 1235 |
Tll2 | 1166 |
Pxdn | 1009 |
Col4a1 | -844 |
Tll1 | -3733 |
Lox | -4657 |
GeneID | Gene Rank |
---|---|
Bmp1 | 7814 |
Col1a2 | 7492 |
Loxl3 | 7065 |
Col4a2 | 5670 |
Pcolce | 4733 |
Col1a1 | 2599 |
Col4a5 | 2486 |
Col4a3 | 1850 |
Loxl1 | 1235 |
Tll2 | 1166 |
Pxdn | 1009 |
Col4a1 | -844 |
Tll1 | -3733 |
Lox | -4657 |
SEMA4D IN SEMAPHORIN SIGNALING
908 | |
---|---|
set | SEMA4D IN SEMAPHORIN SIGNALING |
setSize | 24 |
pANOVA | 0.00468 |
s.dist | 0.334 |
p.adjustANOVA | 0.0976 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Myl9 | 7852 |
Myh11 | 7708 |
Myh14 | 7493 |
Limk2 | 7421 |
Plxnb1 | 6902 |
Limk1 | 6628 |
Myh9 | 6341 |
Rras | 6066 |
Rhoc | 5770 |
Rnd1 | 5407 |
Myl6 | 4895 |
Myl12b | 4330 |
Myh10 | 3504 |
Arhgap35 | 2431 |
Arhgef11 | 2057 |
Erbb2 | 8 |
Sema4d | -257 |
Rock2 | -657 |
Rock1 | -1112 |
Arhgef12 | -2059 |
GeneID | Gene Rank |
---|---|
Myl9 | 7852 |
Myh11 | 7708 |
Myh14 | 7493 |
Limk2 | 7421 |
Plxnb1 | 6902 |
Limk1 | 6628 |
Myh9 | 6341 |
Rras | 6066 |
Rhoc | 5770 |
Rnd1 | 5407 |
Myl6 | 4895 |
Myl12b | 4330 |
Myh10 | 3504 |
Arhgap35 | 2431 |
Arhgef11 | 2057 |
Erbb2 | 8 |
Sema4d | -257 |
Rock2 | -657 |
Rock1 | -1112 |
Arhgef12 | -2059 |
Rhoa | -3484 |
Rhob | -5010 |
Rac1 | -7094 |
Met | -7793 |
ESTROGEN DEPENDENT NUCLEAR EVENTS DOWNSTREAM OF ESR MEMBRANE SIGNALING
300 | |
---|---|
set | ESTROGEN DEPENDENT NUCLEAR EVENTS DOWNSTREAM OF ESR MEMBRANE SIGNALING |
setSize | 21 |
pANOVA | 0.00855 |
s.dist | -0.332 |
p.adjustANOVA | 0.139 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Mapk1 | -8630 |
Creb1 | -7647 |
Akt3 | -7429 |
Btc | -6799 |
Cdkn1b | -6707 |
Uhmk1 | -6500 |
Elk1 | -5299 |
Foxo3 | -5228 |
Xpo1 | -4807 |
Ccnd1 | -4628 |
Egf | -4464 |
Tgfa | -3521 |
Fos | -2716 |
Srf | -1840 |
Ptk2 | -1711 |
Mapk3 | -652 |
Egfr | -281 |
Akt2 | 1546 |
Hbegf | 1766 |
Akt1 | 2472 |
GeneID | Gene Rank |
---|---|
Mapk1 | -8630 |
Creb1 | -7647 |
Akt3 | -7429 |
Btc | -6799 |
Cdkn1b | -6707 |
Uhmk1 | -6500 |
Elk1 | -5299 |
Foxo3 | -5228 |
Xpo1 | -4807 |
Ccnd1 | -4628 |
Egf | -4464 |
Tgfa | -3521 |
Fos | -2716 |
Srf | -1840 |
Ptk2 | -1711 |
Mapk3 | -652 |
Egfr | -281 |
Akt2 | 1546 |
Hbegf | 1766 |
Akt1 | 2472 |
Bcl2 | 6063 |
SELENOAMINO ACID METABOLISM
905 | |
---|---|
set | SELENOAMINO ACID METABOLISM |
setSize | 108 |
pANOVA | 2.69e-09 |
s.dist | 0.331 |
p.adjustANOVA | 4.36e-07 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Ahcy | 7694 |
Rps28 | 7597 |
Rps8 | 7450 |
Gnmt | 7447 |
Rpl26 | 7359 |
Rpl28 | 7124 |
Rpl38 | 6634 |
Sars | 6629 |
Rplp2 | 6619 |
Rps29 | 6609 |
Aimp2 | 6285 |
Rpl35 | 6264 |
Mars1 | 6189 |
Rpl23a | 6154 |
Secisbp2 | 6007 |
Rps13 | 5967 |
Rps27a | 5852 |
Rps21 | 5714 |
Rps2 | 5693 |
Rpl23 | 5633 |
GeneID | Gene Rank |
---|---|
Ahcy | 7694 |
Rps28 | 7597 |
Rps8 | 7450 |
Gnmt | 7447 |
Rpl26 | 7359 |
Rpl28 | 7124 |
Rpl38 | 6634 |
Sars | 6629 |
Rplp2 | 6619 |
Rps29 | 6609 |
Aimp2 | 6285 |
Rpl35 | 6264 |
Mars1 | 6189 |
Rpl23a | 6154 |
Secisbp2 | 6007 |
Rps13 | 5967 |
Rps27a | 5852 |
Rps21 | 5714 |
Rps2 | 5693 |
Rpl23 | 5633 |
Rps9 | 5593 |
Rpl37a | 5545 |
Rps4x | 5533 |
Rps26 | 5531 |
Rpl37 | 5530 |
Rps19 | 5400 |
Rpl6 | 5381 |
Rps18 | 5259 |
Rpl8 | 5182 |
Rps27l | 4781 |
Rpl35a | 4749 |
Rplp1 | 4497 |
Rpl7a | 4489 |
Rpl24 | 4485 |
Rps25 | 4349 |
Rps3a1 | 4211 |
Rpl14 | 4027 |
Rpl32 | 4021 |
Rpl13 | 3983 |
Rps17 | 3940 |
Rps11 | 3934 |
Rpl18a | 3929 |
Uba52 | 3876 |
Rpl12 | 3790 |
Rpl10 | 3755 |
Rps6 | 3747 |
Fau | 3714 |
Rpl30 | 3435 |
Rps16 | 3425 |
Iars | 3409 |
Rpl31 | 3267 |
Rps14 | 3149 |
Rps24 | 3077 |
Rps15 | 3027 |
Rpl21 | 3024 |
Rps10 | 2979 |
Rpl27a | 2892 |
Rpl36al | 2751 |
Rps7 | 2731 |
Cbs | 2675 |
Rpl19 | 2668 |
Rpl3 | 2654 |
Rpsa | 2614 |
Eprs | 2605 |
Rpl36 | 2443 |
Rpl11 | 2320 |
Rps5 | 2249 |
Rpl18 | 1869 |
Rps27 | 1669 |
Rpl9 | 1493 |
Aimp1 | 1374 |
Rpl5 | 1297 |
Rps12 | 1217 |
Papss1 | 1045 |
Rpl36a | 927 |
Scly | 914 |
Rpl10a | 895 |
Rpl4 | 873 |
Rps23 | 872 |
Rpl22 | 732 |
Rpl27 | 529 |
Rpl13a | 406 |
Eefsec | 40 |
Rps20 | -240 |
Kars | -285 |
Rplp0 | -309 |
Rpl29 | -312 |
Rpl34 | -373 |
Rps3 | -775 |
Eef1e1 | -1262 |
Cth | -1320 |
Rpl7 | -1359 |
Lars | -1628 |
Rps15a | -1947 |
Rpl39 | -2430 |
Rpl17 | -2699 |
Rars | -3016 |
Qars | -3269 |
Rpl15 | -3330 |
Gsr | -3354 |
Rpl22l1 | -3372 |
Pstk | -3567 |
Txnrd1 | -3581 |
Papss2 | -5732 |
Sepsecs | -6611 |
Dars | -7284 |
Hnmt | -7349 |
Sephs2 | -7623 |
P75NTR SIGNALS VIA NF KB
675 | |
---|---|
set | P75NTR SIGNALS VIA NF KB |
setSize | 16 |
pANOVA | 0.025 |
s.dist | 0.324 |
p.adjustANOVA | 0.273 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Myd88 | 6716 |
Ikbkb | 6593 |
Nfkb1 | 6575 |
Irak1 | 6335 |
Rps27a | 5852 |
Ngfr | 5541 |
Uba52 | 3876 |
Ubc | 3089 |
Ubb | 2615 |
Ngf | 2468 |
Nfkbia | 2118 |
Sqstm1 | 727 |
Rela | 29 |
Ripk2 | -3192 |
Traf6 | -3825 |
Prkci | -8596 |
GeneID | Gene Rank |
---|---|
Myd88 | 6716 |
Ikbkb | 6593 |
Nfkb1 | 6575 |
Irak1 | 6335 |
Rps27a | 5852 |
Ngfr | 5541 |
Uba52 | 3876 |
Ubc | 3089 |
Ubb | 2615 |
Ngf | 2468 |
Nfkbia | 2118 |
Sqstm1 | 727 |
Rela | 29 |
Ripk2 | -3192 |
Traf6 | -3825 |
Prkci | -8596 |
ABERRANT REGULATION OF MITOTIC G1 S TRANSITION IN CANCER DUE TO RB1 DEFECTS
6 | |
---|---|
set | ABERRANT REGULATION OF MITOTIC G1 S TRANSITION IN CANCER DUE TO RB1 DEFECTS |
setSize | 17 |
pANOVA | 0.0225 |
s.dist | -0.32 |
p.adjustANOVA | 0.257 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Cdkn1a | -8508 |
E2f3 | -6816 |
Cdkn1b | -6707 |
Rb1 | -6356 |
Ccne2 | -5713 |
E2f2 | -5139 |
E2f1 | -4656 |
Ccnd2 | -4633 |
Ccnd1 | -4628 |
Cdkn1c | -4601 |
Tfdp2 | -3110 |
Cdk6 | -2299 |
Tfdp1 | -2272 |
Cdk4 | 2011 |
Ccne1 | 2945 |
Cdk2 | 2990 |
Ccnd3 | 4933 |
GeneID | Gene Rank |
---|---|
Cdkn1a | -8508 |
E2f3 | -6816 |
Cdkn1b | -6707 |
Rb1 | -6356 |
Ccne2 | -5713 |
E2f2 | -5139 |
E2f1 | -4656 |
Ccnd2 | -4633 |
Ccnd1 | -4628 |
Cdkn1c | -4601 |
Tfdp2 | -3110 |
Cdk6 | -2299 |
Tfdp1 | -2272 |
Cdk4 | 2011 |
Ccne1 | 2945 |
Cdk2 | 2990 |
Ccnd3 | 4933 |
CASPASE ACTIVATION VIA DEPENDENCE RECEPTORS IN THE ABSENCE OF LIGAND
117 | |
---|---|
set | CASPASE ACTIVATION VIA DEPENDENCE RECEPTORS IN THE ABSENCE OF LIGAND |
setSize | 10 |
pANOVA | 0.0806 |
s.dist | -0.319 |
p.adjustANOVA | 0.48 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Casp3 | -7553 |
Dcc | -7423 |
Unc5b | -6259 |
Appl1 | -5628 |
Dapk2 | -4725 |
Casp9 | -4449 |
Maged1 | -3228 |
Unc5a | -2134 |
Dapk1 | 4834 |
Dapk3 | 5681 |
GeneID | Gene Rank |
---|---|
Casp3 | -7553 |
Dcc | -7423 |
Unc5b | -6259 |
Appl1 | -5628 |
Dapk2 | -4725 |
Casp9 | -4449 |
Maged1 | -3228 |
Unc5a | -2134 |
Dapk1 | 4834 |
Dapk3 | 5681 |
ASSEMBLY OF COLLAGEN FIBRILS AND OTHER MULTIMERIC STRUCTURES
74 | |
---|---|
set | ASSEMBLY OF COLLAGEN FIBRILS AND OTHER MULTIMERIC STRUCTURES |
setSize | 51 |
pANOVA | 8.18e-05 |
s.dist | 0.319 |
p.adjustANOVA | 0.00354 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Bmp1 | 7814 |
Col9a2 | 7757 |
Col27a1 | 7737 |
Col11a2 | 7685 |
Col12a1 | 7671 |
Col1a2 | 7492 |
Loxl3 | 7065 |
Col2a1 | 7012 |
Col5a2 | 6994 |
Col7a1 | 6814 |
Col5a3 | 6711 |
Col6a2 | 6291 |
Plec | 6231 |
Col3a1 | 5984 |
Col6a1 | 5959 |
Col4a2 | 5670 |
Ctsl | 4853 |
Pcolce | 4733 |
Col6a3 | 4621 |
Col15a1 | 4606 |
GeneID | Gene Rank |
---|---|
Bmp1 | 7814 |
Col9a2 | 7757 |
Col27a1 | 7737 |
Col11a2 | 7685 |
Col12a1 | 7671 |
Col1a2 | 7492 |
Loxl3 | 7065 |
Col2a1 | 7012 |
Col5a2 | 6994 |
Col7a1 | 6814 |
Col5a3 | 6711 |
Col6a2 | 6291 |
Plec | 6231 |
Col3a1 | 5984 |
Col6a1 | 5959 |
Col4a2 | 5670 |
Ctsl | 4853 |
Pcolce | 4733 |
Col6a3 | 4621 |
Col15a1 | 4606 |
Col9a3 | 3789 |
Col18a1 | 3050 |
Col24a1 | 2997 |
Cd151 | 2679 |
Col1a1 | 2599 |
Col4a5 | 2486 |
Col17a1 | 2390 |
Col6a5 | 2356 |
Mmp9 | 1954 |
Col4a3 | 1850 |
Dst | 1522 |
Lamb3 | 1434 |
Loxl1 | 1235 |
Col11a1 | 1221 |
Tll2 | 1166 |
Pxdn | 1009 |
Col14a1 | -449 |
Itgb4 | -468 |
Col8a1 | -758 |
Col4a1 | -844 |
Itga6 | -930 |
Col5a1 | -939 |
Ctsb | -1721 |
Ctss | -1913 |
Tll1 | -3733 |
Col9a1 | -4500 |
Lox | -4657 |
Col6a6 | -5128 |
Lamc2 | -5811 |
Col8a2 | -7555 |
Lama3 | -8651 |
SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE
1004 | |
---|---|
set | SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE |
setSize | 106 |
pANOVA | 1.55e-08 |
s.dist | 0.318 |
p.adjustANOVA | 1.81e-06 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Rps28 | 7597 |
Rps8 | 7450 |
Rpl26 | 7359 |
Rpl28 | 7124 |
Rpl38 | 6634 |
Rplp2 | 6619 |
Rps29 | 6609 |
Rpl35 | 6264 |
Rpl23a | 6154 |
Rps13 | 5967 |
Rps27a | 5852 |
Rps21 | 5714 |
Rps2 | 5693 |
Rpl23 | 5633 |
Rps9 | 5593 |
Rpl37a | 5545 |
Rps4x | 5533 |
Rps26 | 5531 |
Rpl37 | 5530 |
Rps19 | 5400 |
GeneID | Gene Rank |
---|---|
Rps28 | 7597 |
Rps8 | 7450 |
Rpl26 | 7359 |
Rpl28 | 7124 |
Rpl38 | 6634 |
Rplp2 | 6619 |
Rps29 | 6609 |
Rpl35 | 6264 |
Rpl23a | 6154 |
Rps13 | 5967 |
Rps27a | 5852 |
Rps21 | 5714 |
Rps2 | 5693 |
Rpl23 | 5633 |
Rps9 | 5593 |
Rpl37a | 5545 |
Rps4x | 5533 |
Rps26 | 5531 |
Rpl37 | 5530 |
Rps19 | 5400 |
Rpl6 | 5381 |
Rps18 | 5259 |
Rpl8 | 5182 |
Srp72 | 5118 |
Srpr | 4813 |
Rps27l | 4781 |
Rpl35a | 4749 |
Rplp1 | 4497 |
Rpl7a | 4489 |
Rpl24 | 4485 |
Rps25 | 4349 |
Rps3a1 | 4211 |
Sec11c | 4176 |
Rpl14 | 4027 |
Rpl32 | 4021 |
Rpl13 | 3983 |
Rps17 | 3940 |
Rps11 | 3934 |
Rpl18a | 3929 |
Uba52 | 3876 |
Srprb | 3806 |
Rpl12 | 3790 |
Rpl10 | 3755 |
Rps6 | 3747 |
Fau | 3714 |
Rpl30 | 3435 |
Rps16 | 3425 |
Srp19 | 3357 |
Rpl31 | 3267 |
Sec11a | 3241 |
Rps14 | 3149 |
Rps24 | 3077 |
Rps15 | 3027 |
Rpl21 | 3024 |
Rps10 | 2979 |
Rpl27a | 2892 |
Rpl36al | 2751 |
Rps7 | 2731 |
Rpl19 | 2668 |
Rpl3 | 2654 |
Rpsa | 2614 |
Rpl36 | 2443 |
Rpl11 | 2320 |
Rps5 | 2249 |
Rpl18 | 1869 |
Rpn2 | 1760 |
Sec61a2 | 1735 |
Rps27 | 1669 |
Rpl9 | 1493 |
Rpl5 | 1297 |
Rps12 | 1217 |
Sec61b | 1077 |
Srp68 | 978 |
Srp14 | 947 |
Rpl36a | 927 |
Rpl10a | 895 |
Rpl4 | 873 |
Rps23 | 872 |
Spcs1 | 764 |
Rpl22 | 732 |
Rpl27 | 529 |
Rpl13a | 406 |
Ssr4 | -188 |
Rps20 | -240 |
Rplp0 | -309 |
Rpl29 | -312 |
Rpl34 | -373 |
Rps3 | -775 |
Spcs2 | -1146 |
Rpl7 | -1359 |
Ddost | -1477 |
Rps15a | -1947 |
Sec61a1 | -2415 |
Rpl39 | -2430 |
Ssr2 | -2654 |
Rpl17 | -2699 |
Srp9 | -3121 |
Rpl15 | -3330 |
Rpl22l1 | -3372 |
Rpn1 | -4199 |
Sec61g | -4276 |
Ssr1 | -5676 |
Srp54a | -5701 |
Ssr3 | -5770 |
Spcs3 | -7102 |
Tram1 | -8162 |
FERTILIZATION
317 | |
---|---|
set | FERTILIZATION |
setSize | 12 |
pANOVA | 0.0567 |
s.dist | 0.318 |
p.adjustANOVA | 0.434 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Izumo4 | 7532 |
Catsperg1 | 6963 |
Ovgp1 | 6808 |
Catsperd | 6036 |
Adam21 | 4738 |
Catsperg2 | 4262 |
Catsper2 | 2372 |
Kcnu1 | 1703 |
Acr | 619 |
B4galt1 | -3841 |
Cd9 | -4535 |
Hvcn1 | -5555 |
GeneID | Gene Rank |
---|---|
Izumo4 | 7532 |
Catsperg1 | 6963 |
Ovgp1 | 6808 |
Catsperd | 6036 |
Adam21 | 4738 |
Catsperg2 | 4262 |
Catsper2 | 2372 |
Kcnu1 | 1703 |
Acr | 619 |
B4galt1 | -3841 |
Cd9 | -4535 |
Hvcn1 | -5555 |
POST CHAPERONIN TUBULIN FOLDING PATHWAY
722 | |
---|---|
set | POST CHAPERONIN TUBULIN FOLDING PATHWAY |
setSize | 17 |
pANOVA | 0.0236 |
s.dist | 0.317 |
p.adjustANOVA | 0.262 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Tubb4a | 7514 |
Tubb3 | 7125 |
Tubb6 | 5562 |
Arl2 | 4776 |
Tbcb | 4619 |
Tbca | 4002 |
Tuba1b | 3388 |
Tuba4a | 2983 |
Tbcd | 2217 |
Tubb4b | 1266 |
Tubb2a | 982 |
Tuba8 | 723 |
Tubb2b | 597 |
Tbcc | -144 |
Tuba1c | -502 |
Tuba1a | -1498 |
Tbce | -5313 |
GeneID | Gene Rank |
---|---|
Tubb4a | 7514 |
Tubb3 | 7125 |
Tubb6 | 5562 |
Arl2 | 4776 |
Tbcb | 4619 |
Tbca | 4002 |
Tuba1b | 3388 |
Tuba4a | 2983 |
Tbcd | 2217 |
Tubb4b | 1266 |
Tubb2a | 982 |
Tuba8 | 723 |
Tubb2b | 597 |
Tbcc | -144 |
Tuba1c | -502 |
Tuba1a | -1498 |
Tbce | -5313 |
TRANSPORT OF CONNEXONS TO THE PLASMA MEMBRANE
1129 | |
---|---|
set | TRANSPORT OF CONNEXONS TO THE PLASMA MEMBRANE |
setSize | 13 |
pANOVA | 0.0478 |
s.dist | 0.317 |
p.adjustANOVA | 0.387 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Tubb4a | 7514 |
Tubb3 | 7125 |
Tubb6 | 5562 |
Tuba1b | 3388 |
Tuba4a | 2983 |
Gjb2 | 1872 |
Tubb4b | 1266 |
Tubb2a | 982 |
Tuba8 | 723 |
Tubb2b | 597 |
Tuba1c | -502 |
Gja1 | -720 |
Tuba1a | -1498 |
GeneID | Gene Rank |
---|---|
Tubb4a | 7514 |
Tubb3 | 7125 |
Tubb6 | 5562 |
Tuba1b | 3388 |
Tuba4a | 2983 |
Gjb2 | 1872 |
Tubb4b | 1266 |
Tubb2a | 982 |
Tuba8 | 723 |
Tubb2b | 597 |
Tuba1c | -502 |
Gja1 | -720 |
Tuba1a | -1498 |
CD28 DEPENDENT VAV1 PATHWAY
123 | |
---|---|
set | CD28 DEPENDENT VAV1 PATHWAY |
setSize | 11 |
pANOVA | 0.0687 |
s.dist | -0.317 |
p.adjustANOVA | 0.449 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Pak1 | -7266 |
Rac1 | -7094 |
Cd86 | -6957 |
Cdc42 | -6790 |
Lck | -5243 |
Fyn | -4003 |
Pak3 | -3689 |
Grb2 | -3233 |
Pak2 | -2269 |
Cd80 | 5006 |
Vav1 | 7763 |
GeneID | Gene Rank |
---|---|
Pak1 | -7266 |
Rac1 | -7094 |
Cd86 | -6957 |
Cdc42 | -6790 |
Lck | -5243 |
Fyn | -4003 |
Pak3 | -3689 |
Grb2 | -3233 |
Pak2 | -2269 |
Cd80 | 5006 |
Vav1 | 7763 |
NOTCH2 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION
634 | |
---|---|
set | NOTCH2 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION |
setSize | 11 |
pANOVA | 0.0708 |
s.dist | -0.315 |
p.adjustANOVA | 0.449 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Hes1 | -8398 |
Creb1 | -7647 |
Rbpj | -6451 |
Fcer2a | -6103 |
Mamld1 | -6045 |
Maml1 | -5814 |
Maml2 | -3706 |
Ep300 | -801 |
Notch2 | 1342 |
Maml3 | 3509 |
Hes5 | 6550 |
GeneID | Gene Rank |
---|---|
Hes1 | -8398 |
Creb1 | -7647 |
Rbpj | -6451 |
Fcer2a | -6103 |
Mamld1 | -6045 |
Maml1 | -5814 |
Maml2 | -3706 |
Ep300 | -801 |
Notch2 | 1342 |
Maml3 | 3509 |
Hes5 | 6550 |
INSULIN PROCESSING
449 | |
---|---|
set | INSULIN PROCESSING |
setSize | 24 |
pANOVA | 0.00789 |
s.dist | -0.313 |
p.adjustANOVA | 0.132 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Exoc5 | -8628 |
Exoc6 | -8582 |
Slc30a5 | -8069 |
Pcsk2 | -7692 |
Exoc2 | -6922 |
Slc30a7 | -6645 |
Ero1a | -6454 |
Myrip | -5647 |
Kif5c | -5367 |
Cpe | -5080 |
Myo5a | -5057 |
Kif5b | -3438 |
Exoc1 | -3319 |
Ero1b | -2868 |
Rab27a | -2778 |
Kif5a | -2298 |
Pcsk1 | -1677 |
Slc30a6 | -1209 |
Vamp2 | -235 |
Exoc3 | 451 |
GeneID | Gene Rank |
---|---|
Exoc5 | -8628 |
Exoc6 | -8582 |
Slc30a5 | -8069 |
Pcsk2 | -7692 |
Exoc2 | -6922 |
Slc30a7 | -6645 |
Ero1a | -6454 |
Myrip | -5647 |
Kif5c | -5367 |
Cpe | -5080 |
Myo5a | -5057 |
Kif5b | -3438 |
Exoc1 | -3319 |
Ero1b | -2868 |
Rab27a | -2778 |
Kif5a | -2298 |
Pcsk1 | -1677 |
Slc30a6 | -1209 |
Vamp2 | -235 |
Exoc3 | 451 |
Stx1a | 1991 |
Exoc8 | 4506 |
Exoc4 | 4818 |
Exoc7 | 7290 |
RHO GTPASES ACTIVATE ROCKS
848 | |
---|---|
set | RHO GTPASES ACTIVATE ROCKS |
setSize | 19 |
pANOVA | 0.0184 |
s.dist | 0.313 |
p.adjustANOVA | 0.227 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Myl9 | 7852 |
Myh11 | 7708 |
Myh14 | 7493 |
Limk2 | 7421 |
Limk1 | 6628 |
Myh9 | 6341 |
Rhoc | 5770 |
Myl6 | 4895 |
Myl12b | 4330 |
Myh10 | 3504 |
Ppp1r12a | 1973 |
Ppp1r12b | 1690 |
Cfl1 | 3 |
Rock2 | -657 |
Rock1 | -1112 |
Rhoa | -3484 |
Rhob | -5010 |
Ppp1cb | -6009 |
Pak1 | -7266 |
GeneID | Gene Rank |
---|---|
Myl9 | 7852 |
Myh11 | 7708 |
Myh14 | 7493 |
Limk2 | 7421 |
Limk1 | 6628 |
Myh9 | 6341 |
Rhoc | 5770 |
Myl6 | 4895 |
Myl12b | 4330 |
Myh10 | 3504 |
Ppp1r12a | 1973 |
Ppp1r12b | 1690 |
Cfl1 | 3 |
Rock2 | -657 |
Rock1 | -1112 |
Rhoa | -3484 |
Rhob | -5010 |
Ppp1cb | -6009 |
Pak1 | -7266 |
PEXOPHAGY
687 | |
---|---|
set | PEXOPHAGY |
setSize | 11 |
pANOVA | 0.0755 |
s.dist | 0.31 |
p.adjustANOVA | 0.468 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Epas1 | 7120 |
Pex5 | 5945 |
Rps27a | 5852 |
Uba52 | 3876 |
Ubc | 3089 |
Ubb | 2615 |
Map1lc3b | 2184 |
Nbr1 | 1545 |
Sqstm1 | 727 |
Usp30 | -445 |
Atm | -8415 |
GeneID | Gene Rank |
---|---|
Epas1 | 7120 |
Pex5 | 5945 |
Rps27a | 5852 |
Uba52 | 3876 |
Ubc | 3089 |
Ubb | 2615 |
Map1lc3b | 2184 |
Nbr1 | 1545 |
Sqstm1 | 727 |
Usp30 | -445 |
Atm | -8415 |
TIGHT JUNCTION INTERACTIONS
1071 | |
---|---|
set | TIGHT JUNCTION INTERACTIONS |
setSize | 18 |
pANOVA | 0.0231 |
s.dist | -0.309 |
p.adjustANOVA | 0.26 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Crb3 | -8748 |
Prkci | -8596 |
Cldn3 | -8209 |
Cldn2 | -7403 |
Cldn1 | -6903 |
Pard6b | -5977 |
Pard6g | -5913 |
Pard6a | -5895 |
Cldn5 | -4581 |
Cldn10 | -3261 |
Pals1 | -2577 |
Cldn23 | -1580 |
Cldn12 | -1182 |
F11r | 462 |
Cldn11 | 1022 |
Pard3 | 3801 |
Cldn14 | 5169 |
Patj | 6287 |
GeneID | Gene Rank |
---|---|
Crb3 | -8748 |
Prkci | -8596 |
Cldn3 | -8209 |
Cldn2 | -7403 |
Cldn1 | -6903 |
Pard6b | -5977 |
Pard6g | -5913 |
Pard6a | -5895 |
Cldn5 | -4581 |
Cldn10 | -3261 |
Pals1 | -2577 |
Cldn23 | -1580 |
Cldn12 | -1182 |
F11r | 462 |
Cldn11 | 1022 |
Pard3 | 3801 |
Cldn14 | 5169 |
Patj | 6287 |
E2F MEDIATED REGULATION OF DNA REPLICATION
270 | |
---|---|
set | E2F MEDIATED REGULATION OF DNA REPLICATION |
setSize | 19 |
pANOVA | 0.0205 |
s.dist | -0.307 |
p.adjustANOVA | 0.236 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Orc3 | -8141 |
Ppp2cb | -8046 |
Orc5 | -7741 |
Orc4 | -6544 |
Rb1 | -6356 |
Orc6 | -5379 |
E2f1 | -4656 |
Tfdp2 | -3110 |
Mcm8 | -2883 |
Prim1 | -2873 |
Ppp2ca | -2528 |
Tfdp1 | -2272 |
Orc2 | -1709 |
Ppp2r1b | -941 |
Prim2 | -243 |
Ppp2r1a | 137 |
Pola2 | 980 |
Pola1 | 1144 |
Ppp2r3d | 4405 |
GeneID | Gene Rank |
---|---|
Orc3 | -8141 |
Ppp2cb | -8046 |
Orc5 | -7741 |
Orc4 | -6544 |
Rb1 | -6356 |
Orc6 | -5379 |
E2f1 | -4656 |
Tfdp2 | -3110 |
Mcm8 | -2883 |
Prim1 | -2873 |
Ppp2ca | -2528 |
Tfdp1 | -2272 |
Orc2 | -1709 |
Ppp2r1b | -941 |
Prim2 | -243 |
Ppp2r1a | 137 |
Pola2 | 980 |
Pola1 | 1144 |
Ppp2r3d | 4405 |
P75NTR RECRUITS SIGNALLING COMPLEXES
673 | |
---|---|
set | P75NTR RECRUITS SIGNALLING COMPLEXES |
setSize | 13 |
pANOVA | 0.0553 |
s.dist | 0.307 |
p.adjustANOVA | 0.427 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Myd88 | 6716 |
Ikbkb | 6593 |
Irak1 | 6335 |
Rps27a | 5852 |
Ngfr | 5541 |
Uba52 | 3876 |
Ubc | 3089 |
Ubb | 2615 |
Ngf | 2468 |
Sqstm1 | 727 |
Ripk2 | -3192 |
Traf6 | -3825 |
Prkci | -8596 |
GeneID | Gene Rank |
---|---|
Myd88 | 6716 |
Ikbkb | 6593 |
Irak1 | 6335 |
Rps27a | 5852 |
Ngfr | 5541 |
Uba52 | 3876 |
Ubc | 3089 |
Ubb | 2615 |
Ngf | 2468 |
Sqstm1 | 727 |
Ripk2 | -3192 |
Traf6 | -3825 |
Prkci | -8596 |
RNA POLYMERASE II TRANSCRIPTION TERMINATION
874 | |
---|---|
set | RNA POLYMERASE II TRANSCRIPTION TERMINATION |
setSize | 65 |
pANOVA | 1.88e-05 |
s.dist | 0.307 |
p.adjustANOVA | 0.000998 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Srsf4 | 7950 |
Zc3h11a | 7655 |
Snrpf | 7556 |
Srsf9 | 7513 |
Cpsf1 | 7480 |
Dhx38 | 7462 |
Pabpn1 | 7401 |
Srsf2 | 7200 |
Ddx39a | 7174 |
U2af1 | 7002 |
Alyref | 6744 |
Srsf6 | 6718 |
Cpsf4 | 6689 |
Srrm1 | 6369 |
Cpsf7 | 6324 |
Sympk | 5955 |
U2af1l4 | 5879 |
Ddx39b | 5833 |
Upf3b | 5809 |
Snrpb | 5626 |
GeneID | Gene Rank |
---|---|
Srsf4 | 7950 |
Zc3h11a | 7655 |
Snrpf | 7556 |
Srsf9 | 7513 |
Cpsf1 | 7480 |
Dhx38 | 7462 |
Pabpn1 | 7401 |
Srsf2 | 7200 |
Ddx39a | 7174 |
U2af1 | 7002 |
Alyref | 6744 |
Srsf6 | 6718 |
Cpsf4 | 6689 |
Srrm1 | 6369 |
Cpsf7 | 6324 |
Sympk | 5955 |
U2af1l4 | 5879 |
Ddx39b | 5833 |
Upf3b | 5809 |
Snrpb | 5626 |
U2af2 | 5490 |
Cstf3 | 5338 |
Srsf1 | 5312 |
Srsf11 | 5304 |
Rbm8a | 5293 |
Sarnp | 5125 |
Casc3 | 5113 |
Thoc6 | 4876 |
Eif4a3 | 4762 |
Thoc5 | 4461 |
Zfp473 | 4029 |
Cstf2 | 3654 |
Cpsf3 | 3473 |
Magohb | 3263 |
Slu7 | 3125 |
Srsf5 | 2852 |
Poldip3 | 2055 |
Rnps1 | 1880 |
Ncbp2 | 1712 |
Snrpg | 1226 |
Cstf1 | 1127 |
Thoc1 | 1115 |
Fip1l1 | 1013 |
Ncbp1 | 630 |
Papola | 592 |
Wdr33 | 242 |
Snrpe | 67 |
Chtop | -246 |
Thoc7 | -394 |
Lsm10 | -1318 |
Srsf7 | -1588 |
Magoh | -2121 |
Nudt21 | -2125 |
Cdc40 | -2471 |
Pcf11 | -2877 |
Srsf3 | -3336 |
Thoc2 | -3961 |
Lsm11 | -5020 |
Snrpd3 | -6248 |
Cstf2t | -7252 |
Clp1 | -7568 |
Thoc3 | -7896 |
Slbp | -7908 |
Cpsf2 | -8203 |
Fyttd1 | -8539 |
REDUCTION OF CYTOSOLIC CA LEVELS
781 | |
---|---|
set | REDUCTION OF CYTOSOLIC CA LEVELS |
setSize | 11 |
pANOVA | 0.0804 |
s.dist | -0.304 |
p.adjustANOVA | 0.48 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Slc8a1 | -8586 |
Calm1 | -6803 |
Atp2b4 | -6663 |
Atp2a2 | -5583 |
Atp2b1 | -4619 |
Sri | -3789 |
Atp2a3 | -1039 |
Slc8a2 | -990 |
Atp2b3 | -261 |
Atp2b2 | 400 |
Slc8a3 | 5314 |
GeneID | Gene Rank |
---|---|
Slc8a1 | -8586 |
Calm1 | -6803 |
Atp2b4 | -6663 |
Atp2a2 | -5583 |
Atp2b1 | -4619 |
Sri | -3789 |
Atp2a3 | -1039 |
Slc8a2 | -990 |
Atp2b3 | -261 |
Atp2b2 | 400 |
Slc8a3 | 5314 |
COLLAGEN DEGRADATION
165 | |
---|---|
set | COLLAGEN DEGRADATION |
setSize | 51 |
pANOVA | 0.000187 |
s.dist | 0.303 |
p.adjustANOVA | 0.00726 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Col13a1 | 7899 |
Col26a1 | 7772 |
Col9a2 | 7757 |
Col11a2 | 7685 |
Col12a1 | 7671 |
Col1a2 | 7492 |
Col16a1 | 7367 |
Col2a1 | 7012 |
Col5a2 | 6994 |
Col7a1 | 6814 |
Col5a3 | 6711 |
Col6a2 | 6291 |
Col3a1 | 5984 |
Col6a1 | 5959 |
Mmp19 | 5794 |
Col4a2 | 5670 |
Ctsl | 4853 |
Col6a3 | 4621 |
Col15a1 | 4606 |
Mmp15 | 4535 |
GeneID | Gene Rank |
---|---|
Col13a1 | 7899 |
Col26a1 | 7772 |
Col9a2 | 7757 |
Col11a2 | 7685 |
Col12a1 | 7671 |
Col1a2 | 7492 |
Col16a1 | 7367 |
Col2a1 | 7012 |
Col5a2 | 6994 |
Col7a1 | 6814 |
Col5a3 | 6711 |
Col6a2 | 6291 |
Col3a1 | 5984 |
Col6a1 | 5959 |
Mmp19 | 5794 |
Col4a2 | 5670 |
Ctsl | 4853 |
Col6a3 | 4621 |
Col15a1 | 4606 |
Mmp15 | 4535 |
Ctsk | 4049 |
Col9a3 | 3789 |
Adam9 | 3081 |
Col18a1 | 3050 |
Tmprss6 | 2868 |
Col1a1 | 2599 |
Col4a5 | 2486 |
Col17a1 | 2390 |
Col6a5 | 2356 |
Furin | 2198 |
Mmp9 | 1954 |
Col4a3 | 1850 |
Col11a1 | 1221 |
Phykpl | 93 |
Col14a1 | -449 |
Col19a1 | -590 |
Ctsd | -733 |
Col8a1 | -758 |
Adam17 | -843 |
Col4a1 | -844 |
Col5a1 | -939 |
Ctsb | -1721 |
Mmp14 | -3447 |
Col23a1 | -3675 |
Col9a1 | -4500 |
Col6a6 | -5128 |
Col25a1 | -5179 |
Mmp2 | -5447 |
Adam10 | -5747 |
Mmp11 | -7537 |
Col8a2 | -7555 |
LYSOSPHINGOLIPID AND LPA RECEPTORS
519 | |
---|---|
set | LYSOSPHINGOLIPID AND LPA RECEPTORS |
setSize | 12 |
pANOVA | 0.0702 |
s.dist | -0.302 |
p.adjustANOVA | 0.449 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Plppr5 | -8371 |
Plppr4 | -7718 |
S1pr1 | -6232 |
Plppr1 | -6119 |
S1pr2 | -5470 |
Lpar1 | -3230 |
Lpar2 | -2736 |
Plppr2 | -2017 |
S1pr5 | -1545 |
S1pr4 | -703 |
S1pr3 | 2254 |
Plppr3 | 6567 |
GeneID | Gene Rank |
---|---|
Plppr5 | -8371 |
Plppr4 | -7718 |
S1pr1 | -6232 |
Plppr1 | -6119 |
S1pr2 | -5470 |
Lpar1 | -3230 |
Lpar2 | -2736 |
Plppr2 | -2017 |
S1pr5 | -1545 |
S1pr4 | -703 |
S1pr3 | 2254 |
Plppr3 | 6567 |
CGMP EFFECTS
141 | |
---|---|
set | CGMP EFFECTS |
setSize | 15 |
pANOVA | 0.0432 |
s.dist | -0.301 |
p.adjustANOVA | 0.371 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Pde1a | -8709 |
Kcnma1 | -7641 |
Prkg1 | -6664 |
Kcnmb1 | -5795 |
Pde11a | -4241 |
Itpr1 | -3732 |
Pde2a | -3715 |
Pde9a | -2935 |
Kcnmb4 | -2881 |
Pde10a | -2223 |
Pde5a | -1891 |
Pde1b | 313 |
Kcnmb2 | 1566 |
Irag1 | 2032 |
Prkg2 | 2417 |
GeneID | Gene Rank |
---|---|
Pde1a | -8709 |
Kcnma1 | -7641 |
Prkg1 | -6664 |
Kcnmb1 | -5795 |
Pde11a | -4241 |
Itpr1 | -3732 |
Pde2a | -3715 |
Pde9a | -2935 |
Kcnmb4 | -2881 |
Pde10a | -2223 |
Pde5a | -1891 |
Pde1b | 313 |
Kcnmb2 | 1566 |
Irag1 | 2032 |
Prkg2 | 2417 |
SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL
1029 | |
---|---|
set | SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL |
setSize | 13 |
pANOVA | 0.0602 |
s.dist | 0.301 |
p.adjustANOVA | 0.447 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Ptgis | 7770 |
Slc27a2 | 6336 |
Rxra | 5870 |
Cyp27a1 | 5848 |
Acot8 | 5801 |
Hsd17b4 | 4959 |
Hsd3b7 | 4665 |
Scp2 | 1613 |
Slc27a5 | 716 |
Cyp7b1 | -698 |
Ncoa2 | -4279 |
Ncoa1 | -5337 |
Amacr | -5715 |
GeneID | Gene Rank |
---|---|
Ptgis | 7770 |
Slc27a2 | 6336 |
Rxra | 5870 |
Cyp27a1 | 5848 |
Acot8 | 5801 |
Hsd17b4 | 4959 |
Hsd3b7 | 4665 |
Scp2 | 1613 |
Slc27a5 | 716 |
Cyp7b1 | -698 |
Ncoa2 | -4279 |
Ncoa1 | -5337 |
Amacr | -5715 |
Here is the session info with all the versions of packages used.
sessionInfo()
## R version 4.1.3 (2022-03-10)
## Platform: x86_64-pc-linux-gnu (64-bit)
## Running under: Ubuntu 20.04.4 LTS
##
## Matrix products: default
## BLAS: /usr/lib/x86_64-linux-gnu/blas/libblas.so.3.9.0
## LAPACK: /usr/lib/x86_64-linux-gnu/lapack/liblapack.so.3.9.0
##
## locale:
## [1] LC_CTYPE=en_US.UTF-8 LC_NUMERIC=C
## [3] LC_TIME=en_US.UTF-8 LC_COLLATE=en_US.UTF-8
## [5] LC_MONETARY=en_US.UTF-8 LC_MESSAGES=en_US.UTF-8
## [7] LC_PAPER=en_US.UTF-8 LC_NAME=C
## [9] LC_ADDRESS=C LC_TELEPHONE=C
## [11] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=C
##
## attached base packages:
## [1] parallel stats4 stats graphics grDevices utils datasets
## [8] methods base
##
## other attached packages:
## [1] pkgload_1.2.4 GGally_2.1.2
## [3] gtools_3.9.2 echarts4r_0.4.3
## [5] beeswarm_0.4.0 vioplot_0.3.7
## [7] sm_2.2-5.7 kableExtra_1.3.4
## [9] topconfects_1.8.0 limma_3.48.3
## [11] eulerr_6.1.1 mitch_1.4.1
## [13] MASS_7.3-55 fgsea_1.18.0
## [15] gplots_3.1.1 DESeq2_1.32.0
## [17] SummarizedExperiment_1.22.0 Biobase_2.52.0
## [19] MatrixGenerics_1.4.3 matrixStats_0.61.0
## [21] GenomicRanges_1.44.0 GenomeInfoDb_1.28.4
## [23] IRanges_2.26.0 S4Vectors_0.30.2
## [25] BiocGenerics_0.38.0 reshape2_1.4.4
## [27] forcats_0.5.1 stringr_1.4.0
## [29] dplyr_1.0.8 purrr_0.3.4
## [31] readr_2.1.2 tidyr_1.2.0
## [33] tibble_3.1.6 ggplot2_3.3.5
## [35] tidyverse_1.3.1 zoo_1.8-9
##
## loaded via a namespace (and not attached):
## [1] readxl_1.3.1 backports_1.4.1 fastmatch_1.1-3
## [4] systemfonts_1.0.3 plyr_1.8.6 polylabelr_0.2.0
## [7] splines_4.1.3 BiocParallel_1.26.2 digest_0.6.29
## [10] htmltools_0.5.2 fansi_1.0.2 magrittr_2.0.2
## [13] memoise_2.0.1 tzdb_0.2.0 Biostrings_2.60.2
## [16] annotate_1.70.0 modelr_0.1.8 svglite_2.1.0
## [19] prettyunits_1.1.1 colorspace_2.0-2 blob_1.2.2
## [22] rvest_1.0.2 haven_2.4.3 xfun_0.29
## [25] crayon_1.4.2 RCurl_1.98-1.6 jsonlite_1.7.3
## [28] genefilter_1.74.1 survival_3.2-13 glue_1.6.1
## [31] polyclip_1.10-0 gtable_0.3.0 zlibbioc_1.38.0
## [34] XVector_0.32.0 webshot_0.5.2 DelayedArray_0.18.0
## [37] scales_1.1.1 DBI_1.1.2 Rcpp_1.0.8
## [40] progress_1.2.2 viridisLite_0.4.0 xtable_1.8-4
## [43] bit_4.0.4 htmlwidgets_1.5.4 httr_1.4.2
## [46] RColorBrewer_1.1-2 ellipsis_0.3.2 farver_2.1.0
## [49] pkgconfig_2.0.3 reshape_0.8.8 XML_3.99-0.8
## [52] sass_0.4.0 dbplyr_2.1.1 locfit_1.5-9.4
## [55] utf8_1.2.2 labeling_0.4.2 tidyselect_1.1.1
## [58] rlang_1.0.1 later_1.3.0 AnnotationDbi_1.54.1
## [61] munsell_0.5.0 cellranger_1.1.0 tools_4.1.3
## [64] cachem_1.0.6 cli_3.1.1 generics_0.1.2
## [67] RSQLite_2.2.9 broom_0.7.12 evaluate_0.14
## [70] fastmap_1.1.0 yaml_2.2.2 knitr_1.37
## [73] bit64_4.0.5 fs_1.5.2 caTools_1.18.2
## [76] KEGGREST_1.32.0 mime_0.12 xml2_1.3.3
## [79] compiler_4.1.3 rstudioapi_0.13 png_0.1-7
## [82] reprex_2.0.1 geneplotter_1.70.0 bslib_0.3.1
## [85] stringi_1.7.6 highr_0.9 desc_1.4.0
## [88] lattice_0.20-45 Matrix_1.4-0 vctrs_0.3.8
## [91] pillar_1.7.0 lifecycle_1.0.1 jquerylib_0.1.4
## [94] data.table_1.14.2 bitops_1.0-7 httpuv_1.6.5
## [97] R6_2.5.1 promises_1.2.0.1 KernSmooth_2.23-20
## [100] gridExtra_2.3 assertthat_0.2.1 rprojroot_2.0.2
## [103] withr_2.4.3 GenomeInfoDbData_1.2.6 hms_1.1.1
## [106] grid_4.1.3 rmarkdown_2.11 shiny_1.7.1
## [109] lubridate_1.8.0
END of report